Exhibit 2.1
EXECUTION VERSION
MERGER
AGREEMENT AND PLAN OF REORGANIZATION
BY
AND AMONG
HENNESSY
CAPITAL ACQUISITION CORP. IV,
HCAC IV
FIRST MERGER SUB, LTD.,
HCAC
IV SECOND MERGER SUB, LLC
AND
CANOO
HOLDINGS LTD.
DATED
AS OF AUGUST 17, 2020
Table
of Contents
| |
|
Page |
| |
|
|
| ARTICLE I DEFINITIONS |
3 |
| |
SECTION
1.01 |
Certain
Definitions |
3 |
| |
SECTION
1.02 |
Further
Definitions |
12 |
| |
SECTION
1.03 |
Construction. |
15 |
| ARTICLE II AGREEMENT AND
PLAN OF MERGER |
16 |
| |
SECTION
2.01 |
The
Mergers |
16 |
| |
SECTION
2.02 |
Effective
Times; Closing. |
16 |
| |
SECTION
2.03 |
Effect
of the Mergers |
17 |
| |
SECTION
2.04 |
Governing
Documents. |
17 |
| |
SECTION
2.05 |
Directors
and Officers. |
17 |
| ARTICLE III CONVERSION OF
SECURITIES; EXCHANGE OF COMPANY SECURITIES |
18 |
| |
SECTION
3.01 |
Conversion
of Securities. |
18 |
| |
SECTION
3.02 |
Exchange
of Company Securities. |
20 |
| |
SECTION
3.03 |
Register
of Members |
22 |
| |
SECTION
3.04 |
Payment
of Expenses. |
22 |
| |
SECTION
3.05 |
Dissenters’
Rights. |
23 |
| |
SECTION
3.06 |
Earnout
Shares |
23 |
| ARTICLE IV REPRESENTATIONS
AND WARRANTIES OF THE COMPANY |
24 |
| |
SECTION
4.01 |
Organization
and Qualification; Subsidiaries. |
24 |
| |
SECTION
4.02 |
Certificate
of Incorporation and Bylaws |
24 |
| |
SECTION
4.03 |
Capitalization. |
25 |
| |
SECTION
4.04 |
Authority
Relative to This Agreement |
26 |
| |
SECTION
4.05 |
No
Conflict; Required Filings and Consents. |
27 |
| |
SECTION
4.06 |
Permits;
Compliance |
27 |
| |
SECTION
4.07 |
Financial
Statements. |
28 |
| |
SECTION
4.08 |
Absence
of Certain Changes or Events |
30 |
| |
SECTION
4.09 |
Absence
of Litigation |
30 |
| |
SECTION
4.10 |
Employee
Benefit Plans. |
30 |
| |
SECTION
4.11 |
Labor
and Employment Matters. |
32 |
| |
SECTION
4.12 |
Real
Property; Title to Assets. |
33 |
Table of Contents
(continued)
| |
|
|
Page |
| |
|
|
|
| |
SECTION
4.13 |
Intellectual
Property. |
34 |
| |
SECTION
4.14 |
Taxes. |
37 |
| |
SECTION
4.15 |
Environmental
Matters |
39 |
| |
SECTION
4.16 |
Material
Contracts. |
39 |
| |
SECTION
4.17 |
Insurance. |
41 |
| |
SECTION
4.18 |
Board
Approval; Vote Required |
42 |
| |
SECTION
4.19 |
Certain
Business Practices. |
42 |
| |
SECTION
4.20 |
Interested
Party Transactions |
43 |
| |
SECTION
4.21 |
Exchange
Act |
43 |
| |
SECTION
4.22 |
Brokers |
43 |
| |
SECTION
4.23 |
Exclusivity
of Representations and Warranties |
43 |
| ARTICLE V REPRESENTATIONS
AND WARRANTIES OF HCAC, FIRST MERGER SUB AND SECOND MERGER SUB |
44 |
| |
SECTION
5.01 |
Corporate
Organization. |
44 |
| |
SECTION
5.02 |
Governing
Documents |
44 |
| |
SECTION
5.03 |
Capitalization. |
44 |
| |
SECTION
5.04 |
Authority
Relative to This Agreement |
46 |
| |
SECTION
5.05 |
No
Conflict; Required Filings and Consents. |
46 |
| |
SECTION
5.06 |
Compliance |
47 |
| |
SECTION
5.07 |
SEC
Filings; Financial Statements; Sarbanes-Oxley. |
47 |
| |
SECTION
5.08 |
Absence
of Certain Changes or Events |
49 |
| |
SECTION
5.09 |
Absence
of Litigation |
49 |
| |
SECTION
5.10 |
Board
Approval; Vote Required. |
50 |
| |
SECTION
5.11 |
No
Prior Operations of First Merger Sub and Second Merger Sub |
50 |
| |
SECTION
5.12 |
Brokers |
50 |
| |
SECTION
5.13 |
HCAC
Trust Fund |
51 |
| |
SECTION
5.14 |
Employees |
51 |
| |
SECTION
5.15 |
Taxes. |
51 |
| |
SECTION
5.16 |
Registration
and Listing |
53 |
| |
SECTION
5.17 |
HCAC’s,
First Merger Subs’ and Second Merger Sub’s Investigation and Reliance |
54 |
Table of Contents
(continued)
| |
|
|
Page |
| |
|
|
|
| ARTICLE VI CONDUCT OF BUSINESS
PENDING THE MERGER |
54 |
| |
SECTION
6.01 |
Conduct
of Business by the Company Pending the Mergers. |
54 |
| |
SECTION
6.02 |
Conduct
of Business by HCAC, First Merger Sub, and Second Merger Sub Pending the Mergers |
57 |
| |
SECTION
6.03 |
Claims
Against Trust Account |
59 |
| ARTICLE VII ADDITIONAL AGREEMENTS |
60 |
| |
SECTION
7.01 |
Proxy
Statement; Registration Statement. |
60 |
| |
SECTION
7.02 |
HCAC
Stockholders’ Meeting; First Merger Sub Stockholder’s Approval and Second Merger Sub Shareholder’s Approval. |
61 |
| |
SECTION
7.03 |
Requisite
Approval |
62 |
| |
SECTION
7.04 |
Access
to Information; Confidentiality. |
62 |
| |
SECTION
7.05 |
Exclusivity |
63 |
| |
SECTION
7.06 |
Employee
Benefits Matters. |
64 |
| |
SECTION
7.07 |
Directors’
and Officers’ Indemnification |
65 |
| |
SECTION
7.08 |
Notification
of Certain Matters |
66 |
| |
SECTION
7.09 |
Further
Action; Reasonable Best Efforts. |
66 |
| |
SECTION
7.10 |
Public
Announcements |
67 |
| |
SECTION
7.11 |
Tax
Matters |
67 |
| |
SECTION
7.12 |
Stock
Exchange Listing |
67 |
| |
SECTION
7.13 |
Antitrust. |
68 |
| |
SECTION
7.14 |
PCAOB
Audited Financials |
69 |
| |
SECTION
7.15 |
Trust
Account |
69 |
| |
SECTION
7.16 |
Directors |
69 |
| |
SECTION
7.17 |
Extension |
69 |
| |
SECTION
7.18 |
Company
Share Purchase Warrant |
69 |
| |
SECTION
7.19 |
Amended
and Restated Voting and Preemptive Rights Agreement |
69 |
| |
SECTION
7.20 |
Lock-Up
Agreements |
70 |
| ARTICLE VIII CONDITIONS TO
THE MERGER |
70 |
| |
SECTION
8.01 |
Conditions
to the Obligations of Each Party |
70 |
| |
SECTION
8.02 |
Conditions
to the Obligations of HCAC, First Merger Sub, and Second Merger Sub |
71 |
| |
SECTION
8.03 |
Conditions
to the Obligations of the Company |
72 |
Table of Contents
(continued)
| |
|
|
Page |
| |
|
|
|
| ARTICLE IX TERMINATION, AMENDMENT
AND WAIVER |
74 |
| |
SECTION
9.01 |
Termination |
74 |
| |
SECTION
9.02 |
Effect
of Termination |
75 |
| |
SECTION
9.03 |
Amendment |
75 |
| |
SECTION
9.04 |
Waiver |
75 |
| ARTICLE X GENERAL PROVISIONS |
75 |
| |
SECTION
10.01 |
Notices |
75 |
| |
SECTION
10.02 |
Nonsurvival
of Representations, Warranties and Covenants |
76 |
| |
SECTION
10.03 |
Severability |
76 |
| |
SECTION
10.04 |
Entire
Agreement; Assignment |
77 |
| |
SECTION
10.05 |
Parties
in Interest |
77 |
| |
SECTION
10.06 |
Governing
Law |
77 |
| |
SECTION
10.07 |
Waiver
of Jury Trial |
78 |
| |
SECTION
10.08 |
Headings |
78 |
| |
SECTION
10.09 |
Counterparts;
Electronic Delivery |
78 |
| |
SECTION
10.10 |
Specific
Performance |
78 |
| |
SECTION
10.11 |
No
Recourse |
78 |
| |
SECTION
10.12 |
Waiver
of Conflicts |
79 |
INDEX
OF ANNEX AND EXHIBITS
| Annex
I |
Earnout Merger Consideration |
Annex-1 |
| |
|
|
| Exhibit A |
Form of Amended and
Restated Registration Rights Agreement |
A-1 |
| Exhibit B |
Form of Lock-Up Agreement |
B-1 |
| Exhibit C |
Form of Third Amended
and Restated Charter of the Surviving Corporation |
C-1 |
| Exhibit D |
Form of Second Amended
and Restated Certificate of Incorporation of HCAC |
D-1 |
MERGER
AGREEMENT AND PLAN OF REORGANIZATION
This
MERGER AGREEMENT AND PLAN OF REORGANIZATION, dated as of August 17, 2020 (this “Agreement”), is made by and
among Hennessy Capital Acquisition Corp. IV, a Delaware corporation (“HCAC”), HCAC IV First Merger Sub, Ltd.,
an exempted company incorporated with limited liability in the Cayman Islands and a direct, wholly owned subsidiary of HCAC (“First
Merger Sub”), HCAC IV Second Merger Sub, LLC, a Delaware limited liability company and a direct, wholly owned subsidiary
of HCAC (“Second Merger Sub”), and Canoo Holdings Ltd., an exempted company incorporated with limited liability
in the Cayman Islands (the “Company”).
RECITALS
WHEREAS,
upon the terms and subject to the conditions of this Agreement and in accordance with the Companies Law (2020 Revision), as amended,
of the Cayman Islands (the “Cayman Companies Law”), and the Delaware Limited Liability Company Act (the “DLLCA”),
HCAC and the Company will enter into a business combination transaction pursuant to which: (a) First Merger Sub will merge with
and into the Company (the “First Merger”), with the Company surviving the First Merger as a wholly owned subsidiary
of HCAC (the Company, in its capacity as the surviving corporation of the First Merger, is sometimes referred to as the “Surviving
Corporation”); and (b) as soon as practicable, but in any event within 10 days following the First Merger and as part
of the same overall transaction as the First Merger, the Surviving Corporation will merge with and into Second Merger Sub (the
“Second Merger” and, together with the First Merger, the “Mergers”), with Second Merger
Sub being the surviving entity of the Second Merger (Second Merger Sub, in its capacity as the surviving entity of the Second
Merger, is sometimes referred to herein as the “Surviving Entity”);
WHEREAS,
the Board of Directors of the Company (the “Company Board”) has unanimously (a) determined that the Mergers
are fair to, and in the best interests of, the Company and has approved and adopted this Agreement and declared its advisability
and approved the Mergers and the other transactions contemplated by this Agreement, and (b) has recommended the approval
and adoption of this Agreement and the Mergers by the shareholders of the Company;
WHEREAS,
the Board of Directors of HCAC (the “HCAC Board”) has (a) approved and adopted this Agreement and declared
its advisability and approved the payment of the Per Share Merger Consideration to the shareholders of the Company pursuant to
this Agreement and the other transactions contemplated by this Agreement, and (b) recommended the approval and adoption of this
Agreement and the Transactions by the stockholders of HCAC;
WHEREAS,
the Board of Directors of First Merger Sub (the “First Merger Sub Board”) and the Board of Managers of Second
Merger Sub (the “Second Merger Sub Board”) have each (a) determined that the Mergers are fair to, and
in the best interests of, First Merger Sub and Second Merger Sub, respectively, and their sole shareholder or member, respectively
and approved and adopted this Agreement and declared its advisability and approved the Mergers and the other transactions contemplated
by this Agreement, and (b) recommended the approval and adoption of this Agreement and the Mergers by the sole shareholder or
member of First Merger Sub and Second Merger Sub, respectively;
WHEREAS,
HCAC, the Company and the Requisite Shareholders, concurrently with the execution and delivery of this Agreement, are entering
into Shareholder Support Agreements, dated as of the date hereof (the “Shareholder Support Agreements”), providing
that, among other things, the Requisite Shareholders will vote their Company Shares in favor of this Agreement, the Merger and
the other Transactions;
WHEREAS,
in connection with the Closing, HCAC, certain shareholders of the Company and certain stockholders of HCAC, shall enter into an
Amended and Restated Registration Rights Agreement (the “Registration Rights Agreement”) substantially in the
form attached hereto as Exhibit A;
WHEREAS,
in connection with the Closing, HCAC and certain shareholders of the Company shall enter into Lock-Up Agreements (the “Lock-Up
Agreements”) substantially in the form attached hereto as Exhibit B;
WHEREAS,
the officers and directors of HCAC and Hennessy Capital Partners IV LLC (the “Sponsor”) have entered into a
Voting and Support Agreement, dated as of the date hereof (the “Sponsor Support Agreement”), pursuant to which,
among other things, the persons indicated on the signature pages thereof have agreed to vote their HCAC Common Stock in favor
of this Agreement, the Mergers and the other Transactions;
WHEREAS,
HCAC shall enter into subscription agreements (the “Subscription Agreements”) with certain investors, pursuant
to which such investors, upon the terms and subject to the conditions set forth therein, shall purchase shares of HCAC Common
Stock at $10.00 per share in a private placement or placements (the “Private Placements”), to be consummated
immediately prior to the consummation of the Transactions;
WHEREAS,
concurrently with the execution of this Agreement, HCAC and the Sponsor are entering into a Sponsor Warrant Exchange and Share
Cancellation Agreement (the “Exchange and Cancellation Agreement”), whereby the Sponsor has agreed, among other
things, that immediately prior to the Closing, subject to the terms and conditions set forth therein, (a) the Sponsor shall
exchange 11,739,394 HCAC Warrants for 2,347,879 newly issued shares of HCAC Class B Common Stock, and (b) the Sponsor shall
transfer to HCAC for cancellation, the Sponsor Cancelled Shares; and
WHEREAS,
for United States federal and applicable state income Tax purposes, it is intended that the First Merger and the Second Merger,
taken together shall be viewed as a single integrated transaction that shall qualify as a reorganization within the meaning of
Section 368(a) of the Code (the “Intended Tax Treatment”).
NOW,
THEREFORE, in consideration of the foregoing and the mutual covenants and agreements herein contained, and intending to be legally
bound hereby, the parties hereto hereby agree as follows:
ARTICLE
I
DEFINITIONS
SECTION
1.01 Certain Definitions. For purposes of this Agreement:
“A
Series Preference Shares” means the preference shares of the Company, par value $0.0001 per share, designated as A Series
Preference Shares in the Company Charter.
“A-1
Series Preference Shares” means the preference shares of the Company, par value $0.0001 per share, designated as A-1
Series Preference Shares in the Company Charter.
“Action”
means any litigation, suit, claim, action, proceeding, audit or investigation by or before any Governmental Authority.
“affiliate”
of a specified person means a person who, directly or indirectly through one or more intermediaries, controls, is controlled by,
or is under common control with, such specified person.
“Ancillary
Agreements” means the Shareholder Support Agreements, the Sponsor Support Agreement, the Registration Rights Agreement,
the Lock-Up Agreements, the Exchange and Cancellation Agreement and all other agreements, certificates and instruments executed
and delivered by HCAC, First Merger Sub, Second Merger Sub or the Company in connection with the Transactions and specifically
contemplated by this Agreement.
“Anti-Corruption
Laws” means, as applicable (i) the U.S. Foreign Corrupt Practices Act of 1977, as amended, (ii) the UK
Bribery Act 2010, (iii) anti-bribery legislation promulgated by the European Union and implemented by its member states,
(iv) legislation implementing the OECD Convention on Combating Bribery of Foreign Public Officials in International Business
Transactions, and (v) similar legislation applicable to the Company or any Company Subsidiary from time to time.
“Business
Data” means all business information and data, including Personal Information (whether of employees, contractors, consultants,
customers, consumers, or other persons and whether in electronic or any other form or medium) that is accessed, collected, used,
stored, shared, distributed, transferred, disclosed, destroyed, disposed of or otherwise processed by any of the Business Systems
or otherwise in the course of the conduct of the business of the Company or any Company Subsidiaries.
“Business
Day” means any day on which the principal offices of the SEC in Washington, D.C. are open to accept filings, or, in
the case of determining a date when any payment is due, any day on which banks are not required or authorized to close in New
York, NY; provided, that banks shall not be deemed to be authorized or obligated to be closed due to a “shelter in
place” or similar closure of physical branch locations at the direction of any Governmental Authority if such banks’
electronic funds transfer systems (including for wire transfers) are open for use by customers on such day.
“Business
Systems” means all Software, firmware, middleware, equipment, workstations, routers, hubs, computer hardware (whether
general or special purpose), electronic data processors, databases, communications, telecommunications, networks, interfaces,
platforms, servers, peripherals, and computer systems, including any outsourced systems and processes, and any Software and systems
provided via the cloud or “as a service,” that are owned or used in the conduct of the business of the Company or
any Company Subsidiaries.
“CCC”
means the Corporations Code of the State of California.
“Company
Charter” means the Second Amended and Restated Memorandum and Articles of Association of the Company, adopted by special
resolution dated August 16, 2020, as may be amended, restated or otherwise modified from time to time.
“Company
IP” means, collectively, all Company Owned IP and Company Licensed IP.
“Company
Licensed IP” means all Intellectual Property rights owned or purported to be owned by a third party and licensed to
the Company or any Company Subsidiary or that the Company or any Company Subsidiary otherwise has a right to use.
“Company
Material Adverse Effect” means any event, circumstance, change or effect that, individually or in the aggregate with
any one or more other events, circumstances, changes and effects, (i) is or would reasonably be expected to be materially
adverse to the business, financial condition, assets and liabilities or results of operations of the Company and the Company Subsidiaries
taken as a whole or (ii) would prevent, materially delay or materially impede the performance by the Company of its obligations
under this Agreement or the consummation of the Mergers or any of the other Transactions; provided, however, that
none of the following shall be deemed to constitute, alone or in combination, or be taken into account in the determination of
whether, there has been or will be a Company Material Adverse Effect: (a) any change or proposed change in or change in the
interpretation of any Law or GAAP; (b) events or conditions generally affecting the industries or geographic areas in which
the Company and the Company Subsidiaries operate; (c) any downturn in general economic conditions, including changes in the
credit, debt, securities, financial or capital markets (including changes in interest or exchange rates, prices of any security
or market index or commodity or any disruption of such markets); (d) any geopolitical conditions, outbreak of hostilities,
acts of war, sabotage, civil unrest, cyberterrorism, terrorism, military actions, earthquakes, volcanic activity, hurricanes,
tsunamis, tornadoes, floods, mudslides, wild fires or other natural disasters, weather conditions, epidemics, pandemics or other
outbreaks of illness or public health events and other force majeure events (including any escalation or general worsening of
any of the foregoing); (e) any actions taken or not taken by the Company or the Company Subsidiaries as required by this
Agreement or any Ancillary Agreement; (f) any event, circumstance, change or effect attributable to the announcement or execution,
pendency, negotiation or consummation of the Mergers or any of the other Transactions (including the impact thereof on relationships
with customers, suppliers, employees or Governmental Authorities) (provided that this clause (f) shall not
apply to any representations or warranty set forth in Section 4.04 or Section 4.05 but subject to any disclosures set forth in
Section 4.04 or Section 4.05 of the Company Disclosure Schedule); (g) any failure to meet any projections, forecasts, guidance,
estimates, milestones, budgets or financial or operating predictions of revenue, earnings, cash flow or cash position (provided
that this clause (g) shall not prevent a determination that any event, circumstance, change or effect underlying
such failure has resulted in a Company Material Adverse Effect) or (h) any actions taken, or failures to take action, or
such other changes or events, in each case, which HCAC has requested or to which it has consented or which actions are contemplated
by this Agreement, except in the cases of clauses (a) through (d), to the extent that the Company and the Company
Subsidiaries, taken as a whole, are disproportionately and adversely affected thereby as compared with other participants in the
industries in which the Company and the Company Subsidiaries operate.
“Company
Merger Shares” means a number of shares of HCAC Class A Common Stock equal to the quotient determined by dividing (a) 1,750,000,000
by (b) 10.00.
“Company
Option Plan” means the EVelozcity Holdings Ltd. 2018 Share Option and Grant Plan, as such may have been amended, supplemented
or modified from time to time.
“Company
Options” means all outstanding options to purchase Company Ordinary Shares, whether or not exercisable and whether or
not vested, immediately prior to the Closing under the Company Option Plan or otherwise.
“Company
Ordinary Share Purchase Warrant” means the Ordinary Share Purchase Warrant issued pursuant to the Domain Name &
Intellectual Property Purchase Agreement, dated April 30, 2019, between the Company and the Informatique-MTF SA.
“Company
Ordinary Shares” means the ordinary shares of the Company, par value of $0.0001 per share, designated as ordinary shares
in the Company Charter.
“Company
Outstanding Shares” means the total number of Company Ordinary Shares outstanding immediately prior to the Effective
Time, expressed on a fully diluted and as-converted to Company Ordinary Shares basis, and including, without limitation or duplication,
(i) the number of Company Ordinary Shares subject to unexpired, issued and outstanding Company Options, (ii) the Company
Restricted Shares, (iii) the number of Company Ordinary Shares issuable upon exercising the Company Ordinary Share Purchase Warrant,
(iv) the number of Company Ordinary Shares issuable upon the conversion of the Company Preferred Shares pursuant to Section
3.01(a) and (v) the number of Company Ordinary Shares subject to unexpired, issued and outstanding Company RSUs or any other
Company Share Awards.
“Company
Owned IP” means all Intellectual Property rights owned or purported to be owned by the Company or any of the Company
Subsidiaries.
“Company
Preferred Shares” means the A Series Preference Shares and the A-1 Series Preference Shares.
“Company
Restricted Shares” means the Company Ordinary Shares subject to forfeiture restrictions or other restrictions issued
pursuant to an award granted under Section 6 of the Company Option Plan or otherwise.
“Company
RSUs” means all outstanding restricted stock units to acquire Company Ordinary Shares immediately prior to the Closing
issued pursuant to an award granted under the Company Option Plan or otherwise.
“Company
Securities” means the Company Ordinary Shares, the Company Preferred Shares, the Company Options, the Company Restricted
Shares, the Company RSUs and the Company Ordinary Share Purchase Warrant.
“Company
Shares” means the Company Ordinary Shares (including the Company Restricted Shares, as applicable) and the Company Preferred
Shares.
“Confidential
Information” means any information, knowledge or data concerning the businesses and affairs of the Company, the Company
Subsidiaries, or any Suppliers or customers of the Company or any Company Subsidiaries or HCAC or its subsidiaries (as applicable)
that is not already generally available to the public, including any Intellectual Property rights.
“control”
(including the terms “controlled by” and “under common control with”) means the possession,
directly or indirectly, or as trustee or executor, of the power to direct or cause the direction of the management and policies
of a person, whether through the ownership of voting securities, as trustee or executor, by contract or otherwise.
“Disabling
Devices” means Software, viruses, time bombs, logic bombs, trojan horses, trap doors, back doors, spyware, malware,
worms, other computer instructions, intentional devices, techniques, other technology, disabling codes, instructions, or other
similar code or software routines or components that are designed to threaten, infect, assault, vandalize, defraud, disrupt, damage,
disable, delete, maliciously encumber, hack into, incapacitate, perform unauthorized modifications, infiltrate or slow or shut
down a computer system or data, software, system, network, other device, or any component of such computer system, including any
such device affecting system security or compromising or disclosing user data in an unauthorized manner, other than those incorporated
by the Company or the applicable third party intentionally to protect Company IP, or Business Systems from misuse.
“Earnout
Shares” means the shares of HCAC Class A Common Stock that may be issued pursuant to Section 3.06 and Annex
I.
“Employee
Benefit Plan” means each “employee benefit plan,” as defined in Section 3(3) of ERISA (whether or not
subject to ERISA), any nonqualified deferred compensation plan subject to Section 409A of the Code, and each other retirement,
health, welfare, cafeteria, bonus, commission, stock option, stock purchase, restricted stock, other equity or equity-based compensation,
performance award, incentive, deferred compensation, retiree medical or life insurance, death or disability benefit, supplemental
retirement, severance, retention, change in control, employment, consulting, fringe benefit, sick pay, vacation, and similar plan,
program, policy, practice, agreement, or arrangement, whether written or unwritten.
“Environmental
Laws” means any United States federal, state or local or non-United States Laws relating to: (i) releases or threatened
releases of, or exposure of any person to, Hazardous Substances or materials containing Hazardous Substances; (ii) the manufacture,
handling, transport, use, treatment, storage or disposal of Hazardous Substances or materials containing Hazardous Substances;
or (iii) pollution or protection of the environment, natural resources or human health and safety.
“ERISA”
means the Employee Retirement Income Security Act of 1974.
“Ex-Im
Laws” means all applicable Laws relating to export, re-export, transfer, and import controls, including the U.S. Export
Administration Regulations, the customs and import Laws administered by U.S. Customs and Border Protection, and the EU Dual
Use Regulation.
“Exchange
Act” means the Exchange Act of 1934, as amended.
“Exchange
Ratio” means the following ratio: the quotient obtained by dividing (i) the Company Merger Shares by (ii) the
Company Outstanding Shares.
“Existing
Permitted Indebtedness” means the indebtedness of the Company identified on Section 1.01(D) of the Company Disclosure
Schedules.
“First
Merger Sub Organizational Documents” means the certificate of incorporation and memorandum and articles of association
of First Merger Sub, as amended, modified or supplemented from time to time.
“Formation
Date” means November 14, 2017.
“Hazardous
Substance(s)” means: (i) any substances, wastes, or materials defined, identified or regulated as hazardous or
toxic or as a pollutant or a contaminant under any Environmental Law; (ii) petroleum and petroleum products, including crude
oil and any fractions thereof; (iii) natural gas, synthetic gas, and any mixtures thereof; (iv) polychlorinated biphenyls,
per- and polyfluoroalkyl substances, asbestos and radon; and (v) any other substance, material or waste regulated by, or
for which standards of care may be imposed under any Environmental Law.
“HCAC
Certificate of Incorporation” means the Amended and Restated HCAC Certificate of Incorporation, dated as of February
28, 2019.
“HCAC
Material Adverse Effect” means any event, circumstance, change or effect that, individually or in the aggregate with
any one or more other events, circumstances, changes and effects, (i) is or would reasonably be expected to be materially
adverse to the business, financial condition, assets and liabilities or results of operations of HCAC; or (ii) would prevent,
materially delay or materially impede the performance by HCAC, First Merger Sub or Second Merger Sub of their respective obligations
under this Agreement or the consummation of the Mergers or any of the other Transactions; provided, however, that
none of the following shall be deemed to constitute, alone or in combination, or be taken into account in the determination of
whether, there has been or will be a HCAC Material Adverse Effect: (a) any change or proposed change in or change in the
interpretation of any Law or GAAP; (b) events or conditions generally affecting the industries or geographic areas in which
HCAC operates; (c) any downturn in general economic conditions, including changes in the credit, debt, securities, financial
or capital markets (including changes in interest or exchange rates, prices of any security or market index or commodity or any
disruption of such markets); (d) any geopolitical conditions, outbreak of hostilities, acts of war, sabotage, civil unrest,
cyberterrorism, terrorism, military actions, earthquakes, volcanic activity, hurricanes, tsunamis, tornadoes, floods, mudslides,
wild fires or other natural disasters, weather conditions, epidemics, pandemics or other outbreaks of illness or public health
events and other force majeure events (including any escalation or general worsening of any of the foregoing); (e) any actions
taken or not taken by HCAC as required by this Agreement or any Ancillary Agreement, (f) any event, circumstance change or
effect attributable to the announcement or execution, pendency, negotiation or consummation of the Mergers or any of the other
Transactions or (g) any actions taken, or failures to take action, or such other changes or events, in each case, which the
Company has requested or to which it has consented or which actions are contemplated by this Agreement, except in the cases of
clauses (a) through (c), to the extent that HCAC is disproportionately and adversely affected thereby as compared
with other participants in the industry in which HCAC operate.
“HCAC
Organizational Documents” means the HCAC Certificate of Incorporation and bylaws, in each case as amended, modified
or supplemented from time to time.
“HCAC
Units” means the units issued in the IPO or the overallotment consisting of one (1) share of HCAC Class A Common Stock
and three-quarters (3/4) of one (1) HCAC Warrant.
“HIPAA”
means the Health Insurance Portability and Accountability Act of 1996 and its implementing regulations, including as amended by
the Health Information Technology for Clinical Health Act provisions of the American Recovery and Reinvestment Act of 2009, Pub.
Law No. 111-5 and its implementing regulations.
“HSR
Act” means the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended.
“Intellectual
Property” means (i) patents, patent applications (including provisional and non-provisional applications) and patent
disclosures, together with all reissues, continuations, continuations-in-part, divisionals, revisions, extensions or reexaminations
thereof, (ii) trademarks and service marks, trade dress, logos, trade names, corporate names, brands, slogans, and other
source identifiers together with all translations, adaptations, derivations, combinations and other variants of the foregoing,
and all applications, registrations, and renewals in connection therewith, together with all of the goodwill associated with the
foregoing, (iii) copyrights, and other works of authorship (whether or not copyrightable), and moral rights, and registrations
and applications for registration, renewals and extensions thereof, (iv) trade secrets, know-how (including ideas, formulas,
compositions, inventions (whether or not patentable or reduced to practice)), customer and supplier lists, improvements, protocols,
processes, methods and techniques, research and development information, industry analyses, algorithms, architectures, layouts,
drawings, specifications, designs, plans, methodologies, proposals, industrial models, technical data, financial and accounting
and all other data, databases, database rights, including rights to use any Personal Information, pricing and cost information,
business and marketing plans and proposals, and customer and supplier lists (including lists of prospects) and related information,
(v) Internet domain names and social media accounts, (vi) rights of publicity and all other intellectual property or
proprietary rights of any kind or description, (vii) copies and tangible embodiments of any of the foregoing, in whatever
form or medium, including all Software, and (viii) all legal rights arising from items (i) through (vi), including the
right to prosecute, enforce and perfect such interests and rights to sue, oppose, cancel, interfere, enjoin and collect damages
based upon such interests, including such rights based on past infringement, if any, in connection with any of the foregoing.
“knowledge”
or “to the knowledge” of a person means in the case of the Company, the actual knowledge of the persons listed
on Section 1.01(F) of the Company Disclosure Schedule after reasonable inquiry (and for all purposes of Section 4.13
hereof, “reasonable inquiry” shall not require Company to have conducted patent clearance or similar freedom to
operate searches, or other Intellectual Property searches), and in the case of HCAC, the actual knowledge of Dan Hennessy, Greg
Ethridge or Nicholas Petruska after reasonable inquiry.
“Leased
Real Property” means the real property leased by the Company or Company Subsidiaries as tenant, together with, to the
extent leased by the Company or Company Subsidiaries, all buildings and other structures, facilities or improvements located thereon
and all easements, licenses, rights and appurtenances of the Company or Company Subsidiaries relating to the foregoing.
“Lien”
means any lien, security interest, mortgage, deed of trust, defect of title, easement, right of way, pledge, adverse claim or
other encumbrance of any kind that secures the payment or performance of an obligation (other than those created under applicable
securities Laws).
“Milestone”
means each of the $18 Share Price Milestone, the $25 Share Price Milestone and the $30 Share Price Milestone.
“Open
Source Software” means any Software in source code form that is licensed pursuant to (i) any license that is a
license now or in the future approved by the open source initiative and listed at http://www.opensource.org/licenses, which
licenses include all versions of the GNU General Public License (GPL), the GNU Lesser General Public License (LGPL), the GNU Affero
GPL, the MIT license, the Eclipse Public License, the Common Public License, the CDDL, the Mozilla Public License (MPL), the Artistic
License, the Netscape Public License, the Sun Community Source License (SCSL), and the Sun Industry Standards License (SISL),
(ii) any license to Software that is considered “free” or “open source software” by the open source
foundation or the free software foundation, (iii) the Server Side Public License, or (iv) any Reciprocal License.
“PCAOB”
means the Public Company Accounting Oversight Board and any division or subdivision thereof.
“PCI
DSS” means the Payment Card Industry Data Security Standard, issued by the Payment Card Industry Security Standards
Council.
“Permitted
Liens” means (i) such imperfections of title, easements, encumbrances, Liens or restrictions that do not materially
impair or interfere with the current use of the Company’s or any Company Subsidiary’s assets that are subject thereto,
(ii) materialmen’s, mechanics’, carriers’, workmen’s, warehousemen’s, repairmen’s, landlord’s
and other similar Liens arising in the ordinary course of business, or deposits to obtain the release of such Liens, (iii) Liens
for Taxes not yet due and delinquent, or if delinquent, being contested in good faith and for which appropriate reserves have
been made, (iv) zoning, entitlement, conservation restriction and other land use and environmental regulations promulgated
by Governmental Authorities that are not violated in any material respect by the Company’s or any Company Subsidiary’s
current use of the assets that are subject thereto, (v) revocable, non-exclusive licenses (or sublicenses) of Company Owned
IP granted in the ordinary course of business, (vi) non-monetary Liens, encumbrances and restrictions on real property (including
easements, covenants, rights of way and similar restrictions of record) that do not materially interfere with the present uses
of such real property, (vii) Liens identified in the Annual Financial Statements, and (viii) Liens on leases, subleases,
easements, licenses, rights of use, rights to access and rights of way arising from the provisions of such agreements or benefiting
or created by any superior estate, right or interest.
“person”
means an individual, corporation, partnership, limited partnership, limited liability company, syndicate, person (including, without
limitation, a “person” as defined in Section 13(d)(3) of the Exchange Act), trust, association or entity or government,
political subdivision, agency or instrumentality of a government.
“Personal
Information” means “personal information,” “personal data,” “personally identifiable information”
or equivalent terms as defined by applicable Privacy/Data Security Laws.
“Privacy/Data
Security Laws” means all Laws governing the receipt, collection, use, storage, processing, sharing, security, disclosure,
or transfer of Personal Information, such as, to the extent applicable, the following Laws and their implementing regulations:
the Fair Credit Reporting Act, the Federal Trade Commission Act, the CAN-SPAM Act, the Telephone Consumer Protection Act, the
Telemarketing and Consumer Fraud and Abuse Prevention Act, Children’s Online Privacy Protection Act, California Consumer
Privacy Act, state data security Laws, state data breach notification Laws, applicable Laws relating to the transfer of Personal
Information, and any applicable Laws concerning requirements for website and mobile application privacy policies and practices,
call or electronic monitoring or recording or any outbound communications (including outbound calling and text messaging, telemarketing,
and e-mail marketing).
“Products”
means any products or services under development, developed, manufactured, performed, out-licensed, sold, distributed other otherwise
made available by or on behalf of the Company or any Company Subsidiary, from which the Company or any Company Subsidiary has
derived previously, is currently deriving or is scheduled or intends to derive, revenue from the sale or provision thereof.
“Public
Shares” means the 30,015,000 shares of HCAC Class A Common Stock issued and sold as part of HCAC units in the IPO contemplated
by the Prospectus.
“Reciprocal
License” means a license of an item of Software that requires or that conditions any rights granted in such license
upon (i) the disclosure, distribution or licensing of any other Software (other than such item of Software as provided by
a third party in its unmodified form), (ii) a requirement that any disclosure, distribution or licensing of any other Software
(other than such item of Software in its unmodified form) be at no charge, (iii) a requirement that any other licensee of
the Software be permitted to access the source code of, modify, make derivative works of, or reverse-engineer any such other Software,
(iv) a requirement that such other Software be redistributable by other licensees, or (v) the grant of any patent rights
(other than patent rights in such item of Software), including non-assertion or patent license obligations (other than patent
obligations relating to the use of such item of Software).
“Redemption
Rights” means the redemption rights provided for in Section 9.2 of Article IX of the HCAC Certificate
of Incorporation.
“Registered
Intellectual Property” means all Intellectual Property that is the subject of an issued patent or registration (or a
patent application or an application for registration), including domain names.
“Requisite
Approval” means the affirmative vote of (i) the holders of at least two-thirds of the shares of the Company Shares outstanding
who attend and vote in person or by proxy at a duly convened general meeting of the Company if approved at a meeting, or (ii)
all holders of Company Shares outstanding if approved by written consent.
“Requisite
Shareholders” means the persons or entities listed on Section 1.01(E) of the Company Disclosure Schedule.
“Sanctioned
Person” means at any time any person (i) listed on any Sanctions-related list of designated or blocked persons,
(ii) the government of, resident in, or organized under the laws of a country or territory that is the subject of comprehensive
restrictive Sanctions from time to time (which includes, as of the date of this Agreement, Cuba, Iran, North Korea, Syria, and
the Crimea region), or (iii) majority-owned or controlled by any of the foregoing.
“Sanctions”
means those applicable, economic and financial sanctions Laws, regulations, embargoes, and restrictive measures administered or
enforced by (i) the United States (including without limitation the U.S. Treasury Department’s Office of Foreign
Assets Control), (ii) the European Union and enforced by its member states, (iii) the United Nations, (iv) Her
Majesty’s Treasury, or (v) any other similar governmental authority with jurisdiction over the Company or any Company
Subsidiary from time to time.
“Second
Merger Sub Organizational Documents” means the certificate of formation and operating agreement of Second Merger Sub,
as amended, modified or supplemented from time to time.
“Securities
Act” means the Securities Act of 1933, as amended.
“Software”
means all computer software (in object code or source code format), data and databases, and related documentation and materials.
“Sponsor
Cancelled Shares” means the number of Sponsor Shares to be forfeited to the Company by the Sponsor in accordance with
the Exchange and Cancellation Agreement, such number being 2,347,879.
“Sponsor
Shares” means the shares of the HCAC Class B Common Stock held by the Sponsor as of immediately prior to the Closing.
“stockholder”
means a holder of stock or shares, as appropriate.
“Subsidiary”
or “Subsidiaries” of the Company, the Surviving Corporation, the Surviving Entity, HCAC or any other person
means an affiliate controlled by such person, directly or indirectly, through one or more intermediaries.
“Supplier”
means any person that supplies inventory or other materials or personal property, components, or other goods or services (including,
design, development and manufacturing services) that comprise or are utilized in, including in connection with the design, development,
manufacture or sale of, the Products of the Company or any Company Subsidiary.
“Tax”
or “Taxes” means any and all taxes (including any duties, levies or other similar governmental assessments
in the nature of taxes), including, but not limited to, income, estimated, business, occupation, corporate, capital, gross receipts,
transfer, stamp, registration, employment, payroll, unemployment, withholding, occupancy, license, severance, capital, production,
ad valorem, excise, windfall profits, customs duties, real property, personal property, sales, use, turnover, value added
and franchise taxes, in each case imposed by any Governmental Authority, whether disputed or not, together with all interest,
penalties, and additions to tax imposed with respect thereto.
“Tax
Return” means any return, declaration, report, claim for refund, or information return or statement relating to Taxes,
including any schedule or attachment thereto and any amendment thereof, in each case filed or required to be filed with a Tax
authority.
“Transaction
Documents” means this Agreement, including all Schedules and Exhibits hereto, the Company Disclosure Schedule, the Ancillary
Agreements, and all other agreements, certificates and instruments executed and delivered by HCAC, First Merger Sub, Second Merger
Sub or the Company in connection with the Transaction and specifically contemplated by this Agreement.
“Transactions”
means the transactions contemplated by this Agreement and the Transaction Documents.
“Treasury
Regulations” means the United States Treasury regulations issued pursuant to the Code.
“Virtual
Data Room” means the virtual data room established by the Company or its Representatives, hosted by Datasite Diligence,
with access made available to HCAC and its Representatives.
SECTION 1.02 Further
Definitions. The following terms have the meaning set forth in the Sections set forth below:
| Defined
Term |
|
Location
of Definition |
| $18
Earnout Shares |
|
Annex
I |
| $18
Share Price Milestone |
|
Annex
I |
| $25
Earnout Shares |
|
Annex
I |
| $25
Share Price Milestone |
|
Annex
I |
| $30
Earnout Shares |
|
Annex
I |
| $30
Share Price Milestone |
|
Annex
I |
| Acceleration
Event |
|
Annex
I |
| Agreement |
|
Preamble |
| Alternative
Transaction |
|
§
7.05 |
| Annual
Financial Statements |
|
§
4.07(a) |
| Defined
Term |
|
Location
of Definition |
| Antitrust
Laws |
|
§
7.13(a) |
| Blue
Sky Laws |
|
§
4.05(b) |
| Business
Combination |
|
§ 6.03 |
| Cayman
Companies Law |
|
Recitals |
| Closing |
|
§
2.02(b) |
| Closing
Date |
|
§
2.02(b) |
| Code |
|
§
3.02(g) |
| Company |
|
Preamble |
| Company
Board |
|
Recitals |
| Company
Disclosure Schedule |
|
Article IV |
|
Company
Officer’s Certificate |
|
§
8.02(c) |
| Company
Permits |
|
§
4.06 |
| Company
Share Awards |
|
§
4.03(a) |
| Company
Shareholder Approval |
|
§
4.18 |
| Company
Shareholders Meeting |
|
§
7.03 |
| Company
Subsidiary |
|
§
4.01(a) |
| Continuing
Employees |
|
§
7.06(a) |
| Converted
Option |
|
§
3.01(b)(iv) |
| Data
Security Requirements |
|
§
4.13(i) |
| DGCL |
|
§
2.05(b) |
| DLLCA |
|
Recitals |
| Dissenting
Shares |
|
§ 3.05(a) |
| Effective
Time |
|
§ 2.02(a) |
| EGS |
|
§ 10.12 |
| Environmental
Permits |
|
§ 4.15 |
| ERISA
Affiliate |
|
§ 4.10(c) |
| Exchange
Agent |
|
§ 3.02(a) |
| Exchange
and Cancellation Agreement |
|
Recitals |
| Exchange
Fund |
|
§ 3.02(a) |
| Extension |
|
§ 7.17 |
| First
Merger |
|
Recitals |
| First
Merger Sub |
|
Preamble |
| First
Merger Sub Board |
|
Recitals |
| First
Merger Sub Common Stock |
|
§ 5.03(b) |
| GAAP |
|
§ 4.07(a) |
| Governmental
Authority |
|
§ 4.05(b) |
| HCAC |
|
Preamble |
| HCAC
Board |
|
Recitals |
| HCAC
Class A Common Stock |
|
§ 5.03(a) |
| HCAC
Class B Common Stock |
|
§ 5.03(a) |
| HCAC
Common Stock |
|
§ 5.03(a) |
| HCAC
Disclosure Schedule |
|
Article
V |
| HCAC
Preferred Stock |
|
§ 5.03(a) |
| HCAC
Proposals |
|
§ 7.01(a) |
| HCAC
Public Warrants |
|
§ 5.16 |
| Defined
Term |
|
Location
of Definition |
| HCAC
SEC Reports |
|
§ 5.07(a) |
| HCAC
Stockholders’ Meeting |
|
§ 7.01(a) |
| HCAC
Warrants |
|
§ 5.03(a) |
| Health
Plan |
|
§ 4.10(k) |
| Intended
Tax Treatment |
|
Recitals |
| Interim
Financial Statements |
|
§ 4.07(b) |
| Interim
Financial Statements Date |
|
§ 4.07(b) |
| IPO |
|
§ 6.03 |
| IRS |
|
§ 4.10(b) |
| Law |
|
§ 4.05(a) |
| Lease |
|
§ 4.12(b) |
| Lease
Documents |
|
§ 4.12(b) |
| Lock-Up
Agreements |
|
Recitals |
| Material
Contracts |
|
§ 4.16(a) |
| Merger
Payment Schedule |
|
§ 3.02(i) |
| Mergers |
|
Recitals |
| Non-Disclosure
Agreement |
|
§
7.04(b) |
| Ordinary
Commercial Agreement |
|
§
4.14(b) |
| Outside
Date |
|
§ 9.01(b) |
| Outstanding
Company Transaction Expenses |
|
§ 3.04(a) |
| Outstanding
HCAC Transaction Expenses |
|
§ 3.04(b) |
| PCAOB
Audited Financials |
|
§ 7.14 |
| Per
Share Merger Consideration |
|
§ 3.01(b)(i) |
| Plan
of Merger |
|
§
2.02(a) |
| Plans |
|
§ 4.10(a) |
| PPACA |
|
§ 4.10(k) |
| Private
Placements |
|
Recitals |
| Pro
Rata Share |
|
§ 3.02(i) |
| Prospectus |
|
§ 6.03 |
| Proxy
Statement |
|
§ 7.01(a) |
| Public
Stockholders |
|
§ 6.03 |
| Registration
Rights Agreement |
|
Recitals |
| Registration
Statement |
|
§ 7.01(a) |
| Released
Claims |
|
§ 6.03 |
| Remedies
Exceptions |
|
§ 4.04 |
| Representatives |
|
§ 7.04(a) |
| Sarbanes-Oxley
Act |
|
§
5.07(a) |
| SEC |
|
§ 5.07(a) |
| Second
Effective Time |
|
§ 2.02(a) |
| Second
Merger |
|
Recitals |
| Second
Merger Sub |
|
Preamble |
| Second
Merger Sub Board |
|
Recitals |
| Shareholder
Support Agreements |
|
Recitals |
| Sidley |
|
§ 10.12 |
| Sponsor |
|
Recitals |
| Defined
Term |
|
Location
of Definition |
| Sponsor
Support Agreement |
|
Recitals |
| Subscription
Agreements |
|
Recitals |
| Surviving
Corporation |
|
Recitals |
| Surviving
Entity |
|
Recitals |
| Terminating
Company Breach |
|
§
9.01(f) |
| Terminating
HCAC Breach |
|
§
9.01(g) |
| Trust
Account |
|
§
5.13 |
| Trust
Agreement |
|
§
5.13 |
| Trust
Fund |
|
§
5.13 |
| Trustee |
|
§
5.13 |
| Unaudited
Interim Financial Statements |
|
§
7.14 |
| Written
Consent |
|
§
7.03 |
SECTION
1.03 Construction.
(a)
Unless the context of this Agreement otherwise requires, (i) words of any gender include each other gender, (ii) words
using the singular or plural number also include the plural or singular number, respectively, (iii) the definitions contained
in this agreement are applicable to the other grammatical forms of such terms, (iv) the terms “hereof,” “herein,”
“hereby,” “hereto” and derivative or similar words refer to this entire Agreement, (v) the terms
“Article,” “Section,” “Schedule” and “Exhibit” refer to the specified Article,
Section, Schedule or Exhibit of or to this Agreement, (vi) the word “including” means “including without
limitation,” (vii) the word “or” shall be disjunctive but not exclusive, (viii) references to agreements
and other documents shall be deemed to include all subsequent amendments and other modifications thereto and references to any
Law shall include all rules and regulations promulgated thereunder and (ix) references to any Law shall be construed as including
all statutory, legal, and regulatory provisions consolidating, amending or replacing such Law.
(b)
The language used in this Agreement shall be deemed to be the language chosen by the parties to express their mutual intent and
no rule of strict construction shall be applied against any party.
(c)
Whenever this Agreement refers to a number of days, such number shall refer to calendar days unless Business Days are specified,
and when counting days, the date of commencement will not be included as a full day for purposes of computing any applicable time
periods (except as otherwise may be required under any applicable Law). If any action is to be taken or given on or by a particular
calendar day, and such calendar day is not a Business Day, then such action may be deferred until the next Business Day.
(d)
All accounting terms used herein and not expressly defined herein shall have the meanings given to them under GAAP.
ARTICLE
II
AGREEMENT AND PLAN OF MERGER
SECTION
2.01 The Mergers.
(a)
Upon the terms and subject to the conditions set forth in Article VIII, and in accordance with the Cayman Companies
Law, at the Effective Time, First Merger Sub shall be merged with and into the Company. As a result of the First Merger, the separate
corporate existence of First Merger Sub shall cease and the Company shall continue as the surviving corporation of the First Merger
(provided that references to the Company for periods after the Effective Time until the Second Effective Time shall include the
Surviving Corporation).
(b)
Upon the terms and subject to the conditions set forth in Article VIII, and in accordance with the DLLCA, at the Second
Effective Time, the Surviving Corporation shall be merged with and into the Second Merger Sub. As a result of the Second Merger
Sub, the separate corporate existence of the Surviving Corporation shall cease and the Second Merger Sub shall continue as the
surviving entity of the Second Merger (provided that references to the Company or the Surviving Corporation for periods after
the Second Effective Time shall include the Surviving Entity).
SECTION
2.02 Effective Times; Closing.
(a)
As promptly as practicable, but in no event later than three (3) Business Days, after the satisfaction or, if permissible,
waiver of the conditions set forth in Article VIII (other than those conditions that by their nature are to be satisfied
at the Closing, it being understood that the occurrence of the Closing shall remain subject to the satisfaction or, if permissible,
waiver of such conditions at the Closing), the parties hereto shall cause the First Merger to be consummated by filing a plan
of merger (a “Plan of Merger”) with the Registrar of Companies, in such form as is required by, and executed
in accordance with, the relevant provisions of the Cayman Companies Law and mutually agreed by the parties (the date and time
of the filing of such Plan of Merger (or such later time as may be agreed by each of the parties hereto and specified in such
Plan of Merger) being the “Effective Time”). As soon as practicable following the Effective Time, but in any
event within 10 days of the Effective Time, the parties hereto shall cause the Second Merger to be consummated by filing a plan
of merger with the Registrar of Companies, in such form as is required by, and executed in accordance with, the relevant provisions
of the Cayman Companies Law and mutually agreed by the parties and the Certificate of Merger with the Secretary of State of the
State of Delaware, in such form as is required by, and executed in accordance with the relevant provisions of the DLLCA and mutually
agreed by the parties (the date and time of the filing of such Certificate of Merger (or such later time as may be agreed by each
of the parties hereto and specified in the Certificate of Merger) being the “Second Effective Time”).
(b)
Immediately prior to such filing of a Plan of Merger in accordance with Section 2.02(a), the closing (the “Closing”)
shall be held at the offices of Sidley Austin LLP, One South Dearborn Street, Chicago, Illinois 60603 or by electronic exchange
of deliverables and release of signatures, for the purpose of confirming the satisfaction or waiver, as the case may be, of the
conditions set forth in Article VIII. The date on which the Closing shall occur is referred to herein as the “Closing
Date.”
SECTION
2.03 Effect of the Mergers.
(a)
At the Effective Time, the effect of the First Merger shall be as provided in the applicable provisions of the Cayman Companies
Law. Without limiting the generality of the foregoing, and subject thereto, at the Effective Time, all the property, rights, privileges,
immunities, powers, franchises, licenses and authority of the Company and First Merger Sub shall vest in the Surviving Corporation,
and all debts, liabilities, obligations, restrictions, disabilities and duties of each of the Company and First Merger Sub shall
become the debts, liabilities, obligations, restrictions, disabilities and duties of the Surviving Corporation.
(b)
At the Second Effective Time, the effect of the Second Merger shall be as provided in the applicable provisions of the Cayman
Companies Law and DLLCA. Without limiting the generality of the foregoing, and subject thereto, at the Second Effective Time,
all the property, rights, privileges, immunities, powers, franchises, licenses and authority of the Surviving Corporation and
Second Merger Sub shall vest in the Surviving Entity, and all debts, liabilities, obligations, restrictions, disabilities and
duties of each of the Surviving Corporation and Second Merger Sub shall become the debts, liabilities, obligations, restrictions,
disabilities and duties of the Surviving Entity.
SECTION
2.04 Governing Documents.
(a)
At the Effective Time, the Company Charter, as in effect immediately prior to the Effective Time, shall be amended and restated
in its entirety to read as set forth on Exhibit C attached hereto and, as so amended and restated, shall be the memorandum
and articles of association of the Surviving Corporation until thereafter amended as provided by the Cayman Companies Law and
such Charter (subject to Section 7.07). At the Second Effective Time, the certificate of formation and operating agreement
of Second Merger Sub, as in effect immediately prior to the Second Effective Time, shall be amended to change the name of the
Surviving Entity to such name as is determined by the Company no later than five (5) Business Days prior to the Closing Date,
but otherwise shall continue to be the certificate of formation and operating agreement of the Surviving Entity until thereafter
amended in accordance with their terms and as provided by DLLCA (subject to Section 7.07).
(b)
At the Closing, HCAC shall amend and restate, effective as of the Effective Time, the HCAC Certificate of Incorporation to be
as set forth on Exhibit D.
SECTION
2.05 Directors and Officers.
(a)
The parties will take all requisite actions such that the initial directors of the Surviving Corporation and the initial officers
of the Surviving Corporation immediately after the Effective Time shall be the individuals indicated on Section 2.05(a)
of the Company Disclosure Schedule, each to hold office in accordance with the provisions of the Cayman Companies Law and the
certificate of incorporation and bylaws of the Surviving Corporation and until their respective successors are, in the case of
the initial directors, duly elected or appointed and qualified and, in the case of the initial officers, duly appointed. The parties
will take all requisite actions such that the initial officers of the Surviving Entity immediately after the Second Effective
Time shall be the individuals indicated on Section 2.05(a) of the Company Disclosure Schedule, each to hold office in accordance
with the provisions of the DLLCA and the operating agreement of the Surviving Entity and until their respective successors are,
in the case of the initial directors, duly elected or appointed and qualified and, in the case of the initial officers, duly appointed.
(b)
The parties shall cause the HCAC Board and the officers of HCAC as of immediately following the Effective Time to be comprised
of the individuals set forth on Section 2.05(b) of the Company Disclosure Schedule, each to hold office in accordance with
the General Corporation Law of the State of Delaware (the “DGCL”) and the HCAC Certificate of Incorporation
and the bylaws of HCAC and until their respective successors are, in the case of the directors, duly elected or appointed and
qualified and, in the case of the officers, duly appointed.
ARTICLE
III
CONVERSION OF SECURITIES; EXCHANGE OF COMPANY SECURITIES
SECTION
3.01 Conversion of Securities.
(a)
Immediately prior to the Effective Time, the Company shall cause each Company Preferred Share that is issued and outstanding immediately
prior to the Effective Time to be automatically converted into a number of Company Ordinary Shares at the then-effective conversion
rate as calculated pursuant to the Company Charter. All of the Company Preferred Shares converted into Company Ordinary Shares
shall no longer be outstanding and shall cease to exist, and each holder of Company Preferred Shares shall thereafter cease to
have any rights with respect to such securities.
(b)
At the Effective Time, by virtue of the Merger and without any action on the part of HCAC, First Merger Sub, the Company or the
holders of any of the following securities:
(i)
each Company Ordinary Share (including each Company Restricted Share, and including Company Ordinary Shares resulting from the
conversion of Company Preferred Shares described in Section 3.01(a)) that is issued and outstanding immediately prior to
the Effective Time shall be canceled and converted into (A) the right to receive the number of shares of HCAC Class A Common Stock
equal to the Exchange Ratio, and (B) the contingent right to receive a number of Earnout Shares following the Closing in accordance
with Section 3.06 and Annex I (which consideration, collectively, shall hereinafter be referred to as the “Per
Share Merger Consideration”); provided, however, that each share of HCAC Class A Common Stock issued
in exchange for Company Restricted Shares shall be subject to the terms and conditions giving rise to a substantial risk of forfeiture
that applied to such Company Restricted Shares immediately prior to the Effective Time to the extent consistent with the terms
of such Company Restricted Shares;
(ii)
each Company Share held in the treasury of the Company shall be canceled without any conversion thereof and no payment or distribution
shall be made with respect thereto;
(iii)
each share of First Merger Sub Common Stock issued and outstanding immediately prior to the Effective Time shall be converted
into and exchanged for one validly issued, fully paid and nonassessable share of common stock, par value $0.0001 per share, of
the Surviving Corporation;
(iv)
each Company Option that is outstanding immediately prior to the Effective Time shall be assumed by HCAC and converted into (A)
an option to purchase shares of HCAC Class A Common Stock (each, a “Converted Option”), provided that
the assumption and conversion of any such Company Options that are incentive stock options under Section 422 of the Code will
be effected in a manner that is intended to be consistent with the applicable requirements of Section 424 of the Code and the
applicable regulations promulgated thereunder, and (B) the contingent right to receive a number of Earnout Shares following the
Closing in accordance with Section 3.06 and Annex I. Each Converted Option will have and be subject to the same
terms and conditions (including vesting and exercisability terms) as were applicable to such Company Option immediately before
the Effective Time, except that (x) each Converted Option will be exercisable for that number of shares of HCAC Class A Common
Stock equal to the product (rounded down to the nearest whole number) of (1) the number of shares of Company Ordinary Shares subject
to the Company Option immediately before the Effective Time and (2) the Exchange Ratio; and (y) the per share exercise price for
each share of HCAC Class A Common Stock issuable upon exercise of the Converted Option will be equal to the quotient (rounded
up to the nearest whole cent) obtained by dividing (1) the exercise price per share of Company Ordinary Shares of such Company
Option immediately before the Effective Time by (2) the Exchange Ratio; provided, however, that the exercise price
and the number of shares of HCAC Class A Common Stock purchasable under each Converted Option will be determined in a manner consistent
with the requirements of Section 409A of the Code and the applicable regulations promulgated thereunder; and
(v)
each award of Company RSUs that is outstanding immediately prior to the Effective Time shall be assumed by HCAC and converted
into (A) an award of restricted share units to acquire shares of HCAC Class A Common Stock (each, a “Converted RSU Award”),
and (B) the contingent right to receive a number of Earnout Shares following the Closing in accordance with Section 3.06
and Annex I. Each Converted RSU Award will have and be subject to the same terms and conditions (including vesting and
exercisability terms) as were applicable to such award of Company RSUs immediately before the Effective Time, except that each
Converted RSU Award will represent the right to acquire that number of shares of HCAC Class A Common Stock equal to the product
(rounded down to the nearest whole number) of (1) the number of shares of Company Ordinary Shares subject to the Company RSU award
immediately before the Effective Time and (2) the Exchange Ratio.
(c)
In connection with the assumption of the Converted Options and Converted RSU Awards pursuant to Section 3.01(b), the Company
and HCAC shall cause HCAC to assume the Company Option Plan as of the Effective Time. Prior to the Effective Time and subject
to the prior reasonable review and approval of HCAC (which approval shall not be unreasonably withheld, delayed, or conditioned),
the Company shall take all actions reasonably necessary to effect the transactions anticipated by Section 3.01(b) under
the Company Option Plan and any Contract applicable to any Company Option or Company RSUs (whether written or oral, formal or
informal), including delivering all required notices, obtaining all necessary approvals and consents, and delivering evidence
reasonably satisfactory to HCAC that all necessary determinations by the Company Board or applicable committee of the Company
Board to assume and convert Company Options and Company RSUs in accordance with Section 3.01(b) have been made.
(d)
At the Second Effective Time, by virtue of the Second Merger and without any action on the part of HCAC, Surviving Corporation,
Second Merger Sub, or the holders of any securities of HCAC or the Surviving Corporation or the Second Merger Sub: (a) each ordinary
share of the Surviving Corporation issued and outstanding immediately prior to the Second Effective Time shall be canceled and
shall cease to exist without any conversion thereof or payment therefor; and (b) each membership interest in Second Merger Sub
issued and outstanding immediately prior to the Second Effective Time shall be converted into and become one validly issued, fully
paid and non-assessable membership interest in the Surviving Entity, which shall constitute the only outstanding equity of the
Surviving Entity. From and after the Second Effective Time, all certificates, if any, representing membership interests in Second
Merger Sub shall be deemed for all purposes to represent the number of membership interests of the Surviving Entity which they
were converted in accordance with the immediately preceding sentence.
SECTION
3.02 Exchange of Company Securities.
(a)
Exchange Agent. On the Closing Date, HCAC shall deposit, or shall cause to be deposited, with a bank or trust company that
shall be designated by HCAC and is reasonably satisfactory to the Company (the “Exchange Agent”), for the benefit
of the holders of Company Ordinary Shares, for exchange in accordance with this Article III, the number of shares
of HCAC Class A Common Stock sufficient to deliver the aggregate Per Share Merger Consideration payable pursuant to this Agreement
(such shares of HCAC Class A Common Stock being hereinafter referred to as the “Exchange Fund”). HCAC shall
cause the Exchange Agent, pursuant to irrevocable instructions, to pay the Per Share Merger Consideration out of the Exchange
Fund in accordance with the Merger Payment Schedule and the other applicable provisions contained in this Agreement. The Exchange
Fund shall not be used for any other purpose.
(b)
Exchange Procedures. As soon as practicable following the Effective Time, and in any event within two (2) Business
Days following the Effective Time (but in no event prior to the Effective Time), HCAC shall cause the Exchange Agent to deliver
to each holder of Company Ordinary Shares, as of immediately prior to the Effective Time, represented by book-entry (including
Company Ordinary Shares resulting from the conversion of the Company Preferred Shares and the Company Ordinary Share Purchase
Warrant), the applicable Per Share Merger Consideration in accordance with the provisions of Section 3.01(b)(i) and such
Company Ordinary Shares shall forthwith be cancelled.
(c)
No Further Rights in Company Ordinary Shares or Company Preferred Shares. The Per Share Merger Consideration payable upon
conversion of the Company Shares (including Company Shares resulting from the conversion of the Company Preferred Shares and the
Company Ordinary Share Purchase Warrant) in accordance with the terms hereof shall be deemed to have been paid and issued in full
satisfaction of all rights pertaining to such Company Shares.
(d)
Adjustments to Per Share Consideration. The Per Share Merger Consideration shall be adjusted to reflect appropriately the
effect of any stock split, reverse stock split, stock dividend, reorganization, recapitalization, reclassification, combination,
exchange of shares or other like change with respect to HCAC Class A Common Stock occurring on or after the date hereof and prior
to the Effective Time.
(e)
Termination of Exchange Fund. Any portion of the Exchange Fund that remains undistributed to the holders of Company Ordinary
Shares for one year after the Effective Time shall be delivered to HCAC, upon demand, and any holders of Company Ordinary Shares
who have not theretofore complied with this Section 3.02 shall thereafter look only to HCAC for the applicable Per
Share Merger Consideration. Any portion of the Exchange Fund remaining unclaimed by holders of Company Ordinary Shares as of a
date which is immediately prior to such time as such amounts would otherwise escheat to or become property of any Governmental
Authority shall, to the extent permitted by applicable Law, become the property of HCAC free and clear of any claims or interest
of any person previously entitled thereto.
(f)
No Liability. None of the Exchange Agent, HCAC, the Surviving Corporation or the Surviving Entity shall be liable to any
holder of Company Shares (including Company Shares resulting from the conversion of the Company Preferred Shares and the Company
Ordinary Share Purchase Warrant) for any such Company Shares (or dividends or distributions with respect thereto) or cash delivered
to a public official pursuant to any abandoned property, escheat or similar Law in accordance with this Section 3.02.
(g)
Withholding Rights. Notwithstanding anything in this Agreement to the contrary, each of the Surviving Corporation, Surviving
Entity, HCAC, First Merger Sub, Second Merger Sub and the Exchange Agent shall be entitled to deduct and withhold from amounts
(including shares, options or other property) otherwise payable, issuable or transferable pursuant to this Agreement to any holder
of Company Options, Company RSUs or Company Shares (including Company Shares resulting from the conversion of the Company Preferred
Shares and the Company Ordinary Share Purchase Warrant) such amounts as it is required to deduct and withhold with respect to
such payment, issuance or transfer under the United States Internal Revenue Code of 1986 (the “Code”) or any
provision of state, local or non U.S. Tax Law. To the extent that amounts are so deducted or withheld and timely paid to the applicable
Governmental Authority in accordance with applicable Law, such deducted or withheld amounts shall be treated for all purposes
of this Agreement as having been paid, issued or transferred to the holder of the Company Securities (or intended recipients of
compensatory payments) in respect of which such deduction and withholding was made.
(h)
Fractional Shares. No certificates or scrip or shares representing fractional shares of HCAC Class A Common Stock shall
be issued upon the exchange of Company Shares and such fractional share interests will not entitle the owner thereof to vote or
to have any rights of a stockholder of HCAC or a holder of shares of HCAC Class A Common Stock. In lieu of any fractional share
of HCAC Class A Common Stock to which any holder of Company Shares would otherwise be entitled, the Exchange Agent shall round
up or down to the nearest whole share of HCAC Class A Common Stock, as applicable, with a fraction of 0.5 rounded up. No cash
settlements shall be made with respect to fractional shares eliminated by rounding.
(i)
Merger Payment Schedule. At least five (5) Business Days prior to the Closing Date, the Company shall deliver to HCAC and
the Exchange Agent a schedule (the “Merger Payment Schedule”) showing the percentage allocation of the Company
Merger Shares to each of the holders of Company Securities at the Closing (such holder’s “Pro Rata Share”)
as well as the corresponding number of shares of HCAC Class A Common Stock to be issued to such holders of Company Securities
pursuant to Section 3.01.
SECTION
3.03 Register of Members. At the Effective Time, the register of members of the Company shall be closed and there
shall be no further registration of transfers of Company Shares thereafter on the records of the Company. From and after the Effective
Time, the holders of Company Shares outstanding immediately prior to the Effective Time shall cease to have any rights with respect
to such Company Shares, except as otherwise provided in this Agreement or by Law.
SECTION
3.04 Payment of Expenses.
(a)
No sooner than five (5) nor later than two (2) Business Days prior to the Closing Date, the Company shall provide to HCAC
a written report setting forth a list of all of the following fees and expenses incurred by or on behalf of the Company in connection
with the preparation, negotiation and execution of this Agreement and the consummation of the Transactions (together with written
invoices and wire transfer instructions for the payment thereof), solely to the extent such fees and expenses are incurred and
expected to remain unpaid as of the close of business on the Business Day immediately preceding the Closing Date: (i) the
fees and disbursements of outside counsel to the Company incurred in connection with the Transactions and (ii) the fees and
expenses of any other agents, advisors, consultants, experts, financial advisors and other service providers engaged by the Company
in connection with the Transactions (collectively, the “Outstanding Company Transaction Expenses”). On the
Closing Date, following the Closing, HCAC shall pay or cause to be paid, by wire transfer of immediately available funds, all
such Outstanding Company Transaction Expenses. For the avoidance of doubt, the Outstanding Company Transaction Expenses shall
not include any fees and expenses of the Company’s stockholders.
(b)
No sooner than five (5) nor later than two (2) Business Days prior to the Closing Date, HCAC shall provide to the Company
a written report setting forth a list of all fees, expenses and disbursements incurred by or on behalf of HCAC, First Merger Sub,
or Second Merger Sub for outside counsel, agents, advisors, consultants, experts, financial advisors and other service providers
engaged by or on behalf of HCAC, First Merger Sub or Second Merger Sub in connection with the Transactions or otherwise in connection
with HCAC’s operations (together with written invoices and wire transfer instructions for the payment thereof) (collectively,
the “Outstanding HCAC Transaction Expenses”). On the Closing Date, HCAC shall pay or cause to be paid, by wire
transfer of immediately available funds, all such Outstanding HCAC Transaction Expenses.
(c)
Except as set forth in this Section 3.04 or elsewhere in this Agreement, all expenses incurred in connection with this
Agreement and the Transactions shall be paid by the party incurring such expenses, whether or not the Merger or any other Transaction
is consummated, except that the Company shall pay all filing fees relating to all SEC and other regulatory filing fees (including
those incurred in connection with the Proxy Statement and the filing fee for the Notification and Report Forms filed under the
HSR Act).
(d)
HCAC shall not be required to pay or cause to be paid any Outstanding HCAC Transaction Expenses or Outstanding Company Transaction
Expenses other than in accordance with this Section 3.04.
SECTION
3.05 Dissenters’ Rights.
(a)
Notwithstanding any provision of this Agreement to the contrary and to the extent available under the CCC and Cayman Companies
Law, Company Shares that are outstanding immediately prior to the Effective Time and that are held by shareholders of the Company
who shall have demanded properly in writing dissenters’ rights for such Company Shares in accordance with Section 238
of the Cayman Companies Law or, to the extent applicable, Chapter 13 of the CCC, and otherwise complied with all of the provisions
of the Cayman Companies Law relevant to the exercise and perfection of dissenters’ rights, or, to the extent applicable,
complied with all of the provisions of the CCC relevant to the exercise and perfection of dissenters’ rights (collectively,
the “Dissenting Shares”) shall not be converted into, and such stockholders shall have no right to receive,
the applicable Per Share Merger Consideration unless and until such stockholder fails to perfect or withdraws or otherwise loses
his, her or its right to dissenters’ rights under the Cayman Companies Law, or, to the extent applicable, the CCC. Any stockholder
of the Company who fails to perfect or who effectively withdraws or otherwise loses his, her or its dissenters’ rights pursuant
to the Cayman Companies Law, or, to the extent applicable, Chapter 13 or the CCC, shall thereupon be deemed to have been converted
into, and to have become exchangeable for, as of the Effective Time, the right to receive the applicable Per Share Merger Consideration,
without any interest thereon.
(b)
Prior to the Closing, the Company shall give HCAC (i) prompt notice of any demands for dissenters’ rights received
by the Company and any withdrawals of such demands, and (ii) the opportunity to participate in all negotiations and proceedings
with respect to demands for dissenters’ rights under the Cayman Companies Law, or, to the extent applicable, CCC. The Company
shall not, except with the prior written consent of HCAC (which consent shall not be unreasonably withheld), make any payment
with respect to any demands for dissenters’ rights or offer to settle or settle any such demands.
SECTION 3.06 Earnout
Shares. Within five (5) Business Days following the occurrence of the $18 Share Price Milestone, the $25 Share Price Milestone
and/or the $30 Share Price Milestone, as applicable, in accordance with Annex I hereto, HCAC will issue to each holder
of Company Securities as of immediately prior to the Effective Time the $18 Earnout Shares, the $25 Earnout Shares and/or the
$30 Earnout Shares, as applicable, which Earnout Shares shall be fully paid and free and clear of all Liens other than applicable
securities Law restrictions. Notwithstanding the foregoing, the issuance of the Earnout Shares shall be subject to withholding
pursuant to Section 3.02(g).
ARTICLE
IV
REPRESENTATIONS AND WARRANTIES OF THE COMPANY
Except
as set forth in the Company’s disclosure schedule delivered by the Company to HCAC, First Merger Sub, and Second Merger
Sub in connection with this Agreement (the “Company Disclosure Schedule”) (each of which qualifies (a) the
correspondingly numbered representation, warranty or covenant specified therein and (b) such other representations, warranties
or covenants where its relevance as an exception to (or disclosure for purposes of) such other representation, warranty or covenant
is reasonably apparent on its face or cross-referenced), the Company hereby represents and warrants to HCAC, First Merger Sub
and Second Merger Sub as follows:
SECTION
4.01 Organization and Qualification; Subsidiaries.
(a)
The Company and each subsidiary of the Company (each a “Company Subsidiary”), is a corporation, company or
other organization duly organized, validly existing and in good standing under the Laws of the jurisdiction of its incorporation
or organization and has the requisite corporate or other organizational power and authority and all necessary governmental approvals
to own, lease and operate its properties and to carry on its business as it is now being conducted. The Company and each Company
Subsidiary is duly qualified or licensed as a foreign corporation or other organization to do business, and is in good standing,
in each jurisdiction where the character of the properties owned, leased or operated by it or the nature of its business makes
such qualification or licensing necessary, except for such failures to be so qualified or licensed and in good standing that would
not, individually or in the aggregate, be expected to have a Company Material Adverse Effect.
(b)
A true and complete list of all the Company Subsidiaries, together with the jurisdiction of incorporation of each Company Subsidiary
and the percentage of the equity interest of each Company Subsidiary owned by the Company and each other Company Subsidiary, is
set forth in Section 4.01(b) of the Company Disclosure Schedule. The Company does not directly or indirectly own,
and has never owned, any equity or similar interest in, or any interest convertible into or exchangeable or exercisable for any
equity or similar interest in, any other corporation, partnership, joint venture or business association or other entity.
SECTION 4.02 Certificate
of Incorporation and Bylaws. The Company has prior to the date of this Agreement made available to HCAC in the Virtual Data
Room a complete and correct copy of the certificate of incorporation and the bylaws or equivalent organizational documents, each
as amended, restated or otherwise modified to date, of the Company and each Company Subsidiary. Such certificates of incorporation,
bylaws or equivalent organizational documents are in full force and effect. Neither the Company nor any Company Subsidiary is
in violation of any of the provisions of its certificate of incorporation, bylaws or equivalent organizational documents.
SECTION
4.03 Capitalization.
(a)
As of the date hereof, the authorized share capital of the Company consists of 389,666,667 Company Ordinary Shares, 90,913,310
A Series Preference Shares and 19,420,023 A-1 Series Preference Shares. As of the date hereof, (i) 26,145,984 Company Ordinary
Shares are issued and outstanding, (ii) 110,333,333 shares of Company Preferred Shares are issued and outstanding, (iii) no
Company Shares are held in the treasury of the Company and (iv) 14,359,371 Company Ordinary Shares are reserved for future
issuance pursuant to outstanding Company Options, Company RSUs, Company Restricted Shares and other purchase rights (the “Company
Share Awards”) granted pursuant to the Company Option Plan or otherwise.
(b)
Other than the Company Options and the Company Ordinary Share Purchase Warrant, there are no options, warrants, preemptive rights,
calls, convertible securities, conversion rights or other rights, agreements, arrangements or commitments of any character relating
to the issued or unissued share capital of the Company or any Company Subsidiary or obligating the Company or any Company Subsidiary
to issue or sell any shares of, or other equity or voting interests in, or any securities convertible into or exchangeable or
exercisable for shares or other equity or other voting interests in, the Company or any Company Subsidiary. As of the date hereof,
except as set forth on Section 4.03(b) of the Company Disclosure Schedule, neither the Company nor any Company Subsidiary
is a party to, or otherwise bound by, and neither the Company nor any Company Subsidiary has granted, any equity appreciation
rights, participations, phantom equity, restricted shares, restricted share units, performance shares, contingent value rights
or similar securities or rights that are derivative of, or provide economic benefits based, directly or indirectly, on the value
or price of, any shares, or other securities or ownership interests in, the Company or any Company Subsidiary. There are no voting
trusts, voting agreements, proxies, shareholder agreements or other agreements to which the Company or any Company Subsidiary
is a party, or to the Company’s knowledge, among any holder of Company Shares or any other equity interests or other securities
of the Company or any Company Subsidiary to which the Company or any Company Subsidiary is not a party, with respect to the voting
or transfer of the Company Shares or any of the equity interests or other securities of the Company or any of the Company Subsidiaries.
Except for the Company Subsidiaries, the Company does not own any equity interests in any person.
(c)
Section 4.03(c) of the Company Disclosure Schedule sets forth the following information with respect to each Company
Share Award outstanding, if applicable: (i) the name of the Company Share Award recipient; (ii) whether the Company
Share Award was granted pursuant to the Company Option Plan; (iii) the number of shares of the Company outstanding with respect
to such Company Share Award; (iv) the exercise or purchase price of such Company Share Award; (v) the date on which
such Company Share Award was granted; and (vi) the date on which such Company Share Award expires. The Company has made available
to HCAC in the Virtual Data Room an accurate and complete copy of the Company Option Plan and all forms of award agreements evidencing
all outstanding Company Share Awards. No Company Option was granted with an exercise price per share less than the fair market
value of the underlying Company Ordinary Shares as of the date such Company Option was granted. All shares of the Company subject
to issuance as aforesaid, upon issuance on the terms and conditions specified in the instruments pursuant to which they are issuable,
will be duly authorized, validly issued, fully paid and nonassessable.
(d)
There are no outstanding contractual obligations of the Company or any Company Subsidiary to repurchase, redeem or otherwise acquire
any shares of the Company or any capital stock of any Company Subsidiary or to provide funds to or make any investment (in the
form of a loan, capital contribution or otherwise) in any person other than a Company Subsidiary.
(e)
(i) There are no commitments or agreements of any character to which the Company is bound obligating the Company to accelerate
the vesting of any Company Share Award or Company Option as a result of the proposed transactions herein, and (ii) all outstanding
Company Shares, all outstanding Company Share Awards and Company Options, and all outstanding shares of capital stock of each
Company Subsidiary have been issued and granted in compliance with (A) all applicable securities Laws and other applicable
Laws and (B) all preemptive rights and other requirements set forth in applicable contracts to which the Company or any Company
Subsidiary is a party and the organizational documents of the Company and the Company Subsidiaries, as applicable.
(f)
Each outstanding share of capital stock of each Company Subsidiary is duly authorized, validly issued, fully paid and nonassessable,
and each such share is owned 100% by the Company or another Company Subsidiary free and clear of all Liens, options, rights of
first refusal and limitations on the Company’s or any Company Subsidiary’s voting rights, other than transfer restrictions
under applicable securities Laws and their respective organizational documents.
(g)
Except for the Company Shares held by the shareholders of the Company, no shares or other equity or voting interest of the Company,
or options, warrants or other rights to acquire any such shares or other equity or voting interest, of the Company is authorized
or issued and outstanding.
(h)
All outstanding Company Shares and all outstanding shares of capital stock or other equity securities (as applicable) of each
Company Subsidiary have been issued and granted in compliance with (i) applicable securities Laws and other applicable Laws
and (ii) any preemptive rights and other similar requirements set forth in applicable contracts to which the Company or any
Company Subsidiary is a party.
SECTION
4.04 Authority Relative to This Agreement. The Company has all necessary corporate power and authority to execute and
deliver this Agreement, to perform its obligations hereunder and, subject to receiving the Company Shareholder Approval, to consummate
the Transactions. The execution and delivery of this Agreement by the Company and the consummation by the Company of the Transactions
have been duly and validly authorized by all necessary corporate action, and no other corporate proceedings on the part of the
Company are necessary to authorize this Agreement or to consummate the Transactions (other than, with respect to the Mergers,
the Company Shareholder Approval, which the Written Consent shall satisfy, and the filing and recordation of appropriate merger
documents as required by the Cayman Companies Law). This Agreement has been duly and validly executed and delivered by the Company
and, assuming the due authorization, execution and delivery by HCAC, First Merger Sub and Second Merger Sub, constitutes a legal,
valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, except as limited by
applicable bankruptcy, insolvency, reorganization, moratorium and other Laws of general application affecting enforcement of creditors’
rights generally, by general equitable principles (the “Remedies Exceptions”). The Company Board has approved
this Agreement and the Transactions. To the knowledge of the Company, no other state takeover Law is applicable to the Merger
or the other Transactions.
SECTION
4.05 No Conflict; Required Filings and Consents.
(a)
The execution and delivery of this Agreement by the Company does not, and subject to receipt of the filing and recordation of
appropriate merger documents as required by the Cayman Companies Law and of the consents, approvals, authorizations or permits,
filings and notifications, expiration or termination of waiting periods after filings and other actions set forth on Section 4.05(b)
of the Company Disclosure Schedule, including the Written Consent, being made, obtained or given, the performance of this
Agreement by the Company will not (i) conflict with or violate the certificate of incorporation or bylaws or any equivalent
organizational documents of the Company or any Company Subsidiary, (ii) conflict with or violate any United States or non-United
States statute, law, ordinance, regulation, rule, code, executive order, injunction, judgment, decree or other order (“Law”)
applicable to the Company or any Company Subsidiary or by which any property or asset of the Company or any Company Subsidiary
is bound or affected, or (iii) result in any breach of or constitute a default (or an event which, with notice or lapse of
time or both, would become a default) under, or give to others any right of termination, amendment, acceleration or cancellation
of, or result in the creation of a Lien (other than any Permitted Lien) on any material property or asset of the Company or any
Company Subsidiary pursuant to, any Material Contract, except, with respect to clauses (ii) and (iii), for
any such conflicts, violations, breaches, defaults or other occurrences which would not have or reasonably be expected to have
a Company Material Adverse Effect.
(b)
The execution and delivery of this Agreement by the Company does not, and the performance of this Agreement by the Company will
not, require any consent, approval, authorization or permit of, or filing with or notification to, or expiration or termination
of any waiting period by, any United States federal, state, county or local or non-United States government, governmental, regulatory
or administrative authority, agency, instrumentality or commission or any court, tribunal, or judicial or arbitral body (a “Governmental
Authority”), except (i) for applicable requirements, if any, of the Exchange Act, the Securities Act, state securities
or “blue sky” laws (“Blue Sky Laws”) and state takeover Laws, the pre-merger notification requirements
of the HSR Act, and filing with and registration by the Registrar of Companies of appropriate merger documents as required by
the Cayman Companies Law, and (ii) where the failure to obtain such consents, approvals, authorizations or permits, or to
make such filings or notifications, would not have or would not reasonably be expected to have a Company Material Adverse Effect.
SECTION
4.06 Permits; Compliance. Each of the Company and the Company Subsidiaries is in possession of all material franchises,
grants, authorizations, licenses, permits, easements, variances, exceptions, consents, certificates, approvals and orders of any
Governmental Authority necessary for each of the Company or the Company Subsidiaries to own, lease and operate its properties
or to carry on its business as it is now being conducted (the “Company Permits”), except where the failure
to have such Company Permits would not reasonably be expected to have a Company Material Adverse Effect. No suspension or cancellation
of any of the Company Permits is pending or, to the knowledge of the Company, threatened in writing. Neither the Company nor any
Company Subsidiary is in conflict with, or in default, breach or violation of, (a) any Law applicable to the Company or any
Company Subsidiary or by which any property or asset of the Company or any Company Subsidiary is bound or affected, or (b) any
Material Contract or Company Permit, except, in each case, for any such conflicts, defaults, breaches or violations that would
not have or would not reasonably be expected to have a Company Material Adverse Effect.
SECTION
4.07 Financial Statements.
(a)
The Company has made available to HCAC in the Virtual Data Room true and complete copies of the audited consolidated balance sheet
of the Company and the Company Subsidiaries as of December 31, 2018 and the unaudited consolidated balance sheet of the Company
and Company Subsidiaries as of December 31, 2019, and the related consolidated statements of operations and cash flows of
the Company and the Company Subsidiaries for each of the years then ended (collectively, the “Annual Financial Statements”),
which are attached as Section 4.07(a) of the Company Disclosure Schedule, and which contain an unqualified report
of the Company’s auditors. Each of the Annual Financial Statements (including the notes thereto) (i) was prepared in
accordance with United States generally accepted accounting principles (“GAAP”) applied on a consistent basis
throughout the periods indicated (except as may be indicated in the notes thereto) and (ii) fairly presents, in all material
respects, the financial position, results of operations and cash flows of the Company and the Company Subsidiaries as of and at
the date thereof and for the period indicated therein, except as otherwise noted therein.
(b)
The Company has made available to HCAC in the Virtual Data Room true and complete copies of the unaudited consolidated balance
sheet of the Company and the Company Subsidiaries as of June 30, 2020 (the “Interim Financial Statements Date”),
and the related unaudited consolidated statements of operations and cash flows of the Company and the Company Subsidiaries for
the six-month period then ended (collectively, the “Interim Financial Statements”), which are attached as Section 4.07(b)
of the Company Disclosure Schedule. The Interim Financial Statements were prepared in accordance with GAAP applied on a consistent
basis throughout the periods indicated (except for the omission of footnotes and subject to year-end adjustments) and fairly present,
in all material respects, the financial position, results of operations and cash flows of the Company and the Company Subsidiaries
as of and at the date thereof and for the period indicated therein, except as otherwise noted therein and subject to normal and
recurring year-end adjustments.
(c)
Except as and to the extent set forth on the Annual Financial Statements or the Interim Financial Statements, neither the Company
nor any Company Subsidiary has any liability or obligation of a nature (whether accrued, absolute, contingent or otherwise) required
to be reflected on a balance sheet prepared in accordance with GAAP, except for: (i) liabilities that were incurred in the
ordinary course of business since the Interim Financial Statements Date, (ii) obligations for future performance under any
contract to which the Company or any Company Subsidiary is a party or (iii) such other liabilities and obligations which
are not, individually or in the aggregate, expected to result in a Company Material Adverse Effect.
(d)
Since the Formation Date, (i) neither the Company nor any Company Subsidiary nor, to the Company’s knowledge, any director,
officer, employee, auditor, accountant or Representative of the Company or any Company Subsidiary, has received or otherwise had
or obtained knowledge of any complaint, allegation, assertion or claim, whether written or, to the knowledge of the Company, oral,
regarding the accounting or auditing practices, procedures, methodologies or methods of the Company or any Company Subsidiary
or their respective internal accounting controls, including any such complaint, allegation, assertion or claim that the Company
or any Company Subsidiary has engaged in questionable accounting or auditing practices and (ii) there have been no internal
investigations regarding accounting or revenue recognition discussed with, reviewed by or initiated at the direction of the chief
executive officer, chief financial officer, general counsel, the Company Board or any committee thereof.
(e)
To the knowledge of the Company, no employee of the Company or any Company Subsidiary has provided or is providing information
to any law enforcement agency regarding the commission or possible commission of any crime or the violation or possible violation
of any applicable Law. None of the Company, any Company Subsidiary or, to the knowledge of the Company, any officer, employee,
contractor, subcontractor or agent of the Company or any Company Subsidiary, has discharged, demoted, suspended, threatened, harassed
or in any other manner discriminated against an employee of the Company or any Company Subsidiary in the terms and conditions
of employment because of any act of such employee described in 18 U.S.C. sec. 1514A(a).
(f)
All accounts receivable of the Company and the Company Subsidiaries reflected on the Interim Financial Statements or arising thereafter
have arisen from bona fide transactions in the ordinary course of business consistent with past practices and in accordance
with GAAP and are collectible, subject to bad debts reserved in the Interim Financial Statements. To the knowledge of the Company,
such accounts receivables are not subject to valid defenses, setoffs or counterclaims, other than routine credits granted for
errors in ordering, shipping, pricing, discounts, rebates, returns in the ordinary course of business and other similar matters.
The Company’s reserve for contractual allowances and doubtful accounts is adequate in all material respects and has been
calculated in a manner consistent with past practices. Since December 31, 2019, neither the Company nor any of the Company
Subsidiaries has modified or changed in any material respect its sales practices or methods including, without limitation, such
practices or methods in accordance with which the Company or any of the Company Subsidiaries sell goods, fill orders or record
sales.
(g)
All accounts payable of the Company and the Company Subsidiaries reflected on the Interim Financial Statements or arising thereafter
are the result of bona fide transactions in the ordinary course of business and have been paid or are not yet due or payable.
Since December 31, 2019, the Company and the Company Subsidiaries have not altered in any material respects their practices for
the payment of such accounts payable, including the timing of such payment.
SECTION
4.08 Absence of Certain Changes or Events. Since December 31, 2019 and prior to the date of this Agreement, except as
otherwise reflected in the Annual Financial Statements or the Interim Financial Statements, or as expressly contemplated by this
Agreement, (a) the Company and the Company Subsidiaries have conducted their respective businesses in all material respects in
the ordinary course and in a manner consistent with past practice, other than due to any actions taken due to a “shelter
in place,” “non-essential employee” or similar direction of any Governmental Authority, (b) neither the Company
or any of the Company Subsidiaries have sold, assigned, transferred, permitted to lapse, abandoned, or otherwise disposed of any
right, title or interest in or to any of their respective material assets (including Company Owned IP) other than revocable non-exclusive
licenses (or sublicenses of Company Owned IP granted in the ordinary course of business), (c) there has not been a Company
Material Adverse Effect, and (d) none of the Company or any Company Subsidiary has taken any action that, if taken after
the date of this Agreement, would constitute a material breach of any of the covenants set forth in Section 6.01.
SECTION 4.09 Absence
of Litigation. There is no material Action pending or, to the knowledge of the Company, threatened against the Company or
any Company Subsidiary, or any property or asset of the Company or any Company Subsidiary. Neither the Company nor any Company
Subsidiary nor any property or asset of the Company or any Company Subsidiary is, subject to any continuing order of, consent
decree, settlement agreement or other similar written agreement with, or, to the knowledge of the Company, continuing investigation
by, any Governmental Authority, or any order, writ, judgment, injunction, decree, determination or award of any Governmental Authority.
SECTION
4.10 Employee Benefit Plans.
(a)
Section 4.10(a) of the Company Disclosure Schedule lists, as of the date of this Agreement, all Employee Benefit Plans
that are maintained, contributed to, required to be contributed to, or sponsored by the Company or any Company Subsidiary for
the benefit of any current or former employee, officer, director or consultant, or under which the Company or any Company Subsidiary
has or could incur any liability (contingent or otherwise) (collectively, whether or not material, the “Plans”).
(b)
With respect to each Plan, the Company has made available to HCAC in the Virtual Data Room, if applicable (i) a true and
complete copy of the current plan document and all amendments thereto and each trust or other funding arrangement, (ii) copies
of the most recent summary plan description and any summaries of material modifications, (iii) a copy of the 2019 filed Internal
Revenue Service (“IRS”) Form 5500 annual report and accompanying schedules (or, if not yet filed, the
most recent draft thereof), (iv) copies of the most recently received IRS determination, opinion or advisory letter, and
(v) any material, non-routine correspondence from any Governmental Authority with respect to any Plan since the Formation
Date. Neither the Company nor any Company Subsidiary has any express commitment to modify, change or terminate any Plan, other
than with respect to a modification, change or termination required by ERISA or the Code, or other applicable Law.
(c)
None of the Plans is or was since the Formation Date, nor does the Company, any Company Subsidiary or any ERISA Affiliate have
or reasonably expect to have any liability or obligation under (i) a multiemployer plan (within the meaning of Section 3(37)
or 4001(a)(3) of ERISA), (ii) a single employer pension plan (within the meaning of Section 4001(a)(15) of ERISA) subject
to Section 412 of the Code or Title IV of ERISA, (iii) a multiple employer plan subject to Section 413(c)
of the Code, or (iv) a multiple employer welfare arrangement under ERISA. For purposes of this Agreement, “ERISA
Affiliate” means any entity that together with the Company or any Company Subsidiary would be deemed a “single
employer” for purposes of Section 4001(b)(1) of ERISA or Sections 414(b), (c) or (m) of the Code.
(d)
Neither the Company nor any Company Subsidiary is nor will be obligated, whether under any Plan or otherwise, to pay separation,
severance, termination or similar benefits to any person directly as a result of any Transaction, nor will any such Transaction
accelerate the time of payment or vesting, or increase the amount, of any benefit or other compensation due to any individual.
The Transactions shall not be the direct or indirect cause of any amount paid or payable by the Company or any Company Subsidiary
being classified as an “excess parachute payment” under Section 280G of the Code.
(e)
None of the Plans provides, nor does the Company nor any Company Subsidiary have or reasonably expect to have any obligation to
provide, medical or other welfare benefits to any current or former employee, officer, director or consultant of the Company or
any Company Subsidiary after termination of employment or service except as may be required under Section 4980B of the Code
and Part 6 of Title I of ERISA and the regulations thereunder.
(f)
Each Plan is and has been since the Formation Date in compliance, in all material respects, in accordance with its terms and the
requirements of all applicable Laws including, without limitation, ERISA and the Code. The Company, each Company Subsidiary and
their respective ERISA Affiliates have performed, in all material respects, all obligations required to be performed by them under,
are not in any material respect in default under or in violation of, and have no knowledge of any default or violation in any
material respect by any party to, any Plan. No Action is pending or, to the knowledge of the Company, threatened with respect
to any Plan (other than claims for benefits in the ordinary course) and, to the knowledge of the Company, no fact or event exists
that could reasonably be expected to give rise to any such Action.
(g)
Each Plan that is intended to be qualified under Section 401(a) of the Code has (i) timely received a favorable determination
letter from the IRS covering all of the provisions applicable to the Plan for which determination letters are currently available
that the Plan is so qualified and each trust established in connection with such Plan is exempt from federal income Tax under
Section 501(a) of the Code or (ii) is entitled to rely on a favorable opinion or advisory letter from the IRS, and to
the knowledge of Company, no fact or event has occurred since the date of such determination or opinion letter or letters from
the IRS that could reasonably be expected to adversely affect the qualified status of any such Plan or the exempt status of any
such trust.
(h)
There has not been any prohibited transaction (within the meaning of Section 406 of ERISA or Section 4975 of the Code)
nor any reportable events (within the meaning of Section 4043 of ERISA) with respect to any Plan that could reasonably be
expected to result in material liability to the Company or any of the Company Subsidiaries. There have been no acts or omissions
by the Company, any Company Subsidiary or any ERISA Affiliate that have given or could reasonably be expected to give rise to
any material fines, penalties, Taxes or related charges under Sections 502 or 4071 of ERISA or Section 511 or Chapter 43
of the Code for which the Company, any Company Subsidiary or any ERISA Affiliate may be liable.
(i)
All contributions, premiums or payments required to be made with respect to any Plan have been timely made to the extent due or
properly accrued on the consolidated financial statements of the Company and the Company Subsidiaries, except as would not result
in material liability to the Company and the Company Subsidiaries.
(j)
The Company, each Company Subsidiary and each ERISA Affiliate has complied in all material respects with the notice and continuation
coverage requirements, and all other requirements, of Section 4980B of the Code and Parts 6 and 7 of Title I of
ERISA, and the regulations thereunder, with respect to each Plan that is, or was during any taxable year for which the statute
of limitations on the assessment of federal income Taxes remains open, by consent or otherwise, a group health plan within the
meaning of Section 5000(b)(1) of the Code.
(k)
The Company, each Company Subsidiary and each Plan that is a “group health plan” as defined in Section 733(a)(1)
of ERISA (each, a “Health Plan”) is and has been in compliance, in all material respects, with the Patient
Protection and Affordable Care Act of 2010 (“PPACA”), and no event has occurred, and no condition or circumstance
exists, that could reasonably be expected to subject the Company, any Company Subsidiary, any ERISA Affiliate or any Health Plan
to any material liability for penalties or excise Taxes under Code Section 4980D or 4980H or any other provision of the PPACA.
(l)
Each Plan that constitutes a nonqualified deferred compensation plan subject to Section 409A of the Code has been administered
and operated, in all material respects, in compliance with the provisions of Section 409A of the Code and the Treasury Regulations
thereunder, and no additional Tax under Section 409A(a)(1)(B) of the Code has been or could reasonably be expected to be
incurred by a participant in any such Plan.
SECTION
4.11 Labor and Employment Matters.
(a)
Section 4.11(a) of the Company Disclosure Schedules sets forth a true, correct and complete list of all employees of the
Company and any Company Subsidiary as of the date hereof, including any employee who is on a leave of absence of any nature, authorized
or unauthorized, and sets forth for each such individual the following, on a no name basis: (i) title or position (including
whether full or part time); (ii) hire date and service date (if different); (iii) current annualized base salary or
(if paid on an hourly basis) hourly rate of pay; and (iv) commission, bonus or other incentive based compensation. As of
the date hereof, all compensation, including wages, commissions and bonuses, due and payable to all employees of the Company and
any Company Subsidiary for services performed on or prior to the date hereof have been paid in full (or accrued in full in the
Company’s financial statements).
(b)
(i) There are no material Actions pending or, to the knowledge of the Company, threatened against the Company or any Company Subsidiary
by any of their respective current or former employees; (ii) neither the Company nor any Company Subsidiary is, nor has either
the Company or any Company Subsidiary been since the Formation Date, a party to, bound by, or negotiating any collective bargaining
agreement or other contract with a union, works council or labor organization applicable to persons employed by the Company or
any Company Subsidiary, nor, to the knowledge of the Company, are there any activities or proceedings of any labor union to organize
any such employees; (iii) there are no unfair labor practice complaints pending against the Company or any Company Subsidiary
before the National Labor Relations Board; and (iv) there has never been, nor, to the knowledge of the Company, has there
been any threat of, any strike, slowdown, work stoppage, lockout, concerted refusal to work overtime or other similar labor disruption
or dispute affecting, or, to the knowledge of the Company, threat thereof, by or with respect to any employees of the Company
or any Company Subsidiary.
(c)
The Company and the Company Subsidiaries are and have been since the Formation Date in material compliance in all respects with
all applicable Laws relating to the employment, employment practices, employment discrimination, terms and conditions of employment,
mass layoffs and plant closings (including the Worker Adjustment and Retraining Notification Act of 1988, as amended, or any similar
state or local Laws), immigration, meal and rest breaks, pay equity, workers’ compensation, family and medical leave, and
occupational safety and health requirements, payment of wages, hours of work, and collective bargaining as required by the appropriate
Governmental Authority and are not liable for any material arrears of wages, penalties or other sums for failure to comply with
any of the foregoing.
SECTION
4.12 Real Property; Title to Assets.
(a)
The Company does not own any real property.
(b)
Section 4.12(b) of the Company Disclosure Schedule lists the street address of each parcel of Leased Real Property,
and sets forth a list of each lease, sublease, license or occupancy agreement pursuant to which the Company or any Company Subsidiary
leases, subleases, licenses or occupies any real property (each, a “Lease”), with the name of the lessor or
any other party thereto, and the date of the Lease in connection therewith and each material amendment to any of the foregoing
(collectively, the “Lease Documents”). True, correct and complete copies of all Lease Documents have been made
available to HCAC in the Virtual Data Room. Except as otherwise set forth in Section 4.12(b) of the Company Disclosure
Schedule, (i) there are no leases, subleases, sublicenses, concessions or other contracts granting to any person other than
the Company or Company Subsidiaries the right to use or occupy any Leased Real Property, and (ii) all such Leases are in
full force and effect, are valid and enforceable in accordance with their respective terms, subject to the Remedies Exceptions,
and there is not, under any of such Leases, any existing default or event of default (or event which, with notice or lapse of
time, or both, would constitute a default) by the Company or any Company Subsidiary or, to the Company’s knowledge, by the
other party to such Leases, except as would not, individually or in the aggregate, be material to the Company and the Company
Subsidiaries, taken as a whole. Neither the Company, nor any Company Subsidiary, has subleased, sublicensed or otherwise granted
to any person any right to use, occupy or possess any portion of the Leased Real Property.
(c)
Other than any actions taken due to a “shelter in place,” “non-essential employee” or similar direction
of any Governmental Authority, there are no contractual or legal restrictions that preclude or restrict the ability of the Company
or any Company Subsidiary to use any Leased Real Property by such party for the purposes for which it is currently being used,
except as would not, individually or in the aggregate, be material to the Company and the Company Subsidiaries, taken as a whole.
There are no latent defects or adverse physical conditions affecting the Leased Real Property, and improvements thereon, other
than those that would not have a Company Material Adverse Effect.
(d)
Each of the Company and the Company Subsidiaries has legal and valid title to, or, in the case of Leased Real Property and assets,
valid leasehold or subleasehold interests in, all of its properties and assets, tangible and intangible, real, personal and mixed,
used or held for use in its business, free and clear of all Liens other than Permitted Liens, except as would not, individually
or in the aggregate, be material to the Company and the Company Subsidiaries, taken as a whole.
SECTION
4.13 Intellectual Property.
(a)
Section 4.13(a) of the Company Disclosure Schedule contains a true, correct and complete list of all of the following
that are (as applicable) owned or purported to be owned, used or held for use by the Company or the Company Subsidiaries: (i) Registered
Intellectual Property constituting Company Owned IP (showing in each, as applicable, the filing date, date of issuance, expiration
date and registration or application number, and registrar), (ii) all material contracts or agreements to use any Company
Licensed IP, including for the Software of any other person (other than (x) commercially available, “off-the-shelf”
Software and (y) commercially available service agreements to Business Systems) where such Company Licensed IP is incorporated
into the Products; and (iii) any material Software or Business Systems constituting Company Owned IP that are incorporated
into the Products. The Company IP constitutes all Intellectual Property rights necessary for, or to the knowledge of the Company,
otherwise used in, the operation of the business of the Company and the Company Subsidiaries as currently conducted and is sufficient
for the conduct of such business as currently conducted as of the date hereof; for clarity, the Company’s only representations
of non-infringement are as set out in Section 4.13(d) hereof.
(b)
Other than as set forth in Section 4.13(b) of the Company Disclosure Schedule, the Company or one of the Company Subsidiaries
owns and possesses, free and clear of all Liens (other than Permitted Liens), all right, title and interest in and to the Company
Owned IP and has the right to use pursuant to a valid and enforceable written contract or license, all material Company Licensed
IP. All material Company Owned IP is subsisting and, to the knowledge of the Company, valid and enforceable. No loss or expiration
of any of the Company Owned IP is threatened in writing, or, to the Company’s knowledge, pending.
(c)
The Company and each of its applicable Company Subsidiaries have taken and take reasonable actions to maintain, protect and enforce
the secrecy, confidentiality and value of its trade secrets and other material Confidential Information. Neither the Company nor
any Company Subsidiaries has disclosed any trade secrets or other Confidential Information that relates to the Products or is
otherwise material to the business of the Company and any applicable Company Subsidiaries to any other person other than pursuant
to a written confidentiality agreement under which such other person agrees to maintain the confidentiality and protect such Confidential
Information.
(d)
Other than as set forth in Section 4.13(d) of the Company Disclosure Schedules, (i) there have been no claims filed and
served or material claims threatened in writing, against the Company or any Company Subsidiary, by any person (A) contesting
the validity, use, ownership, enforceability, patentability or registrability of any of the Company IP, or (B) alleging any
infringement or misappropriation of, or other violation of, any Intellectual Property rights of other persons (including any unsolicited
written demands or written offers to license any Intellectual Property rights from any other person); (ii) the operation of the
business of the Company and the Company Subsidiaries (including the Products) has not and does not infringe, misappropriate or
violate, any Intellectual Property rights of other persons provided that, with respect to patents and trademarks, such representation
is made only to the Company’s knowledge; (iii) to the Company’s knowledge, no other person has infringed, misappropriated
or violated any of the Company Owned IP; and (iv) neither the Company nor any of the Company Subsidiaries has received written
notice of any of the foregoing or received any formal written opinion of counsel regarding the foregoing.
(e)
Other than as set forth in Section 4.13(e) of the Company Disclosure Schedule, all persons who have contributed, developed
or conceived any Company Owned IP have executed valid and enforceable written agreements with the Company or one of the Company
Subsidiaries, substantially in the form made available to First Merger Sub, Second Merger Sub or HCAC in the Virtual Data Room,
and pursuant to which such persons assigned to the Company or the applicable Company Subsidiary all of their entire right, title,
and interest in and to any Intellectual Property created, conceived or otherwise developed by such person in the course of and
related to his, her or its relationship with the Company or the applicable Company Subsidiary, without further ongoing consideration
or any restrictions or obligations whatsoever, including on the use or other disposition or ownership of such Intellectual Property;
or, with respect to Intellectual Property rights that cannot be assigned (e.g., “moral rights” in certain jurisdictions),
such person has unconditionally and irrevocably waives the enforcement thereof.
(f)
Section 4.13(f) of the Company Disclosure Schedule sets forth a list of all Open Source Software that has been used
in, incorporated into, integrated or bundled with any Products, and for each such item of Open Source Software, the name
and version number of the applicable license.
(g)
The Company and Company Subsidiaries do not use and have not used any Open Source Software or any modification or derivative thereof
(i) in a manner that would grant or purport to grant to any other person any rights to or immunities under any of the Company
IP, or (ii) under any Reciprocal License, to license or provide the source code to any of the Business Systems or Product
components for the purpose of making derivative works, or to make available for redistribution to any person the source code to
any of the Business Systems or Product components at no or minimal charge.
(h)
The Company and the Company Subsidiaries owns, leases, licenses, or otherwise has the legal right to use all Business Systems,
and such Business Systems are sufficient in all material respects for the current needs of the business of the Company or any
of the Company Subsidiaries as currently conducted by the Company and/or the Company Subsidiaries. The Company and each of the
Company Subsidiaries maintain commercially reasonable disaster recovery, business continuity and risk assessment plans, procedures
and facilities. To the Company’s knowledge since the Formation Date, there has not been any material failure with respect
to any of the Business Systems that are material to the conduct of the Company’s business that has not been remedied or
replaced in all material respects.
(i)
The Company and each of the Company Subsidiaries currently and since the Formation Date have complied in all material respects
with (i) all Privacy/Data Security Laws applicable to the Company or a Company Subsidiary, (ii) any applicable privacy
or other policies of the Company or a Company Subsidiary, respectively, published on a Company website or otherwise made publicly
available by the Company or a Company Subsidiary concerning the collection, dissemination, storage or use of Personal Information
or Business Data, (iii) industry standards to which the Company or any Company Subsidiary is bound to adhere, and (iv) all
contractual commitments that the Company or any Company Subsidiary has entered into or is otherwise bound with respect to privacy
or data security (collectively, the “Data Security Requirements”). The Company and the Company Subsidiaries
have each implemented data security safeguards designed to protect the security and integrity of the Business Systems constituting
Company Owned IP and any Personal Information. The Company’s and the Company Subsidiaries’ employees and contractors
receive commercially reasonable training on information security issues. To the Company’s knowledge there is no Disabling
Device in any of the Business Systems constituting Company Owned IP or Product components. Since the Formation Date, except as
would not reasonably be expected to result in liability material to the Company or Company Subsidiary, neither the Company nor
any of the Company Subsidiaries has (i) to the Company’s knowledge, experienced any data security breaches, unauthorized
access or use of any of the Business Systems constituting Company Owned IP, or unauthorized acquisition, destruction, damage,
disclosure, loss, corruption, alteration, or use of any Personal Information or Business Data; or (ii) to the Company’s
knowledge, been subject to or received written notice of any audits, proceedings or investigations by any Governmental Authority
or any customer, or received any material claims or complaints regarding the collection, dissemination, storage or use of Personal
Information, or the violation of any applicable Data Security Requirements.
(j)
The Company or one of the Company Subsidiaries (i) owns the Business Data constituting Company Owned IP free and clear of
any restrictions other than those imposed by applicable Privacy/Data Security Laws, or (ii) has the right, as applicable,
to use, exploit, publish, reproduce, distribute, license, sell, and create derivative works of the other Business Data, in whole
or in part, in the manner in which the Company and the Company Subsidiaries receive and use such Business Data prior to the Closing
Date. The Company and the Company Subsidiaries are not subject to any material legal obligations, including based on the Transactions
contemplated hereunder, that would prohibit First Merger Sub, Second Merger Sub or HCAC from receiving or using Personal Information
after the Closing Date, in a similar manner in which the Company and the Company Subsidiaries receive and use such Personal Information
immediately prior to the Closing Date or result in material liabilities in connection with Data Security Requirements.
(k)
Neither the Company nor any Company Subsidiary is, nor has it ever been, a member or promoter of, or a contributor to, any industry
standards body or similar standard setting organization that could require or obligate the Company or any Company Subsidiary to
grant or offer to any other person any license or right to any Company Owned IP.
SECTION
4.14 Taxes.
(a)
The Company and each of its Company Subsidiaries: (i) have duly filed all material Tax Returns they are required to have
filed as of the date hereof (taking into account any extension of time within which to file) and all such filed Tax Returns are
complete and accurate in all material respects; (ii) have paid all Taxes that are shown as due on such filed Tax Returns
and any other material Taxes that they are required to have paid as of the date hereof to avoid penalties or charges for late
payment; (iii) with respect to all material Tax Returns filed by or with respect to them, have not waived any statute of
limitations with respect to Taxes or agreed to any extension of time with respect to a Tax assessment or deficiency (other than
pursuant to customary extensions of the due date for filing a Tax Return obtained in the ordinary course of business); (iv) do
not have any material deficiency, assessment, claim, audit, examination, investigation, litigation or other proceeding in respect
of Taxes or Tax matters pending or asserted, proposed or threatened in writing, for a Tax period which the statute of limitations
for assessments remains open. The unpaid Taxes of the Company and its Company Subsidiaries as of the date of the Interim Financial
Statements did not materially exceed the reserves for Taxes of the Company and the Company Subsidiaries set forth in the Interim
Financial Statements.
(b)
Neither the Company nor any Company Subsidiary is a party to, is bound by or has an obligation under any Tax sharing agreement,
Tax indemnification agreement, Tax allocation agreement or similar contract or arrangement (including any agreement, contract
or arrangement providing for the sharing or ceding of Tax credits or Tax losses) or has a liability or obligation to any person
as a result of or pursuant to any such agreement, contract, arrangement or commitment, in each case other than an agreement, contract,
arrangement or commitment the primary purpose of which does not relate to Taxes (an “Ordinary Commercial Agreement”).
(c)
Neither the Company nor any Company Subsidiary will be required to include any material item of income in, or exclude any material
item of deduction from, taxable income for any Tax period (or portion thereof) ending after the Closing Date as a result of any:
(i) change in method of accounting made prior to the Closing under Code Section 481(c) (or any corresponding or similar
provision of state, local or non-U.S. income Tax Law); (ii) “closing agreement” as described in Code Section 7121
(or any corresponding or similar provision of state, local or non-U.S. income Tax Law) executed prior to the Closing; (iii) installment
sale or open transaction disposition made prior to the Closing; (iv) intercompany transaction or any excess loss account
described in Treasury Regulations under Section 1502 of the Code (or any corresponding or similar provision of state, local
or non-U.S. Tax law) entered into or created prior to the Closing; or (v) prepaid amount received prior to the Closing outside
the ordinary course of business.
(d)
Each of the Company and its Company Subsidiaries has withheld and paid to the appropriate Tax authority all material Taxes required
to have been withheld and paid in connection with amounts paid or owing to any current or former employee, independent contractor,
creditor, shareholder or other third party and, to the Company’s knowledge, has complied (including any applicable cure
provisions) in all material respects with all applicable Laws relating to the reporting and withholding of Taxes.
(e)
Neither the Company nor any Company Subsidiary has been a member of an affiliated group filing a consolidated, combined or unitary
U.S. federal, state, local or non-U.S. income Tax Return (other than a group of which the Company or a Company Subsidiary
was the common parent).
(f)
Neither the Company nor any Company Subsidiary has any material liability for the Taxes of any person (other than the Company
and its Company Subsidiaries) under Treasury Regulation Section 1.1502-6 (or any similar provision of state, local or non-U.S.
law), as a transferee or successor, or, except pursuant to an Ordinary Commercial Agreement, by contract or otherwise.
(g)
Neither the Company nor any Company Subsidiary has any request for a material closing agreement, private letter ruling, or similar
ruling in respect of Taxes pending between the Company or any Company Subsidiary, on the one hand, and any Tax authority, on the
other hand.
(h)
The Company has made available to HCAC in the Virtual Data Room true, correct and complete copies of the U.S. federal income
Tax Return filed by the Company Subsidiaries for tax year 2018.
(i)
Neither the Company nor any Company Subsidiary has in any year for which the applicable statute of limitations remains open distributed
stock of another person, or has had its stock distributed by another person, in a transaction that was purported or intended to
be governed in whole or in part by Section 355 or Section 361 of the Code.
(j)
Neither the Company nor any Company Subsidiary has engaged in or entered into a “listed transaction” within the meaning
of Treasury Regulation Section 1.6011-4(b)(2).
(k)
Neither the IRS nor any other U.S. or non-U.S. taxing authority or agency has asserted in writing against the Company or
any Company Subsidiary any deficiency or claim for any material Taxes or interest thereon or penalties in connection therewith.
(l)
There are no Tax Liens upon any assets of the Company or any of the Company Subsidiaries except for Permitted Liens.
(m)
Neither the Company nor any Company Subsidiary has been a United States real property holding corporation within the meaning of
Section 897(c)(2) of the Code during the applicable period specified in Section 897(c)(1)(A)(ii) of the Code. Neither
the Company nor any Company Subsidiary has received written notice from a non-United States Tax authority that it has a permanent
establishment (within the meaning of an applicable Tax treaty) or otherwise has an office or fixed place of business in a country
other than the country in which it is organized.
(n)
Neither the Company nor any Company Subsidiary has received written notice of any claim from a Tax authority in a jurisdiction
in which the Company or such Company Subsidiary does not file Tax Returns stating that the Company or such Company Subsidiary
is or may be subject to Tax in such jurisdiction.
(o)
For U.S. federal income tax purposes, the Company is, and has been since its formation, classified as a corporation.
(p)
The Company, after consultation with its tax advisors, is not aware of the existence of any fact, or any action it has taken (or
failed to take) or agreed to take, that would reasonably be expected to prevent or impede the Mergers, taken together, from qualifying
for the Intended Tax Treatment.
SECTION 4.15 Environmental
Matters. (a) Each of the Company and each Company Subsidiary is, and since the Formation Date has not materially violated,
applicable Environmental Laws; (b) to the knowledge of the Company, none of the properties currently or formerly owned, leased
or operated by the Company or any Company Subsidiary (including, without limitation, soils and surface and ground waters) are
contaminated with, and no Company or Company Subsidiary has released, any Hazardous Substance which requires reporting, investigation,
remediation, monitoring or other response action by the Company or any Company Subsidiary pursuant to applicable Environmental
Laws; (c) to the Company’s knowledge, none of the Company or any of the Company Subsidiaries is, in any material respect,
actually, potentially or allegedly liable pursuant to applicable Environmental Laws for any off-site contamination by Hazardous
Substances; (d) each of the Company and each Company Subsidiary has all material permits, licenses and other authorizations required
of the Company under applicable Environmental Law (“Environmental Permits”), and the Company and each Company Subsidiary
is in compliance in all material respects with such Environmental Permits; and (e) neither the Company nor any Company Subsidiary
is the subject of any pending or, or to the Company’s knowledge, threatened Action, nor has the Company or any Company Subsidiary
received any written notice, alleging any material violation of or, or material liability under, Environmental Laws.
SECTION
4.16 Material Contracts.
(a)
Section 4.16(a) of the Company Disclosure Schedule lists, as of the date of this Agreement, the following types of
contracts and agreements to which the Company or any Company Subsidiary is a party, excluding for this purpose, any purchase orders
submitted by customers (such contracts and agreements as are required to be set forth in Section 4.16(a) of the Company
Disclosure Schedule, along with any Plan listed on Section 4.10(a) of the Company Disclosure Schedule, being the “Material
Contracts”):
(i)
all contracts and agreements with consideration payable to the Company or any of the Company Subsidiaries of more than $250,000,
in the aggregate, over any 12-month period;
(ii)
all contracts and agreements with suppliers to the Company or any Company Subsidiary, including those relating to the design,
development, manufacture or sale of Products of the Company or any Company Subsidiary, for expenditures paid or payable by the
Company or any Company Subsidiary of more than $250,000, in the aggregate, over the 12-month period prior to the date hereof,
other than purchase orders on the form of such purchase order made available in the Virtual Data Room;
(iii)
all broker, distributor, dealer, manufacturer’s representative, franchise, agency, sales promotion, market research, marketing
consulting and advertising contracts and agreements to which the Company or any Company Subsidiary is a party that are material
to the business of the Company;
(iv)
all management contracts (excluding contracts for employment) to the extent material to the business of the Company or any Company
Subsidiary;
(v)
all contracts or agreements involving the payment of royalties or other amounts calculated based upon the revenues or income of
the Company or any Company Subsidiary or income or revenues related to any Product of the Company or any Company Subsidiary to
which the Company or any Company Subsidiary is a party;
(vi)
all contracts and agreements evidencing indebtedness for borrowed money in an amount greater than $250,000, and any pledge agreements,
security agreements or other collateral agreements in which the Company or any Company Subsidiary granted to any person a security
interest in or lien on any of the property or assets of the Company or any Company Subsidiary, and all agreements or instruments
guaranteeing the debts or other obligations of any person;
(vii)
all partnership or joint venture;
(viii)
all contracts and agreements with any Governmental Authority to which the Company or any Company Subsidiary is a party, other
than any Company Permits;
(ix)
all contracts and agreements that limit, or purport to limit, the ability of the Company or any Company Subsidiary to compete
in any line of business or with any person or entity or in any geographic area or during any period of time, excluding customary
confidentiality agreements and agreements that contain customary confidentiality clauses;
(x)
all contracts or arrangements that result in any person or entity holding a power of attorney from the Company or any Company
Subsidiary that materially relates to the Company, any Company Subsidiary or materially impacts their respective business;
(xi)
all Leases, and all leases or master leases of personal property, reasonably likely to result in annual payments of $500,000 or
more in a 12-month period;
(xii)
all contracts involving use of any Company Licensed IP required to be listed in Section 4.13(a) of the Company Disclosure
Schedule that are material to the business of the Company, other than collaboration agreements entered into on the form of such
agreement made available in the Virtual Data Room;
(xiii)
all contracts which involve the license or grant of rights to Company Owned IP by the Company or the Company Subsidiaries that
are material to the business of the Company, other than collaboration agreements entered into on the form of such agreement made
available in the Virtual Data Room;
(xiv)
all contracts or agreements under which the Company has agreed to purchase goods or services from a vendor, supplier or other
person on a preferred supplier or “most favored supplier” basis;
(xv)
all contracts or agreements for the development of Company Owned IP for the benefit of the Company that are material to the Company,
other than employment, consulting and collaboration agreements entered into on the form of such agreement made available in the
Virtual Data Room, without material modification; and
(xvi)
all contracts or agreements under which any broker, finder or investment banker is entitled to any brokerage, finder’s or
other fee or commission in connection with the Transactions, or which has a fee tail still in effect, based upon arrangements
made by or on behalf of the Company or any Company Subsidiary.
(b)
Except as has not been, and would not reasonably be expected to be, individually or in the aggregate, material to the Company
and the Company Subsidiaries, taken as a whole (i) each Material Contract is a legal, valid and binding obligation of the Company
or the Company Subsidiaries and, to the knowledge of the Company, the other parties thereto, and neither the Company nor any Company
Subsidiary is in material breach or violation of, or material default under, any Material Contract nor has any Material Contract
been canceled by the other party; (ii) to the Company’s knowledge, no other party is in material breach or violation
of, or material default under, any Material Contract; and (iii) the Company and the Company Subsidiaries have not received
any written, or to the knowledge of the Company, oral claim of any material default under any such Material Contract. The Company
has furnished or made available to HCAC in the Virtual Data Room true and complete copies, in all respects, of all Material Contracts,
including amendments thereto that are material in nature.
SECTION
4.17 Insurance.
(a)
Section 4.17(a) of the Company Disclosure Schedule sets forth, with respect to each material insurance policy under
which the Company or any Company Subsidiary is an insured, a named insured or otherwise the principal beneficiary of coverage
as of the date of this Agreement (i) the names of the insurer, the principal insured and each named insured, (ii) the
policy number, (iii) the period, scope and amount of coverage and (iv) the premium most recently charged.
(b)
With respect to each such insurance policy, except as would not be expected to result in a Company Material Adverse Effect: (i) the
policy is legal, valid, binding and enforceable in accordance with its terms (subject to the Remedies Exceptions) and, except
for policies that have expired under their terms in the ordinary course, is in full force and effect; (ii) neither the Company
nor any Company Subsidiary is in material breach or default (including any such breach or default with respect to the payment
of premiums or the giving of notice), and no event has occurred which, with notice or the lapse of time, would constitute such
a material breach or default, or permit termination or modification, under the policy; and (iii) to the knowledge of the
Company, no insurer on the policy has been declared insolvent or placed in receivership, conservatorship or liquidation.
SECTION 4.18 Board
Approval; Vote Required. The Company Board, by resolutions duly adopted by unanimous vote of those voting at a meeting duly
called and held and not subsequently rescinded or modified in any way, or by unanimous written consent, has duly (a) determined
that this Agreement and the Merger are fair to and in the best interests of the Company, (b) approved this Agreement and
the Merger and declared their advisability, and (c) recommended that the shareholders of the Company approve and adopt this
Agreement and approve the Merger and directed that this Agreement and the Transactions (including the Merger) be submitted for
consideration by the Company’s shareholders. The Requisite Approval (the “Company Shareholder Approval”)
is the only vote of the holders of any class or series of capital stock or other securities of the Company necessary to adopt
this Agreement and approve the Transactions. The Written Consent, if executed and delivered, would qualify as the Company Shareholder
Approval and no additional approval or vote from any holders of any class or series of capital stock of the Company would then
be necessary to adopt this Agreement and approve the Transactions.
SECTION
4.19 Certain Business Practices.
(a)
Since the Formation Date, none of the Company, any Company Subsidiary, any of their respective directors, officers, or employees
or, to the Company’s knowledge, agents, while acting on behalf of the Company or any Company Subsidiary, has: (i) used
any funds for unlawful contributions, gifts, entertainment or other unlawful expenses related to political activity; (ii) made
any unlawful payment to foreign or domestic government officials or employees or to foreign or domestic political parties or campaigns
or violated any provision of any applicable Anti-Corruption Law; or (iii) to the extent not covered by subclause (i) and (ii),
made any payment in the nature of criminal bribery.
(b)
Since the Formation Date, none of the Company, any Company Subsidiary, any of their respective directors, officers, or employees
or, to the Company’s knowledge, agents (i) is or has been a Sanctioned Person; (ii) has transacted business with
or for the benefit of any Sanctioned Person or has otherwise violated applicable Sanctions, while acting on behalf of the Company
or any Company Subsidiary; or (iii) has violated any Ex-Im Laws while acting on behalf of the Company or any Company Subsidiary.
(c)
There are no, and since the Formation Date, there have not been any, material internal investigations, external investigations
to which the Company has knowledge of, audits, actions or proceedings pending, or any voluntary or involuntary disclosures made
to a Governmental Authority, with respect to any apparent or suspected violation by the Company, any Company Subsidiary, or any
of their respective officers, directors, employees, or agents with respect to any Anti-Corruption Laws, Sanctions, or Ex-Im Laws.
SECTION 4.20 Interested
Party Transactions. Except for employment relationships and the payment of compensation, benefits and expense reimbursements
and advances in the ordinary course of business, no director, officer or other affiliate of the Company or any Company Subsidiary,
to the Company’s knowledge, has or has had, directly or indirectly: (a) an economic interest in any person that has
furnished or sold, or furnishes or sells, services or Products that the Company or any Company Subsidiary furnishes or sells,
or proposes to furnish or sell; (b) an economic interest in any person that purchases from or sells or furnishes to, the
Company or any Company Subsidiary, any goods or services; (c) a beneficial interest in any contract or agreement disclosed
in Section 4.16(a) of the Company Disclosure Schedule; or (d) any contractual or other arrangement with the Company
or any Company Subsidiary, other than customary indemnity arrangements; provided, however, that ownership of no
more than five percent (5%) of the outstanding voting stock of a publicly traded corporation shall not be deemed an “economic
interest in any person” for purposes of this Section 4.20. The Company and the Company Subsidiaries have not,
since the Formation Date, (i) extended or maintained credit, arranged for the extension of credit or renewed an extension
of credit in the form of a personal loan to or for any director or executive officer (or equivalent thereof) of the Company, or
(ii) materially modified any term of any such extension or maintenance of credit.
SECTION 4.21 Exchange
Act. Neither the Company nor any Company Subsidiary is currently (nor has either previously been) subject to the requirements
of Section 12 of the Exchange Act.
SECTION 4.22 Brokers.
No broker, finder or investment banker is entitled to any brokerage, finder’s or other fee or commission in connection with
the Transactions based upon arrangements made by or on behalf of the Company or any Company Subsidiary.
SECTION 4.23 Exclusivity
of Representations and Warranties. Except as otherwise expressly provided in this Article IV (as modified by the
Company Disclosure Schedule), the Company hereby expressly disclaims and negates, any other express or implied representation
or warranty whatsoever (whether at Law or in equity) with respect to the Company, its affiliates, and any matter relating to any
of them, including their affairs, the condition, value or quality of the assets, liabilities, financial condition or results of
operations, or with respect to the accuracy or completeness of any other information made available to HCAC, its affiliates or
any of their respective Representatives by, or on behalf of, Company, and any such representations or warranties are expressly
disclaimed. Without limiting the generality of the foregoing, except as expressly set forth in this Agreement (as modified by
the Company Disclosure Schedule) or in the Company Officer’s Certificate, neither Company nor any other person on behalf
of Company has made or makes, any representation or warranty, whether express or implied, with respect to any projections, forecasts,
estimates or budgets made available to HCAC, its affiliates or any of their respective Representatives of future revenues, future
results of operations (or any component thereof), future cash flows or future financial condition (or any component thereof) of
the Company (including the reasonableness of the assumptions underlying any of the foregoing), whether or not included in any
management presentation or in any other information made available to HCAC, its affiliates or any of their respective Representatives
or any other person, and any such representations or warranties are expressly disclaimed.
ARTICLE
V
REPRESENTATIONS AND WARRANTIES OF HCAC, FIRST MERGER SUB AND SECOND MERGER SUB
Except
as set forth in HCAC’s disclosure schedule delivered by HCAC to the Company in connection with this Agreement (the “HCAC
Disclosure Schedule”) and in HCAC SEC Reports (to the extent the qualifying nature of such disclosure is readily apparent
from the content of such HCAC SEC Reports, but excluding disclosures referred to in “Forward-Looking Statements,”
“Risk Factors” and any other disclosures therein to the extent they are of a predictive or cautionary nature or related
to forward-looking statements), HCAC hereby represents and warrants to the Company as follows:
SECTION
5.01 Corporate Organization.
(a)
Each of HCAC, First Merger Sub, and Second Merger Sub is a company duly organized, validly existing and in good standing under
the Laws of the jurisdiction of its incorporation or organization and has the requisite corporate or limited liability power and
authority and all necessary governmental approvals to own, lease and operate its properties and to carry on its business as it
is now being conducted, except where the failure to have such power, authority and governmental approvals would not result in
a HCAC Material Adverse Effect.
(b)
First Merger Sub and Second Merger Sub are the only subsidiaries of HCAC. Except for First Merger Sub and Second Merger Sub, HCAC
does not directly or indirectly own any equity or similar interest in, or any interest convertible into or exchangeable or exercisable
for any equity or similar interest in, any corporation, partnership, joint venture, business association or other person.
SECTION 5.02 Governing
Documents. Each of HCAC, First Merger Sub and Second Merger Sub has heretofore furnished to the Company complete and correct
copies of the HCAC Organizational Documents, the First Merger Sub Organizational Documents, and the Second Merger Sub Organizational
Documents. The HCAC Organizational Documents, the First Merger Sub Organizational Documents and the Second Merger Sub Organizational
Documents are in full force and effect. Neither HCAC, First Merger Sub nor Second Merger Sub is in violation of any of the provisions
of the HCAC Organizational Documents, First Merger Sub Organizational Documents, and the Second Merger Sub Organizational Documents.
SECTION
5.03 Capitalization.
(a)
The authorized capital stock of HCAC consists of (i) 110,000,000 shares of HCAC Common Stock, par value $0.0001 per share
(“HCAC Common Stock”), with (A) 100,000,000 shares of HCAC Common Stock being designated as Class A Common
Stock (“HCAC Class A Common Stock”) and (B) 10,000,000 shares of HCAC Common Stock being designated as Class
B Common Stock (“HCAC Class B Common Stock”), and (ii) 1,000,000 shares of preferred stock, par value
$0.0001 per share (“HCAC Preferred Stock”). As of the date of this Agreement (i) 30,015,000 shares of HCAC
Class A Common Stock and 7,503,750 shares of HCAC Class B Common Stock are issued and outstanding, all of which are validly issued,
fully paid and non-assessable and not subject to any preemptive rights, (ii) no shares of HCAC Common Stock are held in the
treasury of HCAC, (iii) 13,581,500 private placement warrants (as described in the Prospectus) are issued and outstanding
and 13,581,500 shares of HCAC Class A Common Stock are issuable in respect of such private placement warrants, and (iv) 22,511,250
HCAC Public Warrants are issued and outstanding and 22,511,250 shares of HCAC Class A Common Stock are issuable in respect of
the HCAC Public Warrants (the warrants described in clauses (iii) and (iv), the “HCAC Warrants”).
As of the date of this Agreement, there are no shares of HCAC Preferred Stock issued and outstanding. Each HCAC Warrant is exercisable
for one share of HCAC Class A Common Stock at an exercise price of $11.50.
(b)
As of the date of this Agreement, the authorized share capital of First Merger Sub consists of 50,000 ordinary shares, par value
$1.00 per share (the “First Merger Sub Common Stock”). As of the date hereof, HCAC is the sole member and owner
of all (100%) of the membership interests of Second Merger Sub. All outstanding shares of First Merger Sub Common Stock have been
duly authorized, validly issued, fully paid and are non-assessable and are not subject to preemptive rights, and are held by HCAC
free and clear of all Liens, other than transfer restrictions under applicable securities Laws and the First Merger Sub Organizational
Documents. All membership interests of Second Merger Sub have been duly authorized, validly issued, fully paid and are non-assessable
and are not subject to preemptive rights, and are held by HCAC free and clear of all Liens, other than transfer restrictions under
applicable securities Laws and the Second Merger Sub Organizational Documents.
(c)
All outstanding HCAC Units, shares of HCAC Common Stock and HCAC Warrants have been issued and granted in compliance with all
applicable securities Laws and other applicable Laws and were issued free and clear of all Liens other than transfer restrictions
under applicable securities Laws and the HCAC Organizational Documents.
(d)
The Per Share Merger Consideration being delivered by HCAC hereunder shall be duly and validly issued, fully paid and nonassessable,
and each such share or other security shall be issued free and clear of preemptive rights and all Liens, other than transfer restrictions
under applicable securities Laws and the HCAC Organizational Documents. The Per Share Merger Consideration will be issued in compliance
with all applicable securities Laws and other applicable Laws and without contravention of any other person’s rights therein
or with respect thereto.
(e)
Except for securities issued pursuant to the Subscription Agreements, securities issued by HCAC pursuant to the Exchange and Cancellation
Agreement, securities issued by HCAC as permitted by this Agreement and the HCAC Warrants, HCAC has not issued any options, warrants,
preemptive rights, calls, convertible securities or other rights, agreements, arrangements or commitments of any character relating
to the issued or unissued capital stock of HCAC or obligating HCAC to issue or sell any shares of capital stock of, or other equity
interests in, HCAC. All shares of HCAC Common Stock subject to issuance as aforesaid, upon issuance on the terms and conditions
specified in the instruments pursuant to which they are issuable, will be duly authorized, validly issued, fully paid and non-assessable.
Neither HCAC nor any subsidiary of HCAC is a party to, or otherwise bound by, and neither HCAC nor any subsidiary of HCAC has
granted, any equity appreciation rights, participations, phantom equity or similar rights. Except for the Sponsor Support Agreement,
HCAC is not a party to any voting trusts, voting agreements, proxies, shareholder agreements or other agreements with respect
to the voting or transfer of HCAC Common Stock or any of the equity interests or other securities of HCAC or any of its subsidiaries.
Except with respect to the Redemption Rights and the HCAC Warrants, there are no outstanding contractual obligations of HCAC to
repurchase, redeem or otherwise acquire any shares of HCAC Common Stock. There are no outstanding contractual obligations of HCAC
to make any investment (in the form of a loan, capital contribution or otherwise) in, any person.
SECTION 5.04 Authority
Relative to This Agreement. Each of HCAC, First Merger Sub, and Second Merger Sub have all necessary corporate power and authority
to execute and deliver this Agreement, to perform its obligations hereunder and to consummate the Transactions. The execution
and delivery of this Agreement by each of HCAC, First Merger Sub, and Second Merger Sub and the consummation by each of HCAC,
First Merger Sub, and Second Merger Sub of the Transactions, have been duly and validly authorized by all necessary corporate
or limited liability company action, and no other corporate proceedings on the part of HCAC, First Merger Sub, or Second Merger
Sub are necessary to authorize this Agreement or to consummate the Transactions (other than (a) with respect to the Mergers,
(i) the approval and adoption of this Agreement by the holders of a majority of the then-outstanding shares of HCAC Common Stock,
by HCAC, as the sole shareholder of First Merger Sub, either at a duly convened meeting of the sole shareholder of First Merger
Sub or by written consent, and by the holders of a majority of the then-outstanding membership interests of Second Merger, and
(ii) the filing and recordation of appropriate merger documents as required by the Cayman Companies Law and DLLCA, and (b) with
respect to the issuance of HCAC Common Stock and the amendment and restatement of the HCAC Certificate of Incorporation pursuant
to this Agreement, the approval of a majority of the then-outstanding shares of HCAC Common Stock). This Agreement has been duly
and validly executed and delivered by HCAC, First Merger Sub and Second Merger Sub and, assuming due authorization, execution
and delivery by the Company, constitutes a legal, valid and binding obligation of HCAC, First Merger Sub, or Second Merger Sub,
enforceable against HCAC, First Merger Sub, or Second Merger Sub in accordance with its terms subject to the Remedies Exceptions.
SECTION
5.05 No Conflict; Required Filings and Consents.
(a)
The execution and delivery of this Agreement by each of HCAC, First Merger Sub and Second Merger Sub do not, and the performance
of this Agreement by each of HCAC, First Merger Sub, and Second Merger Sub will not, (i) conflict with or violate the HCAC
Organizational Documents, the First Merger Sub Organizational Documents or the Second Merger Sub Organizational Documents, (ii) assuming
that all consents, approvals, authorizations, expiration or termination of waiting periods and other actions described in Section 5.05(b) have
been obtained and all filings and obligations described in Section 5.05(b) have been made, conflict with or violate
any Law applicable to each of HCAC, First Merger Sub or Second Merger Sub or by which any of their property or assets is bound
or affected, or (iii) result in any breach of, or constitute a default (or an event which, with notice or lapse of time or
both, would become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation of,
or result in the creation of a Lien on any property or asset of each of HCAC, First Merger Sub, or Second Merger Sub pursuant
to, any note, bond, mortgage, indenture, contract, agreement, lease, license, permit, franchise or other instrument or obligation
to which each of HCAC, First Merger Sub, or Second Merger Sub is a party or by which each of HCAC, First Merger Sub, or Second
Merger Sub or any of their property or assets is bound or affected, except, with respect to clauses (ii) and (iii),
for any such conflicts, violations, breaches, defaults or other occurrences which would not have or reasonably be expected to
have a HCAC Material Adverse Effect.
(b)
The execution and delivery of this Agreement by each of HCAC, First Merger Sub, and Second Merger Sub do not, and the performance
of this Agreement by each of HCAC, First Merger Sub, and Second Merger Sub will not, require any consent, approval, authorization
or permit of, or filing with or notification to, or expiration or termination of any waiting period by, any Governmental Authority,
except (i) for applicable requirements, if any, of the Exchange Act, the Securities Act, Blue Sky Laws and state takeover
Laws, the pre-merger notification requirements of the HSR Act, and filing and recordation of appropriate merger documents as required
by the Cayman Companies Law and (ii) where the failure to obtain such consents, approvals, authorizations or permits, or
to make such filings or notifications, would not, individually or in the aggregate, prevent or materially delay consummation of
any of the Transactions or otherwise prevent HCAC, First Merger Sub, or Second Merger Sub from performing its material obligations
under this Agreement.
SECTION 5.06 Compliance.
Neither HCAC, First Merger Sub, nor Second Merger Sub is or has been in conflict with, or in default, breach or violation of,
(a) any Law applicable to HCAC, First Merger Sub, or Second Merger Sub or by which any property or asset of HCAC, First Merger
Sub, or Second Merger Sub is bound or affected, or (b) any note, bond, mortgage, indenture, contract, agreement, lease, license,
permit, franchise or other instrument or obligation to which HCAC, First Merger Sub, or Second Merger Sub is a party or by which
HCAC, First Merger Sub, or Second Merger Sub or any property or asset of HCAC, First Merger Sub or Second Merger Sub is bound,
except, in each case, for any such conflicts, defaults, breaches or violations that would not have or reasonably be expected to
have a HCAC Material Adverse Effect. Each of HCAC, First Merger Sub, and First Merger Sub is in possession of all material franchises,
grants, authorizations, licenses, permits, easements, variances, exceptions, consents, certificates, approvals and orders of any
Governmental Authority necessary for HCAC, First Merger Sub, or Second Merger Sub to own, lease and operate its properties or
to carry on its business as it is now being conducted.
SECTION
5.07 SEC Filings; Financial Statements; Sarbanes-Oxley.
(a)
HCAC has filed all forms, reports, schedules, statements and other documents, including any exhibits thereto, required to be filed
by it with the Securities and Exchange Commission (the “SEC”) since February 28, 2019, together with any amendments,
restatements or supplements thereto (collectively, the “HCAC SEC Reports”). HCAC has heretofore furnished to
the Company true and correct copies of all amendments and modifications that have not been filed by HCAC with the SEC to all agreements,
documents and other instruments that previously had been filed by HCAC with the SEC and are currently in effect. As of their respective
dates, the HCAC SEC Reports (i) complied in all material respects with the applicable requirements of the Securities Act,
the Exchange Act and the Sarbanes-Oxley Act of 2002 and the rules and regulations promulgated thereunder (the “Sarbanes-Oxley
Act”), and (ii) did not, at the time they were filed, or, if amended, as of the date of such amendment, contain
any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to
make the statements made therein, in the light of the circumstances under which they were made, not misleading. Each director
and executive officer of HCAC has filed with the SEC on a timely basis all documents required with respect to HCAC by Section 16(a)
of the Exchange Act.
(b)
Each of the financial statements (including, in each case, any notes thereto) contained in the HCAC SEC Reports was prepared in
accordance with GAAP (applied on a consistent basis) and Regulation S-X and Regulation S-K, as applicable, throughout the
periods indicated (except as may be indicated in the notes thereto or, in the case of unaudited financial statements, as permitted
by Form 10-Q of the SEC) and each fairly presents, in all material respects, the financial position, results of operations,
changes in stockholders equity and cash flows of HCAC as at the respective dates thereof and for the respective periods indicated
therein, (subject, in the case of unaudited statements, to normal and recurring year-end adjustments which have not had, and would
not reasonably be expected to individually or in the aggregate be material). HCAC has no off-balance sheet arrangements that are
not disclosed in the HCAC SEC Reports. No financial statements other than those of HCAC are required by GAAP to be included in
the consolidated financial statements of HCAC.
(c)
Except as and to the extent set forth in the HCAC SEC Reports, neither HCAC, First Merger Sub nor Second Merger Sub has any liability
or obligation of a nature (whether accrued, absolute, contingent or otherwise) required to be reflected on a balance sheet prepared
in accordance with GAAP, except for liabilities and obligations arising in the ordinary course of HCAC’s, First Merger Sub’s
and Second Merger Sub’s business.
(d)
HCAC is in compliance in all material respects with the applicable listing and corporate governance rules and regulations of the
Nasdaq Capital Market.
(e)
HCAC has established and maintains disclosure controls and procedures (as defined in Rule 13a-15 under the Exchange Act).
Such disclosure controls and procedures are designed to ensure that material information relating to HCAC and other material information
required to be disclosed by HCAC in the reports and other documents that it files or furnishes under the Exchange Act is recorded,
processed, summarized and reported within the time periods specified in the rules and forms of the SEC, and that all such material
information is accumulated and communicated to HCAC’s principal executive officer and its principal financial officer as
appropriate to allow timely decisions regarding required disclosure and to make the certifications required pursuant to Sections 302
and 906 of the Sarbanes-Oxley Act. Such disclosure controls and procedures are effective in timely alerting HCAC’s principal
executive officer and principal financial officer to material information required to be included in HCAC’s periodic reports
required under the Exchange Act.
(f)
HCAC maintains systems of internal control over financial reporting that are sufficient to provide reasonable assurance regarding
the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP,
including policies and procedures sufficient to provide reasonable assurance: (i) that HCAC maintains records that in reasonable
detail accurately and fairly reflect, in all material respects, its transactions and dispositions of assets; (ii) that transactions
are recorded as necessary to permit the preparation of financial statements in conformity with GAAP; (iii) that receipts
and expenditures are being made only in accordance with authorizations of management and its board of directors; and (iv) regarding
prevention or timely detection of unauthorized acquisition, use or disposition of its assets that could have a material effect
on its financial statements. HCAC has delivered to the Company a true and complete copy of any disclosure (or, if unwritten, a
summary thereof) by any representative of HCAC to HCAC’s independent auditors relating to any material weaknesses in internal
controls and any significant deficiencies in the design or operation of internal controls that would adversely affect the ability
of HCAC to record, process, summarize and report financial data. HCAC has no knowledge of any fraud or whistle-blower allegations,
whether or not material, that involve management or other employees or consultants who have or had a significant role in the internal
control over financial reporting of HCAC. Since March 31, 2020, there have been no material changes in HCAC internal control over
financial reporting.
(g)
There are no outstanding loans or other extensions of credit made by HCAC to any executive officer (as defined in Rule 3b-7
under the Exchange Act) or director of HCAC and HCAC has not taken any action prohibited by Section 402 of the Sarbanes-Oxley
Act.
(h)
Neither HCAC (including any employee thereof) nor HCAC’s independent auditors has identified or been made aware of (i) any
significant deficiency or material weakness in the system of internal accounting controls utilized by HCAC, (ii) any fraud,
whether or not material, that involves HCAC’s management or other employees who have a role in the preparation of financial
statements or the internal accounting controls utilized by HCAC or (iii) any claim or allegation regarding any of the foregoing.
(i)
As of the date hereof, there are no outstanding SEC comments from the SEC with respect to the HCAC SEC Reports. To the knowledge
of HCAC, none of the HCAC SEC Reports filed on or prior to the date hereof is subject to ongoing SEC review or investigation as
of the date hereof.
SECTION 5.08 Absence
of Certain Changes or Events. Since December 31, 2019, except as expressly contemplated by this Agreement, (a) HCAC has
conducted its business in all material respects in the ordinary course and in a manner consistent with past practice, other than
due to any actions taken due to a “shelter in place,” “non-essential employee” or similar direction of
any Governmental Authority, (b) there has not been any HCAC Material Adverse Effect, and (c) HCAC has not taken any action
that, if taken after the date of this Agreement, would constitute a material breach of any of the covenants set forth in Section
6.02.
SECTION 5.09 Absence
of Litigation. There is no Action pending or, to the knowledge of HCAC, threatened against HCAC, or any property or asset
of HCAC, before any Governmental Authority. Neither HCAC nor any material property or asset of HCAC is subject to any continuing
order of, consent decree, settlement agreement or other similar written agreement with, or, to the knowledge of HCAC, continuing
investigation by, any Governmental Authority, or any order, writ, judgment, injunction, decree, determination or award of any
Governmental Authority.
SECTION
5.10 Board Approval; Vote Required.
(a)
The HCAC Board, by resolutions duly adopted by majority vote of those voting at a meeting duly called and held and not subsequently
rescinded or modified in any way, has duly (i) determined that this Agreement and the Transactions are fair to and in the
best interests of HCAC and its stockholders, (ii) approved this Agreement and the Transactions and declared their advisability,
and (iii) recommended that the stockholders of HCAC approve and adopt this Agreement and the Mergers, and directed that this
Agreement and the Mergers, be submitted for consideration by the stockholders of HCAC at the HCAC Stockholders’ Meeting.
(b)
The only vote of the holders of any class or series of capital stock of HCAC necessary to approve the Transactions is the affirmative
vote of the holders of a majority of the outstanding shares of HCAC Common Stock.
(c)
The First Merger Sub Board and Second Merger Sub Board, by resolutions duly adopted by written consent and not subsequently rescinded
or modified in any way, have each duly (i) determined that this Agreement and the Mergers are fair to and in the best interests
of First Merger Sub, Second Merger Sub, and their sole stockholder or member, (ii) approved this Agreement and the Mergers
and declared their advisability, and (iii) recommended that the sole stockholder or member of First Merger Sub and Second
Merger Sub, respectively, approve and adopt this Agreement and approve the Mergers and directed that this Agreement and the Transactions
be submitted for consideration by the sole stockholder and member of First Merger Sub and Second Merger Sub, respectively.
(d)
The only vote of the holders of any class or series of capital stock of First Merger Sub and Second Merger Sub that is necessary
to approve this Agreement, the Mergers and the other transactions contemplated by this Agreement is the affirmative vote of the
holders of a majority of the outstanding shares of First Merger Sub Common Stock and the affirmative vote of the holders of a
majority of the outstanding membership interests of Second Merger Sub.
SECTION 5.11 No
Prior Operations of First Merger Sub and Second Merger Sub. First Merger Sub and Second Merger Sub were formed solely for
the purpose of engaging in the Transactions and have not engaged in any business activities or conducted any operations or incurred
any obligation or liability, other than as contemplated by this Agreement.
SECTION 5.12 Brokers.
Except as set forth on Section 5.12 of the HCAC Disclosure Schedule, no broker, finder or investment banker is entitled
to any brokerage, finder’s or other fee or commission in connection with the Transactions based upon arrangements made by
or on behalf of HCAC, First Merger Sub, or Second Merger Sub.
SECTION 5.13 HCAC
Trust Fund. As of the date of this Agreement, HCAC has no less than $308,737,340 in the trust fund established by HCAC for
the benefit of its public stockholders (the “Trust Fund”) maintained in a trust account (the “Trust
Account”). The monies of such Trust Account are invested in United States Government securities or money market funds
meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act of 1940, as amended, and held in
trust by Continental Stock Transfer & Trust Company (the “Trustee”) pursuant to the Investment Management
Trust Agreement, dated as of February 28, 2019, between HCAC and the Trustee (the “Trust Agreement”). The Trust
Agreement has not been amended or modified and is valid and in full force and effect and is enforceable in accordance with its
terms, subject to the Remedies Exceptions. HCAC has complied in all material respects with the terms of the Trust Agreement and
is not in breach thereof or default thereunder and there does not exist under the Trust Agreement any event which, with the giving
of notice or the lapse of time, would constitute such a breach or default by HCAC or the Trustee. There are no separate contracts,
agreements, side letters or other understandings (whether written or unwritten, express or implied): (i) between HCAC and
the Trustee that would cause the description of the Trust Agreement in the HCAC SEC Reports to be inaccurate in any material respect;
or (ii) to the knowledge of HCAC, that would entitle any person (other than stockholders of HCAC who shall have elected to
redeem their shares of HCAC Class A Common Stock pursuant to the HCAC Organizational Documents) to any portion of the proceeds
in the Trust Account. Prior to the Closing, none of the funds held in the Trust Account may be released except: (A) to pay
income and franchise Taxes from any interest income earned in the Trust Account; and (B) upon the exercise of Redemption
Rights in accordance with the provisions of the HCAC Organizational Documents. As of the date hereof, there are no Actions pending
or, to the knowledge of HCAC, threatened in writing with respect to the Trust Account. Upon consummation of the Mergers and notice
thereof to the Trustee pursuant to the Trust Agreement, HCAC shall cause the Trustee to, and the Trustee shall thereupon be obligated
to, release to HCAC as promptly as practicable, the Trust Funds in accordance with the Trust Agreement at which point the Trust
Account shall terminate; provided, however, that the liabilities and obligations of HCAC due and owing or incurred
at or prior to the Effective Time shall be paid as and when due, including all amounts payable (a) to stockholders of HCAC who
shall have exercised their Redemption Rights and (b) to the Trustee for fees and costs incurred in accordance with the Trust Agreement.
As of the date hereof, assuming the accuracy of the representations and warranties of the Company herein and the compliance by
the Company with its respective obligations hereunder, HCAC has no reason to believe that any of the conditions to the use of
funds in the Trust Account will not be satisfied or funds available in the Trust Account will not be available to HCAC at the
Effective Time.
SECTION
5.14 Employees. Other than any officers as described in the HCAC SEC Reports and consultants and advisors in the ordinary
course of business, HCAC, First Merger Sub and Second Merger Sub have never employed any employees or retained any contractors.
Other than reimbursement of any out-of-pocket expenses incurred by HCAC’s officers and directors in connection with activities
on HCAC’s behalf in an aggregate amount not in excess of the amount of cash held by HCAC outside of the Trust Account, HCAC
has no unsatisfied material liability with respect to any officer or director. HCAC, First Merger Sub and Second Merger Sub have
never and do not currently maintain, sponsor, or contribute to or have any direct or material liability under any Employee Benefit
Plan.
SECTION
5.15 Taxes.
(a)
HCAC, First Merger Sub, and Second Merger Sub (i) have duly filed all material Tax Returns they are required to have filed
as of the date hereof (taking into account any extension of time within which to file) and all such filed Tax Returns are complete
and accurate in all material respects; (ii) have paid all Taxes that are shown as due on such filed Tax Returns and any other
material Taxes that they are required to have paid as of the date hereof to avoid penalties or charges for late payment; (iii) with
respect to all material Tax Returns filed by or with respect to them, have not waived any statute of limitations with respect
to Taxes or agreed to any extension of time with respect to a Tax assessment or deficiency (other than pursuant to customary extensions
of the due date for filing a Tax Return obtained in the ordinary course of business); (iv) do not have any material deficiency,
assessment, claim, audit, examination, investigation, litigation or other proceeding in respect of Taxes or Tax matters pending
or asserted, proposed or threatened in writing, for a Tax period which the statute of limitations for assessments remains open;
and (v) have provided adequate reserves in accordance with GAAP in the most recent consolidated financial statements of HCAC,
for any material Taxes of HCAC as of the date of such financial statements that have not been paid.
(b)
Neither HCAC, First Merger Sub, nor Second Merger Sub is a party to, is bound by or has an obligation under any Tax sharing agreement,
Tax indemnification agreement, Tax allocation agreement or similar contract or arrangement (including any agreement, contract
or arrangement providing for the sharing or ceding of Tax credits or Tax losses) or has a liability or obligation to any person
as a result of or pursuant to any such agreement, contract, arrangement or commitment, in each case other than an Ordinary Commercial
Agreement.
(c)
None of HCAC, First Merger Sub or Second Merger Sub will be required to include any material item of income in, or exclude any
material item of deduction from, taxable income for any Tax period (or portion thereof) ending after the Closing Date as a result
of any: (i) change in method of accounting made prior to the Closing under Code Section 481(c) (or any corresponding
or similar provision of state, local or non-U.S. income Tax Law); (ii) “closing agreement” as described in Code
Section 7121 (or any corresponding or similar provision of state, local or non-U.S. income Tax Law) executed prior to the
Closing; (iii) installment sale or open transaction disposition made prior to the Closing; (iv) intercompany transaction
or any excess loss account described in Treasury Regulations under Section 1502 of the Code (or any corresponding or similar
provision of state, local or non-U.S. Tax law) entered into or created prior to the Closing; or (v) prepaid amount received
prior to the Closing outside the ordinary course of business.
(d)
Each of HCAC, First Merger Sub, and Second Merger Sub has withheld and paid to the appropriate Tax authority all material Taxes
required to have been withheld and paid in connection with amounts paid or owing to any current or former employee, independent
contractor, creditor, shareholder or other third party and, to HCAC’s knowledge, has complied (including any applicable
cure provisions) in all material respects with all applicable Laws relating to the reporting and withholding of Taxes.
(e)
Neither HCAC, First Merger Sub, nor Second Merger Sub has been a member of an affiliated group filing a consolidated, combined
or unitary U.S. federal, state, local or non-U.S. income Tax Return.
(f)
Neither HCAC, First Merger Sub, nor Second Merger Sub has any material liability for the Taxes of any person (other than HCAC,
First Merger Sub, and Second Merger Sub) under Treasury Regulation Section 1.1502-6 (or any similar provision of state, local
or non-U.S. law), as a transferee or successor, or, except pursuant to an Ordinary Commercial Agreement, by contract or otherwise.
(g)
Neither HCAC, First Merger Sub, nor Second Merger Sub has any request for a material closing agreement, private letter ruling,
or similar ruling in respect of Taxes pending between HCAC, First Merger Sub, or Second Merger Sub, on the one hand, and any Tax
authority, on the other hand.
(h)
Neither HCAC, First Merger Sub, nor Second Merger Sub has in any year for which the applicable statute of limitations remains
open distributed stock of another person, or has had its stock distributed by another person, in a transaction that was purported
or intended to be governed in whole or in part by Section 355 or Section 361 of the Code.
(i)
Neither HCAC, First Merger Sub, nor Second Merger Sub has engaged in or entered into a “listed transaction” within
the meaning of Treasury Regulation Section 1.6011-4(b)(2).
(j)
Neither the IRS nor any other U.S. or non-U.S. taxing authority or agency has asserted in writing against HCAC, First Merger
Sub, or Second Merger Sub any deficiency or claim for any material Taxes or interest thereon or penalties in connection therewith.
(k)
There are no Tax liens upon any assets of HCAC, First Merger Sub, or Second Merger Sub except for Permitted Liens.
(l)
Neither HCAC, First Merger Sub, nor Second Merger Sub has been a United States real property holding corporation within the meaning
of Section 897(c)(2) of the Code during the applicable period specified in Section 897(c)(1)(A)(ii) of the Code. Neither
HCAC, First Merger Sub, nor Second Merger Sub has received written notice from a non-United States Tax authority that it
has a permanent establishment (within the meaning of an applicable Tax treaty) or otherwise has an office or fixed place of business
in a country other than the country in which it is organized.
(m)
Neither HCAC, First Merger Sub, nor Second Merger Sub has received written notice of any claim from a Tax authority in a jurisdiction
in which HCAC, First Merger Sub, or Second Merger Sub does not file Tax Returns stating that HCAC, First Merger Sub or Second
Merger Sub is or may be subject to Tax in such jurisdiction.
(n)
For U.S. federal income tax purposes, HCAC is, and has been since its formation, classified as a corporation, and Second
Merger Sub is, and has been since its formation, classified as an entity disregarded as separate from HCAC.
(o)
HCAC, First Merger Sub, and Second Merger Sub, after consultation with their tax advisors, are not aware of the existence of any
fact, or any action it has taken (or failed to take) or agreed to take, that would reasonably be expected to prevent or impede
the Mergers, taken together, from qualifying for the Intended Tax Treatment.
SECTION 5.16 Registration
and Listing. The issued and outstanding HCAC Units are registered pursuant to Section 12(b) of the Exchange Act and are
listed for trading on the Nasdaq Capital Market under the symbol “HCACU.” The issued and outstanding shares of HCAC
Class A Common Stock are registered pursuant to Section 12(b) of the Exchange Act and are listed for trading on the Nasdaq
Capital Market under the symbol “HCAC.” The issued and outstanding HCAC Warrants that were included as part of the
HCAC Units (the “HCAC Public Warrants”) are registered pursuant to Section 12(b) of the Exchange Act and
are listed for trading on the Nasdaq Capital Market under the symbol “HCACW.” As of the date of this Agreement, there
is no Action pending or, to the knowledge of HCAC, threatened in writing against HCAC by the Nasdaq Capital Market or the SEC
with respect to any intention by such entity to deregister the HCAC Units, the shares of HCAC Class A Common Stock, or HCAC Warrants
or terminate the listing of HCAC on the Nasdaq Capital Market. None of HCAC or any of its affiliates has taken any action in an
attempt to terminate the registration of the HCAC Units, the shares of HCAC Class A Common Stock, or the HCAC Warrants under the
Exchange Act.
SECTION 5.17 HCAC’s,
First Merger Subs’ and Second Merger Sub’s Investigation and Reliance. Each of HCAC, First Merger Sub, and Second
Merger Sub is a sophisticated purchaser and has made its own independent investigation, review and analysis regarding the Company
and any Company Subsidiary and the Transactions, which investigation, review and analysis were conducted by HCAC, First Merger
Sub, and Second Merger Sub together with expert advisors, including legal counsel, that they have engaged for such purpose. HCAC,
First Merger Sub, and Second Merger Sub and their Representatives have been provided with full and complete access to the Representatives,
properties, offices, plants and other facilities, books and records of the Company and any Company Subsidiary and other information
that they have requested in connection with their investigation of the Company and the Company Subsidiaries and the Transactions.
Neither HCAC, First Merger Sub, nor Second Merger Sub is relying on any statement, representation or warranty, oral or written,
express or implied, made by the Company or any Company Subsidiary or any of their respective Representatives, except as expressly
set forth in Article IV (as modified by the Company Disclosure Schedule). Neither the Company nor any of its respective
shareholders, affiliates or Representatives shall have any liability to HCAC, First Merger Sub, and Second Merger Sub or any of
their respective stockholders, affiliates or Representatives resulting from the use of any information, documents or materials
made available to HCAC, First Merger Sub, or Second Merger Sub or any of their Representatives, whether orally or in writing,
in any confidential information memoranda, “data rooms,” management presentations, due diligence discussions or in
any other form in expectation of the Transactions. Neither the Company nor any of its stockholders, affiliates or Representatives
is making, directly or indirectly, any representation or warranty with respect to any estimates, projections or forecasts involving
the Company or any Company Subsidiary.
ARTICLE
VI
CONDUCT OF BUSINESS PENDING THE MERGER
SECTION
6.01 Conduct of Business by the Company Pending the Mergers.
(a)
The Company agrees that, between the date of this Agreement and the Effective Time or the earlier termination of this Agreement,
except as (1) expressly contemplated by any other provision of this Agreement or any Ancillary Agreement, (2) as set
forth in Section 6.01 of the Company Disclosure Schedule, and (3) as required by applicable Law (including as
may be requested or compelled by any Governmental Authority), unless HCAC shall otherwise consent in writing (which consent shall
not be unreasonably conditioned, withheld or delayed):
(i)
the Company shall, and shall cause the Company Subsidiaries to, conduct their business in the ordinary course of business; and
(ii)
the Company shall use its reasonable best efforts to preserve substantially intact the business organization of the Company and
the Company Subsidiaries, to keep available the services of the current officers, key employees and consultants of the Company
and the Company Subsidiaries and to preserve the current relationships of the Company and the Company Subsidiaries with customers,
suppliers and other persons with which the Company or any Company Subsidiary has significant business relations.
(b)
By way of amplification and not limitation, except as (1) expressly contemplated by any other provision of this Agreement
or any Ancillary Agreement, (2) as set forth in Section 6.01 of the Company Disclosure Schedule, and (3) as
required by applicable Law (including as may be requested or compelled by any Governmental Authority), the Company shall not,
and shall cause each Company Subsidiary not to, between the date of this Agreement and the Effective Time or the earlier termination
of this Agreement, directly or indirectly, do any of the following without the prior written consent of HCAC (which consent shall
not be unreasonably conditioned, withheld or delayed):
(i)
amend or otherwise change its certificate of incorporation or bylaws or equivalent organizational documents;
(ii)
issue, sell, pledge, dispose of, grant or encumber, or authorize the issuance, sale, pledge, disposition, grant or encumbrance
of, (A) any shares of any class of capital stock of the Company or any Company Subsidiary, or any options, warrants, restricted
share units, convertible securities or other rights of any kind to acquire any shares of such capital stock, or any other ownership
interest (including, without limitation, any phantom interest), of the Company or any Company Subsidiary, provided that
the exercise or settlement of any Company Options or grants of Company Options or Company Share Awards in the ordinary course
of business shall not require the consent of HCAC; or (B) any material assets of the Company or any Company Subsidiary;
(iii)
acquire any equity interest or other interest in any other entity or enter into a joint venture or business association with any
other entity;
(iv)
declare, set aside, make or pay any dividend or other distribution, payable in cash, stock, property or otherwise, with respect
to any of its capital stock;
(v)
reclassify, combine, split, subdivide or redeem, or purchase or otherwise acquire, directly or indirectly, any of its capital
stock, other than redemptions of equity securities from former employees upon the terms set forth in the underlying agreements
governing such equity securities;
(vi)
(A) acquire (including, without limitation, by merger, consolidation, or acquisition of stock or substantially all of the assets
or any other business combination) any corporation, partnership, other business organization or any division thereof; or (B) incur
any indebtedness for borrowed money or issue any debt securities or assume, guarantee or endorse, or otherwise become responsible
for, the obligations of any person, or make any loans or advances, or intentionally grant any security interest in any of its
assets, in excess of $1,000,000 in the aggregate;
(vii)
(A) grant any increase in the compensation, incentives or benefits payable or to become payable to any current or former director,
officer, employee or consultant Company or any Company Subsidiary, (B) enter into any new, or materially amend any existing, employment,
retention, bonus, change in control, or termination agreement with any current or former director, officer, employee or consultant,
(C) accelerate or commit to accelerate the funding, payment, or vesting of any compensation or benefits to any current or former
director, officer, employee or consultant, (D) establish or become obligated under any collective bargaining agreement or other
contract or agreement with a labor union, trade union, works council, or other representative of employees, (E) hire any new employee
whose individual base compensation shall exceed $250,000, except that the Company may (1) provide increases in salary, wages,
bonuses or benefits to employees as required or permitted under any Plan or other employment or consulting agreement in effect
on the date of this Agreement, (2) change the title of its employees in the ordinary course of business, (3) make annual or quarterly
bonus or commission payments in the ordinary course of business and in accordance with the bonus or commission plans existing
on the date of this Agreement, and (4) enter into the retention agreements with executive officers, key employees or directors
set forth on Section 6.01(b)(vii) of the Company Disclosure Schedule);
(viii)
other than as required by Law or pursuant to the terms of an agreement entered into prior to the date of this Agreement and reflected
on Section 4.10(a) of the Company Disclosure Schedule, grant any severance or termination pay to, any employee or
director or officer of the Company or of any Company Subsidiary other than in the ordinary course of business;
(ix)
adopt, amend or terminate any material Plan or any Employee Benefit Plan that would be a Plan if in effect as of the date hereof
except as may be required by applicable Law, is necessary in order to consummate the Transactions, or health and welfare plan
renewals in the ordinary course of business;
(x)
materially amend or change any of the Company’s or any Company Subsidiary’s accounting policies or procedures, other
than reasonable and usual amendments in the ordinary course of business;
(xi)
make any material tax election, amend a material Tax Return or settle or compromise any material United States federal, state,
local or non-United States income tax liability;
(xii)
materially amend, or modify or consent to the termination (excluding any expiration in accordance with its terms) of any Material
Contract or amend, waive, modify or consent to the termination (excluding any expiration in accordance with its terms) of the
Company’s or any Company Subsidiary’s material rights thereunder, in each case in a manner that is adverse to the
Company or any Company Subsidiary, taken as a whole, except in the ordinary course of business;
(xiii)
fail to use reasonable efforts to protect and maintain, material Company IP;
(xiv)
intentionally permit any material item of Company IP to lapse or to be abandoned, invalidated, dedicated to the public, or disclaimed,
or otherwise become unenforceable or fail to perform or make any applicable filings, recordings or other similar actions or filings,
or fail to pay all required fees and Taxes required or advisable to maintain and protect its interest in each and every material
item of Company IP;
(xv)
waive, release, assign, settle or compromise any Action, other than waivers, releases, assignments, settlements or compromises
that are solely monetary in nature and do not exceed $200,000 individually or $500,000 in the aggregate; or
(xvi)
enter into any formal or informal agreement or otherwise make a binding commitment to do any of the foregoing.
Nothing
herein shall require the Company to obtain consent from HCAC to do any of the foregoing if obtaining such consent might reasonably
be expected to violate applicable Law, and nothing contained in this Section 6.01 shall give to HCAC, directly or indirectly,
the right to control or direct the ordinary course of business operations of the Company or any of the Company Subsidiaries prior
to the Closing Date. Prior to the Closing Date, each of HCAC and the Company shall exercise, consistent with the terms and conditions
hereof, complete control and supervision of its respective operations.
SECTION 6.02 Conduct of Business by
HCAC, First Merger Sub, and Second Merger Sub Pending the Mergers. Except as expressly contemplated by any other provision of
this Agreement or any Ancillary Agreement (including entering into various Subscription Agreements and consummating the Private
Placements), and except as set forth on Section 6.02 of the Company Disclosure Schedule and as required by applicable
Law (including as may be requested or compelled by any Governmental Authority), HCAC agrees that from the date of this Agreement
until the earlier of the termination of this Agreement and the Effective Time, unless the Company shall otherwise consent in writing
(which consent shall not be unreasonably withheld, delayed or conditioned), the businesses of HCAC, First Merger Sub, and Second
Merger Sub shall be conducted in the ordinary course of business and in a manner consistent with past practice. By way of amplification
and not limitation, except as expressly contemplated by any other provision of this Agreement or any Ancillary Agreement (including
entering into various Subscription Agreements and consummating the Private Placements or the transactions contemplated by the
Exchange and Cancellation Agreement), or in connection with the terms and conditions of, any Subscription Agreement, as set forth
on Section 6.02 of the Company Disclosure Schedule or as required by applicable Law (including as may be requested
or compelled by any Governmental Authority), neither HCAC, first Merger Sub, nor Second Merger Sub shall, between the date of
this Agreement and the Effective Time or the earlier termination of this Agreement, directly or indirectly, do any of the following
without the prior written consent of the Company, which consent shall not be unreasonably withheld, delayed or conditioned:
(a)
amend or otherwise change the HCAC Organizational Documents, First Merger Sub Organizational Documents or the Second Merger Sub
Organizational Documents or form any subsidiary of HCAC other than First Merger Sub and Second Merger Sub;
(b)
declare, set aside, make or pay any dividend or other distribution, payable in cash, stock, property or otherwise, with respect
to any of its capital stock, other than redemptions from the Trust Fund that are required pursuant to the HCAC Organizational
Documents;
(c)
reclassify, combine, split, subdivide or redeem, or purchase or otherwise acquire, directly or indirectly, any of the HCAC Common
Stock or HCAC Warrants except for redemptions from the Trust Fund that are required pursuant to the HCAC Organizational Documents;
(d)
issue, sell, pledge, dispose of, grant or encumber, or authorize the issuance, sale, pledge, disposition, grant or encumbrance
of, any shares of any class of capital stock or other securities of HCAC, First Merger Sub, or Second Merger Sub, or any options,
warrants, convertible securities or other rights of any kind to acquire any shares of such capital stock, or any other ownership
interest (including, without limitation, any phantom interest), of HCAC, First Merger Sub, or Second Merger Sub, except in connection
with conversion of the HCAC Class B Common Stock pursuant to the HCAC Organizational Documents;
(e)
acquire (including, without limitation, by merger, consolidation, or acquisition of stock or assets or any other business combination)
any corporation, partnership, other business organization or enter into any strategic joint ventures, partnerships or alliances
with any other person;
(f)
incur any indebtedness for borrowed money or guarantee any such indebtedness of another person or persons, issue or sell any debt
securities or options, warrants, calls or other rights to acquire any debt securities of HCAC, as applicable, enter into any “keep
well” or other agreement to maintain any financial statement condition or enter into any arrangement having the economic
effect of any of the foregoing, in each case, except in the ordinary course of business;
(g)
make any change in any method of financial accounting or financial accounting principles, policies, procedures or practices, except
as required by a concurrent amendment in GAAP or applicable Law made subsequent to the date hereof, as agreed to by its independent
accountants;
(h)
make any material tax election, amend a material Tax Return or settle or compromise any material United States federal, state,
local or non-United States income tax liability;
(i)
liquidate, dissolve, reorganize or otherwise wind up the business and operations of HCAC, First Merger Sub, or Second Merger Sub;
(j)
amend the Trust Agreement or any other agreement related to the Trust Account; or
(k)
enter into any formal or informal agreement or otherwise make a binding commitment to do any of the foregoing.
Nothing
in this Section 6.02 shall give to the Company, directly or indirectly, the right to control or direct the ordinary course
of business operations of HCAC prior to the Closing Date. Prior to the Closing Date, each of HCAC and the Company shall exercise,
consistent with the terms and conditions hereof, complete control and supervision of its respective operations, as required by
Law.
SECTION 6.03 Claims
Against Trust Account. Reference is made to the final prospectus of HCAC, dated as of February 28, 2019 and filed with the
SEC (File No. 333- 229608) on March 4, 2019 (the “Prospectus”). The Company hereby represents and warrants
that it has read the Prospectus and understands that HCAC has established the Trust Account containing the proceeds of its initial
public offering (the “IPO”) and the overallotment shares acquired by its underwriters and from certain private
placements occurring simultaneously with the IPO (including interest accrued from time to time thereon) for the benefit of HCAC’s
public stockholders (including overallotment shares acquired by HCAC’s underwriters the “Public Stockholders”),
and that, except as otherwise described in the Prospectus, HCAC may disburse monies from the Trust Account only: (a) to the Public
Stockholders in the event they elect to redeem their HCAC Class A Common Stock in connection with the consummation of HCAC’s
initial business combination (as such term is used in the Prospectus) (the “Business Combination”) or in connection
with an extension of its deadline to consummate a Business Combination, (b) to the Public Stockholders if HCAC fails to consummate
a Business Combination within eighteen (18) months after the closing of the IPO, (c) with respect to any interest earned on the
amounts held in the Trust Account, as necessary to pay any Taxes, or (d) to HCAC after or concurrently with the consummation of
a Business Combination. For and in consideration of HCAC entering into this Agreement, and for other good and valuable consideration,
the receipt and sufficiency of which is hereby acknowledged, the Company hereby agrees on behalf of itself and its affiliates
that, notwithstanding anything to the contrary in this Agreement, neither the Company nor any of its affiliates do now or shall
at any time hereafter have any right, title, interest or claim of any kind in or to any monies in the Trust Account or distributions
therefrom, or make any claim against the Trust Account (including any distributions therefrom), regardless of whether such claim
arises as a result of, in connection with or relating in any way to, this Agreement or any proposed or actual business relationship
between HCAC or its Representatives, on the one hand, and the Company or its Representatives, on the other hand, or any other
matter, and regardless of whether such claim arises based on contract, tort, equity or any other theory of legal liability (any
and all such claims are collectively referred to hereafter as the “Released Claims”). The Company on behalf
of itself and its affiliates hereby irrevocably waives any Released Claims that the Company or any of its affiliates may have
against the Trust Account (including any distributions therefrom) now or in the future as a result of, or arising out of, any
negotiations, contracts or agreements with HCAC or its Representatives and will not seek recourse against the Trust Account (including
any distributions therefrom) for any reason whatsoever (including for an alleged breach of this Agreement or any other agreement
with HCAC or its affiliates). The Company agrees and acknowledges that such irrevocable waiver is material to this Agreement and
specifically relied upon by HCAC and its affiliates to induce HCAC to enter in this Agreement, and the Company further intends
and understands such waiver to be valid, binding and enforceable against the Company and each of its affiliates under applicable
Law. To the extent the Company or any of its affiliates commences any action or proceeding based upon, in connection with, relating
to or arising out of any matter relating to HCAC or its Representatives, which proceeding seeks, in whole or in part, monetary
relief against HCAC or its Representatives, the Company hereby acknowledges and agrees that the Company’s and its affiliates’
sole remedy shall be against funds held outside of the Trust Account and that such claim shall not permit the Company or its affiliates
(or any person claiming on any of their behalves or in lieu of any of them) to have any claim against the Trust Account (including
any distributions therefrom) or any amounts contained therein. In the event the Company or any of its affiliates commences any
action or proceeding based upon, in connection with, relating to or arising out of any matter relating to HCAC or its Representatives,
which proceeding seeks, in whole or in part, relief against the Trust Account (including any distributions therefrom) or the Public
Stockholders of HCAC, whether in the form of money damages or injunctive relief, HCAC and its Representatives, as applicable,
shall be entitled to recover from the Company and its affiliates the associated legal fees and costs in connection with any such
action, in the event HCAC or its Representatives, as applicable, prevails in such action or proceeding. Notwithstanding anything
in this Agreement to the contrary, the provisions of this paragraph shall survive indefinitely with respect to the obligations
set forth in this Agreement.
ARTICLE
VII
ADDITIONAL AGREEMENTS
SECTION
7.01 Proxy Statement; Registration Statement.
(a)
As promptly as practicable after the execution of this Agreement and receipt of the PCAOB Audited Financials and the Unaudited
Interim Financial Statements, (i) HCAC (with the assistance and cooperation of the Company as reasonably requested by HCAC)
shall prepare and file with the SEC a joint information statement/proxy statement (as amended or supplemented, the “Proxy
Statement”) to be sent to the stockholders of HCAC and to the shareholders of the Company (A) as an information
statement relating, with respect to the Company’s stockholders, to the action to be taken by shareholders of the Company
pursuant to the Written Consent or by vote at a Company Shareholders Meeting and (B) as a proxy statement, with respect to
HCAC’s stockholders, in which HCAC shall solicit proxies from HCAC’s stockholders to vote at the special meeting of
HCAC’s stockholders called for the purpose of voting on the following matters (the “HCAC Stockholders’ Meeting”)
in favor of (1) the approval and adoption of this Agreement and the Mergers, (2) the issuance of HCAC Common Stock as contemplated
by this Agreement and the Subscription Agreements, (3) the approval and adoption of the second amended and restated HCAC
Certificate of Incorporation as set forth on Exhibit D, (4) the approval and adoption of an equity incentive plan, in form
and substance reasonably acceptable to HCAC and the Company that provides for grant of awards to employees and other service providers
of the Surviving Entity and its Subsidiaries in the form of options, restricted shares, restricted share units or other equity-based
awards based on HCAC Common Stock with a total pool of awards of HCAC Common Stock not exceeding ten percent (10%) of the aggregate
number of the sum of (x) shares of HCAC Common Stock outstanding at the Closing and (y) securities convertible into HCAC Common
Stock, with an annual “evergreen” increase of not more than five percent (5%) of the shares of HCAC Common Stock outstanding
as of the day prior to such increase, (5) the approval and adoption of an employee stock purchase plan, in form and substance
reasonably acceptable to HCAC and the Company, that provides for grant of purchase rights with respect to HCAC Common Stock to
employees of the Surviving Entity and its Subsidiaries with a total pool of shares of HCAC Common Stock not exceeding one and
one half percent (1.5%) of the aggregate number of the sum of (x) shares of HCAC Common Stock outstanding at the Closing and (y)
securities convertible into HCAC Common Stock, with an annual “evergreen” increase of one percent (1%) of the shares
of HCAC Common Stock outstanding as of the day prior to such increase, and (6) any approval of other proposals the parties deem
necessary to effectuate the Merger and the other Transactions (collectively, the “HCAC Proposals”), and (ii) HCAC
shall prepare and file with the SEC a registration statement on Form S-4 (together with all amendments thereto, the “Registration
Statement”) in which the Proxy Statement shall be included as a prospectus, in connection with the registration under
the Securities Act of the shares of HCAC Common Stock to be issued to the shareholders of the Company pursuant to this Agreement,
including, for avoidance of doubt, any shares of HCAC Common Stock to be issued pursuant to Section 3.06 of this Agreement.
HCAC and the Company each shall use their reasonable best efforts to (i) cause the Proxy Statement and Registration Statement
when filed with the SEC to comply in all material respects with all legal requirements applicable thereto, (ii) respond as
promptly as reasonably practicable to and resolve all comments received from the SEC concerning the Proxy Statement or the Registration
Statement, (iii) cause the Registration Statement to be declared effective under the Securities Act as promptly as practicable
and (iv) to keep the Registration Statement effective as long as is necessary to consummate the Transactions. As promptly
as practicable after the Registration Statement becomes effective, each of the Company and HCAC shall mail the Proxy Statement
to their respective stockholders. Each of HCAC and the Company shall promptly furnish all information concerning it as may reasonably
be requested by the other party in connection with such actions and the preparation of the Registration Statement and the Proxy
Statement.
(b)
No filing of, or amendment or supplement to the Proxy Statement or the Registration Statement will be made by HCAC or the Company
without the approval of the other party (such approval not to be unreasonably withheld, conditioned or delayed). HCAC and the
Company each will advise the other, promptly after they receive notice thereof, of the time when the Registration Statement has
become effective or any supplement or amendment thereto has been filed, of the issuance of any stop order, of the suspension of
the qualification of the HCAC Common Stock to be issued or issuable to the shareholders of the Company in connection with this
Agreement for offering or sale in any jurisdiction, or of any request by the SEC for amendment of the Proxy Statement or the Registration
Statement or comments thereon and responses thereto or requests by the SEC for additional information. Each of HCAC and the Company
shall cooperate and mutually agree upon (such agreement not to be unreasonably withheld or delayed), any response to comments
of the SEC with respect to the Proxy Statement or the Registration Statement and any amendment to the Proxy Statement or the Registration
Statement filed in response thereto.
(c)
HCAC represents that the information supplied by HCAC for inclusion in the Registration Statement and the Proxy Statement shall
not contain any untrue statement of a material fact or fail to state any material fact required to be stated therein or necessary
in order to make the statements therein, in light of the circumstances under which they were made, not misleading at (i) the
time the Registration Statement is declared effective, (ii) the time the Proxy Statement (or any amendment thereof or supplement
thereto) is first mailed to the stockholders of HCAC, (iii) the time of the HCAC Stockholders’ Meeting, and (iv) the
Effective Time. If, at any time prior to the Effective Time, any event or circumstance relating to HCAC, First Merger Sub, or
Second Merger Sub, or their respective officers or directors, should be discovered by HCAC which should be set forth in an amendment
or a supplement to the Registration Statement or the Proxy Statement, HCAC shall promptly inform the Company. All documents that
HCAC is responsible for filing with the SEC in connection with the Merger or the other transactions contemplated by this Agreement
will comply as to form and substance in all material respects with the applicable requirements of the Securities Act and the Exchange
Act.
(d)
The Company represents that the information supplied by the Company for inclusion in the Registration Statement and the Proxy
Statement shall not contain any untrue statement of a material fact or fail to state any material fact required to be stated therein
or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading,
at (i) the time the Registration Statement is declared effective, (ii) the time the Proxy Statement (or any amendment
thereof or supplement thereto) is first mailed to the stockholders of HCAC, (iii) the time of the HCAC Stockholders’
Meeting, and (iv) the Effective Time. If, at any time prior to the Effective Time, any event or circumstance relating to
the Company or any Company Subsidiary, or their respective officers or directors, should be discovered by the Company which should
be set forth in an amendment or a supplement to the Registration Statement or the Proxy Statement, the Company shall promptly
inform HCAC. All documents that the Company is responsible for filing with the SEC in connection with the Merger or the other
transactions contemplated by this Agreement will comply as to form and substance in all material respects with the applicable
requirements of the Securities Act and the Exchange Act.
SECTION
7.02 HCAC Stockholders’ Meeting; First Merger Sub Stockholder’s Approval and Second Merger Sub Shareholder’s
Approval.
(a)
HCAC shall call and hold the HCAC Stockholders’ Meeting as promptly as practicable after the Registration Statement becomes
effective (but in any event no later than 30 days after the date on which the Proxy Statement is mailed to stockholders of HCAC)
for the purpose of voting solely upon the HCAC Proposals; provided that HCAC may postpone or adjourn the HCAC Stockholders’
Meeting on one or more occasions for up to 30 days in the aggregate upon the good faith determination by the HCAC Board that
such postponement or adjournment is necessary to solicit additional proxies to obtain approval of the HCAC Proposals or otherwise
take actions consistent with HCAC’s obligations pursuant to Section 7.09 of this Agreement. HCAC shall use its
reasonable best efforts to hold the HCAC Stockholders’ Meeting as soon as practicable after the date on which the Registration
Statement becomes effective (but in any event no later than 30 days after the date on which the Proxy Statement is mailed to the
HCAC stockholders). HCAC shall use its best efforts to obtain the approval of the HCAC Proposals at the HCAC Stockholders’
Meeting, including by soliciting from its stockholders proxies as promptly as possible in favor of the HCAC Proposals, and shall
take all other action necessary or advisable to secure the required vote or consent of its stockholders. The HCAC Board shall
recommend to its stockholders that they approve the HCAC Proposals and shall include such recommendation in the Proxy Statement.
(b)
Promptly following the execution of this Agreement, HCAC shall approve and adopt this Agreement and approve the Merger and the
other transactions contemplated by this Agreement, in its capacity as the sole stockholder of First Merger Sub and sole member
of Second Merger Sub.
SECTION 7.03 Requisite
Approval. Upon the terms set forth in this Agreement, the Company shall (a) seek the irrevocable written consent, in form
and substance reasonably acceptable to HCAC, of holders of the Requisite Approval (including the Requisite Shareholders) in favor
of the approval and adoption of this Agreement and the Mergers and all other transactions contemplated by this Agreement (the
“Written Consent”) as soon as reasonably practicable after the Registration Statement becomes effective, and
in any event within seventy-two (72) hours after the Registration Statement becomes effective and (b) in the event the Company
determines it is not able to obtain the Written Consent, the Company shall call and hold a meeting of holders of Company Shares
for the purpose of voting solely upon the adoption of this Agreement and the Mergers and all other transaction contemplated by
this Agreement (the “Company Shareholders Meeting”) as soon as reasonably practicable after the Registration
Statement becomes effective, and in any event within ten (10) days after the Registration Statement becomes effective. The Company
shall use its best efforts to obtain the Company Shareholder Approval at the Company Shareholders Meeting, including by soliciting
from its shareholders proxies as promptly as possible in favor of this Agreement and the Mergers, and shall take all other action
necessary or advisable to secure the Company Shareholder Approval. The Company Board shall recommend to its shareholders that
they approve this Agreement and the Mergers.
SECTION
7.04 Access to Information; Confidentiality.
(a)
From the date of this Agreement until the Effective Time, the Company and HCAC shall (and shall cause their respective subsidiaries
to): (i) provide to the other party (and the other party’s officers, directors, employees, accountants, consultants,
legal counsel, agents and other representatives, collectively, “Representatives”) reasonable access at reasonable
times upon prior notice to the officers, employees, agents, properties, offices and other facilities of such party and its subsidiaries
and to the books and records thereof; and (ii) furnish promptly to the other party such information concerning the business,
properties, contracts, assets, liabilities, personnel and other aspects of such party and its subsidiaries as the other party
or its Representatives may reasonably request, including in connection with any Tax disclosure in any statement, filing, notice
or application relating to the Intended Tax Treatment or any Tax opinion requested or required to be filed pursuant to Section
7.11(c). Notwithstanding the foregoing, neither the Company nor HCAC shall be required to provide access to or disclose information
where the access or disclosure would jeopardize the protection of attorney-client privilege or contravene applicable Law (it being
agreed that the parties shall use their reasonable best efforts to cause such information to be provided in a manner that would
not result in such jeopardy or contravention).
(b)
All information obtained by the parties pursuant to this Section 7.04 shall be kept confidential in accordance with
the non-disclosure agreement, dated as of June 30, 2020 (the “Non-Disclosure Agreement”), between HCAC and
the Company.
(c)
Notwithstanding anything in this Agreement to the contrary, each party (and its respective Representatives) may consult any Tax
advisor as is reasonably necessary regarding the Tax treatment and Tax structure of the Transactions and may disclose to such
advisor as reasonably necessary, the intended Tax treatment and Tax structure of the Transactions and all materials (including
any Tax analysis) that are provided relating to such treatment or structure, in each case in accordance with the Non-Disclosure
Agreement.
SECTION 7.05 Exclusivity.
From the date of this Agreement and ending on the earlier of (a) the Closing and (b) the termination of this Agreement,
but only, in the case of HCAC, except to the extent it determines in good faith, after consultation with its outside legal counsel,
that the failure to take such action would be inconsistent with the fiduciary duties of the HCAC Board, the parties shall not,
and shall cause their respective Subsidiaries and its and their respective Representatives not to, directly or indirectly, (i) enter
into, knowingly solicit, initiate or continue any discussions or negotiations with, or knowingly encourage or respond to any inquiries
or proposals by, or participate in any negotiations with, or provide any information to, or otherwise cooperate in any way with,
any person or other entity or “group” (within the meaning of Section 13(d) of the Exchange Act), concerning any
sale of any material assets of such party or any of the outstanding capital stock or any conversion, consolidation, liquidation,
dissolution or similar transaction involving such party or any of such party’s Subsidiaries other than with the other parties
to this Agreement and their respective Representatives (an “Alternative Transaction”), (ii) enter into
any agreement regarding, continue or otherwise knowingly participate in any discussions regarding, or furnish to any person any
information with respect to, or cooperate in any way that would otherwise reasonably be expected to lead to, any Alternative Transaction
or (iii) commence, continue or renew any due diligence investigation regarding any Alternative Transaction; provided
that the execution, delivery and performance of this Agreement and the Transaction Documents and the consummation of the transactions
contemplated hereby shall not be deemed a violation of this Section 7.05. Each party shall, and shall cause its Subsidiaries
and its and their respective affiliates and Representatives to, immediately cease any and all existing discussions or negotiations
with any person conducted heretofore with respect to any Alternative Transaction. Each party also agrees that it will promptly
request each person (other than the parties hereto and their respective Representatives) that has prior to the date hereof executed
a confidentiality agreement in connection with its consideration of an Alternative Transaction to return or destroy all Confidential
Information furnished to such person by or on behalf of it prior to the date hereof (to the extent so permitted under, and in
accordance with the terms of, such confidentiality agreement). If a party or any of its Subsidiaries or any of its or their respective
Representatives receives any inquiry or proposal with respect to an Alternative Transaction at any time prior to the Closing,
then such party shall promptly (and in no event later than twenty-four (24) hours after such party becomes aware of such
inquiry or proposal) notify such person in writing that such party is subject to an exclusivity agreement with respect to the
Transaction that prohibits such party from considering such inquiry or proposal, but only, in the case of HCAC, except to the
extent it determines in good faith, after consultation with its outside legal counsel, that the failure to take such action would
be inconsistent with the fiduciary duties of the HCAC Board. Without limiting the foregoing, the parties agree that any violation
of the restrictions set forth in this Section 7.05 by a party or any of its Subsidiaries or its or their respective
affiliates or Representatives shall be deemed to be a breach of this Section 7.05 by such party.
SECTION
7.06 Employee Benefits Matters.
(a)
HCAC shall, or shall cause the Surviving Entity and each of its subsidiaries, as applicable, to provide the employees of the Company
and the Company Subsidiaries who remain employed immediately after the Effective Time (the “Continuing Employees”)
credit for purposes of eligibility to participate, vesting and determining the level of benefits, as applicable, under any Employee
Benefit Plan established or maintained by the Surviving Entity or any of its subsidiaries (excluding any retiree health plans
or programs or defined benefit retirement plans or programs) for service accrued or deemed accrued prior to the Effective Time
with the Company or any Company Subsidiary; provided, however, that such crediting of service shall not operate
to duplicate any benefit or the funding of any such benefit. In addition, HCAC shall use reasonable best efforts to (i) cause
to be waived any eligibility waiting periods, any evidence of insurability requirements and the application of any pre-existing
condition limitations under each of the Employee Benefit Plans established or maintained by the Surviving Entity or any of its
subsidiaries that cover the Continuing Employees or their dependents, and (ii) cause any eligible expenses incurred by any
Continuing Employee and his or her covered dependents, during the portion of the plan year in which the Closing occurs, under
those health and welfare benefit plans in which such Continuing Employee currently participates to be taken into account under
those health and welfare benefit plans in which such Continuing Employee participates subsequent to the Closing Date for purposes
of satisfying all deductible, coinsurance, and maximum out-of-pocket requirements applicable to such Continuing Employee and his
or her covered dependents for the applicable plan year. Following the Closing, the Surviving Entity will honor all accrued but
unused vacation and other paid time off of the Continuing Employees that existed immediately prior to the Closing with respect
to the calendar year in which the Closing occurs. As a condition to HCAC’s obligations under this Section 7.06(a),
the Company shall provide HCAC or its designee with all information reasonably requested and necessary to allow HCAC or its designee
to comply with such obligations.
(b)
The Company shall cause all notices to be timely provided to each optionee under the Company Stock Option Plan as required by
the Company Stock Option Plan.
(c)
The provisions of this Section 7.06 are solely for the benefit of the parties to the Agreement, and nothing contained
in this Agreement, express or implied, shall confer upon any Continuing Employee or legal representative or beneficiary or dependent
thereof, or any other person, any rights or remedies of any nature or kind whatsoever under or by reason of this Agreement, whether
as a third-party beneficiary or otherwise, including, without limitation, any right to employment or continued employment for
any specified period, or level of compensation or benefits. Nothing contained in this Agreement, express or implied, shall constitute
an amendment or modification of any Employee Benefit Plan or other employee benefit arrangement or shall require the Company,
HCAC, the Surviving Entity or any of its subsidiaries to continue any Plan or other employee benefit arrangements, or prevent
their amendment, modification or termination.
SECTION
7.07 Directors’ and Officers’ Indemnification.
(a)
The memorandum and articles of association of the Surviving Corporation and the operating agreement of the Surviving Entity shall
each contain provisions no less favorable with respect to indemnification, advancement or expense reimbursement than are set forth
in the Company Charter, which provisions shall not be amended, repealed or otherwise modified for a period of six years from the
Effective Time in any manner that would affect adversely the rights thereunder of individuals who, at or prior to the Effective
Time, were directors, officers, employees, fiduciaries or agents of the Company, unless such modification shall be required by
applicable Law. From and after the Effective Time, HCAC agrees that it shall indemnify and hold harmless each present and former
director and officer of the Company against any costs or expenses (including reasonable attorneys’ fees), judgments, fines,
losses, claims, damages or liabilities incurred in connection with any claim, action, suit, proceeding or investigation, whether
civil, criminal, administrative or investigative, arising out of or pertaining to matters existing or occurring at or prior to
the Effective Time whether asserted or claimed prior to, at or after the Effective Time, to the fullest extent that the Company
would have been permitted under applicable Law, the Company Charter in effect on the date of this Agreement to indemnify such
person (including the advancing of expenses as incurred to the fullest extent permitted under applicable Law). HCAC further agrees
that with respect to the provisions of the bylaws or limited liability company agreements of the Company Subsidiaries relating
to indemnification, advancement or expense reimbursement, such provisions shall not be amended, repealed or otherwise modified
for a period of six years from the Effective Time in any manner that would affect adversely the rights thereunder of individuals
who, at or prior to the Effective Time, were directors, officers, employees, fiduciaries or agents of such Company Subsidiary,
unless such modification shall be required by applicable Law.
(b)
From the date hereof, and for a period of six years from the Effective Time, HCAC shall maintain in effect directors’ and
officers’ liability insurance covering those persons who are currently covered by the Company’s directors’ and
officers’ liability insurance policy (true, correct and complete copies of which have been heretofore made available to
HCAC or its agents or Representatives in the Virtual Data Room) on terms not less favorable than the terms of such current insurance
coverage, except that in no event shall HCAC be required to pay an annual premium for such insurance in excess of 300% of the
aggregate annual premium payable by the Company for such insurance policy for the year ended December 31, 2019 (the “Maximum
Annual Premium”); provided, however, that (i) HCAC may cause coverage to be extended under the current
directors’ and officers’ liability insurance by obtaining a six-year “tail” policy containing terms not
materially less favorable than the terms of such current insurance coverage with respect to claims existing or occurring at or
prior to the Effective Time so long as the aggregate cost for such “tail” policy does not exceed the Maximum Annual
Premium and (ii) if any claim is asserted or made within such six-year period, any insurance required to be maintained under this
Section 7.07(b) shall be continued in respect of such claim until the final disposition thereof.
(c)
On the Closing Date, to the extent not already entered into, HCAC shall enter into customary indemnification agreements reasonably
satisfactory to each of the Company and HCAC with the post-Closing directors and officers of HCAC, which indemnification agreements
shall continue to be effective following the Closing.
SECTION 7.08 Notification
of Certain Matters. The Company shall give prompt notice to HCAC, and HCAC shall give prompt notice to the Company, of any
event which a party becomes aware of between the date of this Agreement and the Closing (or the earlier termination of this Agreement
in accordance with Article IX), the occurrence, or non-occurrence of which causes or would reasonably be expected
to cause any of the conditions set forth in Article VIII to fail.
SECTION
7.09 Further Action; Reasonable Best Efforts.
(a)
Upon the terms and subject to the conditions of this Agreement, each of the parties hereto shall use its reasonable best efforts
to take, or cause to be taken, appropriate action, and to do, or cause to be done, such things as are necessary, proper or advisable
under applicable Laws or otherwise, and each shall cooperate with the other, to consummate and make effective the Transactions,
including, without limitation, using its reasonable best efforts to obtain all permits, consents, approvals, authorizations, qualifications
and orders of, and the expiration or termination of waiting periods by, Governmental Authorities and parties to contracts with
the Company and the Company Subsidiaries as set forth in Section 4.05 necessary for the consummation of the Transactions
and to fulfill the conditions to the Mergers. In case, at any time after the Effective Time, any further action is necessary or
desirable to carry out the purposes of this Agreement, the proper officers and directors of each party shall use their reasonable
best efforts to take all such action.
(b)
Each of the parties shall keep each other apprised of the status of matters relating to the Transactions, including promptly notifying
the other parties of any communication it or any of its affiliates receives from any Governmental Authority relating to the matters
that are the subject of this Agreement and permitting the other parties to review in advance, and to the extent practicable consult
about, any proposed communication by such party to any Governmental Authority in connection with the Transactions. No party to
this Agreement shall agree to participate in any meeting, video or telephone conference, or other communications with any Governmental
Authority in respect of any filings, investigation or other inquiry unless it consults with the other parties in advance and,
to the extent permitted by such Governmental Authority, gives the other parties the opportunity to attend and participate at such
meeting, conference or other communications. Subject to the terms of the Non-Disclosure Agreement, the parties will coordinate
and cooperate fully with each other in exchanging such information and providing such assistance as the other parties may reasonably
request in connection with the foregoing. Subject to the terms of the Non-Disclosure Agreement, the parties will provide each
other with copies of all material correspondence, filings or communications, including any documents, information and data contained
therewith, between them or any of their Representatives, on the one hand, and any Governmental Authority, on the other hand, with
respect to this Agreement and the Transactions contemplated hereby. No party shall take or cause to be taken any action before
any Governmental Authority that is inconsistent with or intended to delay its action on requests for a consent or the consummation
of the Transactions.
(c)
Notwithstanding the generality of the foregoing, HCAC shall use its reasonable best efforts to consummate the Private Placements
in accordance with the Subscription Agreements, and the Company shall cooperate with HCAC in such efforts. HCAC shall not, without
the prior written consent of the Company (such consent not to be unreasonably withheld, delayed or conditioned), permit or consent
to any amendment, supplement or modification to any Subscription Agreement that would reasonably be expected to cause the condition
set forth in Section 8.01(f) to fail.
SECTION
7.10 Public Announcements. The initial press release relating to this Agreement shall be a joint press release,
the text of which has been agreed to by each of HCAC and the Company. Thereafter, between the date of this Agreement and the Closing
Date (or the earlier termination of this Agreement in accordance with Article IX) unless otherwise prohibited by applicable
Law or the requirements of the Nasdaq Capital Market, each of HCAC and the Company shall each use its reasonable best efforts
to consult with each other before issuing any press release or otherwise making any public statements with respect to this Agreement,
the Merger or any of the other Transactions, and shall not issue any such press release or make any such public statement without
the prior written consent of the other party. Furthermore, nothing contained in this Section 7.10 shall prevent HCAC
or the Company or its respective affiliates from furnishing customary or other reasonable information concerning the Transactions
to their investors and prospective investors that is substantively consistent with public statements previously consented to by
the other party in accordance with this Section 7.10.
SECTION
7.11 Tax Matters.
(a)
None of HCAC, First Merger Sub, Second Merger Sub or the Company shall (and each shall cause its affiliates not to) take any action
(or fail to take any reasonable action) which action (or failure to act), whether before or after the Effective Time, would reasonably
be expected to prevent or impede the Mergers, taken together, from qualifying for the Intended Tax Treatment.
(b)
This Agreement is intended to constitute, and the parties hereto hereby adopt this Agreement as, a “plan of reorganization”
within the meaning of Treasury Regulation Sections 1.368-2(g) and 1.368-3(a). Each of HCAC, First Merger Sub, Second Merger Sub
and the Company shall report the Mergers, taken together, as a reorganization within the meaning of Section 368(a) of the Code
unless otherwise required pursuant to a “determination” within the meaning of Section 1313(a) of the Code, including
attaching the statement described in Treasury Regulations Section 1.368-3(a) on or with its Tax Return for the taxable year of
the Mergers.
(c)
Each party shall promptly notify the other party in writing if, before the Closing Date, such party knows or has reason to believe
that the Merger may not qualify for the Intended Tax Treatment (and whether the terms of this Agreement could be reasonably amended
in order to facilitate the Merger qualifying for the Intended Tax Treatment). In the event either HCAC or the Company seeks a
tax opinion from its respective tax advisor regarding the Intended Tax Treatment, or the SEC requests or requires tax opinions,
each party shall use reasonable efforts to execute and deliver customary tax representation letters to the applicable tax advisor
in form and substance reasonably satisfactory to such advisor.
SECTION
7.12 Stock Exchange Listing. HCAC will use its reasonable best efforts to cause the HCAC Class A Common Stock issued
in connection with the Transactions to be approved for listing on the Nasdaq Capital Market at the Closing. During the period
from the date hereof until the Closing, HCAC shall use its reasonable best efforts to keep the HCAC Units, the HCAC Common Stock
and HCAC Warrants listed for trading on the Nasdaq Capital Market.
SECTION
7.13 Antitrust.
(a)
To the extent required under any Laws that are designed to prohibit, restrict or regulate actions having the purpose or effect
of monopolization or restraint of trade, including the HSR Act (“Antitrust Laws”), each party hereto agrees
to promptly make any required filing or application under Antitrust Laws, as applicable, and no later than ten (10) Business Days
after the date of this Agreement, the Company and HCAC each shall file (or cause to be filed) with the Antitrust Division of the
U.S. Department of Justice and the U.S. Federal Trade Commission a Notification and Report Form as required by the HSR Act. The
parties hereto agree to supply as promptly as reasonably practicable any additional information and documentary material that
may reasonably be requested pursuant to Antitrust Laws and to take all other actions necessary, proper or advisable to cause the
expiration or termination of the applicable waiting periods or obtain required approvals, as applicable under Antitrust Laws as
soon as practicable, including by requesting early termination of the waiting period provided for under the HSR Act.
(b)
HCAC and the Company each shall, in connection with its efforts to obtain all requisite approvals and expiration or termination
of waiting periods for the Transactions under any Antitrust Law, use its reasonable best efforts to: (i) cooperate in all
respects with each other party or its affiliates in connection with any filing or submission and in connection with any investigation
or other inquiry, including any proceeding initiated by a private person; (ii) keep the other reasonably informed of any
communication received by such party from, or given by such party to, any Governmental Authority and of any communication received
or given in connection with any proceeding by a private person, in each case regarding any of the Transactions, and promptly furnish
the other with copies of all such written communications; (iii) permit the other to review in advance any written communication
to be given by it to, and consult with each other in advance of any meeting or conference with, any Governmental Authority or,
in connection with any proceeding by a private person, with any other person, and to the extent permitted by such Governmental
Authority or other person, give the other party the opportunity to attend and participate in such meetings and conferences; (iv) in
the event a party is prohibited from participating in or attending any meetings or conferences, the other shall keep such party
promptly and reasonably apprised with respect thereto; and (v) use reasonable best efforts to cooperate in the filing of
any memoranda, white papers, filings, correspondence or other written communications explaining or defending the Transactions,
articulating any regulatory or competitive argument, or responding to requests or objections made by any Governmental Authority;
provided that materials required to be provided pursuant to this Section 7.13(b) may be limited to outside counsel and
may be redacted (i) to remove references to the valuation of the Company, and (ii) as necessary to comply with contractual arrangements.
(c)
No party hereto shall take any action that could reasonably be expected to adversely affect or materially delay the approval of
any Governmental Authority, or the expiration or termination of any waiting period of any required filings or applications under
Antitrust Laws, including by agreeing to merge with or acquire any other person or acquire a substantial portion of the assets
of or equity in any other person. The parties hereto further covenant and agree, with respect to a threatened or pending preliminary
or permanent injunction or other order, decree or ruling or statute, rule, regulation or executive order that would adversely
affect the ability of the parties to consummate the Transactions, to use reasonable best efforts to prevent or lift the entry,
enactment or promulgation thereof, as the case may be.
SECTION
7.14 PCAOB Audited Financials. The Company shall use reasonable best efforts to deliver true and complete copies of
(i) the audited consolidated balance sheet of the Company and the consolidated Company Subsidiaries as of December 31, 2018
and December 31, 2019, and the related audited consolidated statements of income, changes in shareholder equity, and cash
flows of the Company and the consolidated Company Subsidiaries for the years then ended, in each case, prepared in accordance
with GAAP and Regulation S-X and audited in accordance with the auditing standards of the PCAOB (collectively, the “PCAOB
Audited Financials”) not later than 60 days from the date hereof and (ii) unaudited financial statements, including
consolidated balance sheets and consolidated statements of income, changes in shareholder equity, and cash flows, of the Company
and the consolidated Company Subsidiaries as at and for the six-months ended June 30, 2020 and June 30, 2019, in each case, prepared
in accordance with GAAP and Regulation S-X (the “Unaudited Interim Financial Statements”).
SECTION
7.15 Trust Account. As of the Effective Time, the obligations of HCAC to dissolve or liquidate within a specified time
period as contained in HCAC’s Certificate of Incorporation will be terminated and HCAC shall have no obligation whatsoever
to dissolve and liquidate the assets of HCAC by reason of the consummation of the Mergers or otherwise, and no stockholder of
HCAC shall be entitled to receive any amount from the Trust Account. At least 48 hours prior to the Effective Time, HCAC shall
provide notice to the Trustee in accordance with the Trust Agreement and shall deliver any other documents, opinions or notices
required to be delivered to the Trustee pursuant to the Trust Agreement and cause the Trustee prior to the Effective Time to,
and the Trustee shall thereupon be obligated to, transfer all funds held in the Trust Account to HCAC (to be held as available
cash on the balance sheet of HCAC, and to be used for working capital and other general corporate purposes of the business following
the Closing) and thereafter shall cause the Trust Account and the Trust Agreement to terminate.
SECTION
7.16 Directors. HCAC and the Company shall take all necessary action so that immediately after the Effective Time,
the board of directors of HCAC is comprised of the individuals designated on Section 2.05(b) of the Company Disclosure
Schedule.
SECTION
7.17 Extension. HCAC shall take all actions necessary to seek the approval of the stockholders of HCAC to extend the
deadline for HCAC to consummate its initial business combination (the “Extension”) to a date after September
5, 2020 in accordance with the HCAC Organizational Documents. HCAC shall use its reasonable best efforts to obtain stockholder
approval for the Extension and any and all further extensions of the deadline for HCAC to consummate its initial business combination
as may be necessary prior to the Outside Date to permit the consummation of the Transactions, including the Mergers.
SECTION
7.18 Company Share Purchase Warrant. Prior to the Closing, the Company shall properly provide timely prior written
notice of this Agreement and the Merger to the holder of the Company Share Purchase Warrant in accordance with the terms of the
Company Share Purchase Warrant.
SECTION
7.19 Amended and Restated Voting and Preemptive Rights Agreement. Prior to the Closing, the Company shall cause the
Amended and Restated Voting and Preemptive Rights Agreement, dated as of March 4, 2019, as amended, by and among the Company and
the other parties thereto, to be terminated.
SECTION
7.20 Lock-Up Agreements. Prior to the Closing, the Company shall use its reasonable best efforts to cause each holder
of Company Securities to deliver, or cause to be delivered, to HCAC copies of the Lock-Up Agreements duly executed by all such
parties.
ARTICLE
VIII
CONDITIONS TO THE MERGER
SECTION
8.01 Conditions to the Obligations of Each Party. The obligations of the Company, HCAC, First Merger Sub, and Second
Merger Sub to consummate the Transactions, including the Mergers, are subject to the satisfaction or waiver (where permissible)
at or prior to the Closing of the following conditions:
(a)
Company Shareholder Approval. The Company Shareholder Approval shall have been obtained.
(b)
HCAC Stockholders’ Approval. The HCAC Proposals shall have been approved and adopted by the requisite affirmative
vote of the stockholders of HCAC in accordance with the Proxy Statement, the DGCL, the HCAC Organizational Documents and the rules
and regulations of the Nasdaq Capital Market.
(c)
No Order. No Governmental Authority shall have enacted, issued, promulgated, enforced or entered any Law, rule, regulation,
judgment, decree, executive order or award which is then in effect and has the effect of making the Transactions, including the
Mergers, illegal or otherwise prohibiting consummation of the Transactions, including the Mergers.
(d)
Antitrust Approvals and Waiting Periods. All required filings under the HSR Act shall have been completed and any applicable
waiting period (and any extension thereof) applicable to the consummation of the Transactions under the HSR Act shall have expired
or been terminated.
(e)
Governmental Consents. All consents, approvals and authorizations set forth on Section 8.01(e) of the Company
Disclosure Schedule, shall have been obtained from and made with all applicable Governmental Authorities.
(f)
Minimum Cash. As of the Closing, after consummation of the Private Placements, and after distribution of the Trust Fund
pursuant to Section 7.15 and deducting all amounts to be paid pursuant to the exercise of Redemption Rights, HCAC shall
have cash on hand equal to or in excess of $200,000,000 (without, for the avoidance of doubt, taking into account any transaction
fees, costs and expenses paid or required to be paid in connection with the Transactions and the Private Placements).
(g)
Registration Statement. The Registration Statement shall have been declared effective under the Securities Act. No stop
order suspending the effectiveness of the Registration Statement shall be in effect, and no proceedings for purposes of suspending
the effectiveness of the Registration Statement shall have been initiated or be threatened by the SEC.
(h)
Stock Exchange Listing. The shares of HCAC Class A Common Stock shall be listed on the Nasdaq Capital Market as of the
Closing Date.
(i)
HCAC Net Tangible Assets. HCAC shall have at least $5,000,001 of net tangible assets following the exercise of Redemption
Rights in accordance with the HCAC Organizational Documents.
SECTION
8.02 Conditions to the Obligations of HCAC, First Merger Sub, and Second Merger Sub. The obligations of HCAC, First
Merger Sub, and Second Merger Sub to consummate the Transactions, including the Mergers, are subject to the satisfaction or waiver
(where permissible) at or prior to the Closing of the following additional conditions:
(a)
Representations and Warranties. The representations and warranties of the Company contained in (i) Section 4.01
(Organization and Qualification; Subsidiaries), Section 4.03 (Capitalization) (other than clauses (a),
(b), (c) and (h) thereof, which are subject to clause (iii) below), Section 4.04
(Authority Relative to this Agreement) and Section 4.22 (Brokers) shall each be true and correct in all material respects
as of the Closing Date as though made on the Closing Date (without giving effect to any limitation as to “materiality”
or “Company Material Adverse Effect” or any similar limitation set forth therein), except to the extent of any changes
that reflect actions permitted in accordance with Section 6.01 of this Agreement and except to the extent that any such
representation and warranty expressly speaks as of an earlier date, in which case such representation and warranty shall be true
and correct as of such earlier date, (ii) Section 4.08(c) (Absence of Certain Changes or Events) shall be true and
correct in all respects as of the date hereof and the Effective Time, (iii) Section 4.03(a), Section 4.03(b),
Section 4.03(c) and Section 4.03(h) (Capitalization) shall be true and correct in all respects except for de minimis
inaccuracies as of the date hereof and as of the Effective Time as though made on and as of such date (except to the extent of
any changes that reflect actions permitted in accordance with Section 6.01 of this Agreement and except to the extent
that any such representation or warranty expressly is made as of an earlier date, in which case such representation and warranty
shall be true and correct as of such specified date), except where the failure of such representations and warranties to be so
true and correct would not, individually or in the aggregate, be reasonably expected to result in more than de minimis additional
cost, expense or liability to the Company, HCAC, First Merger Sub, Second Merger Sub or their affiliates and; and (iv) all other
representations and warranties of the Company set forth in Article IV shall be true and correct (without giving any effect
to any limitation as to “materiality” or “Company Material Adverse Effect” or any similar limitation set
forth therein) in all respects as of the Closing Date, as though made on and as of the Closing Date, except (i) to the extent
that any such representation and warranty expressly speaks as of an earlier date, in which case such representation and warranty
shall be true and correct as of such earlier date and (ii) where the failure of such representations and warranties to be
true and correct (whether as of the Closing Date or such earlier date), taken as a whole, does not result in a Company Material
Adverse Effect.
(b)
Agreements and Covenants. The Company shall have performed or complied in all material respects with all agreements and
covenants required by this Agreement to be performed or complied with by it on or prior to the Effective Time.
(c)
Officer’s Certificate. The Company shall have delivered to HCAC a certificate (the “Company Officer’s
Certificate”), dated as of the Closing Date, signed by an officer of the Company, certifying as to the satisfaction
of the conditions specified in Section 8.02(a), Section 8.02(b) and Section 8.02(d).
(d)
Material Adverse Effect. No Company Material Adverse Effect shall have occurred between the date of this Agreement and
the Closing Date.
(e)
Resignation. Other than those persons identified as continuing directors on Section 2.05(a) of the Company Disclosure
Schedule, all members of the Company Board and the Board of Directors of the Company Subsidiaries shall have executed written
resignations effective as of the Effective Time.
(f)
Registration Rights Agreement. All parties to the Registration Rights Agreement (other than HCAC) shall have delivered,
or cause to be delivered, to HCAC copies of the Registration Rights Agreement duly executed by all such parties.
(g)
Lock-Up Agreements. The parties to the Lock-Up Agreements set forth in Section 8.02(g) of the Company Disclosure
Schedule shall have delivered, or cause to be delivered, to HCAC copies of the Lock-Up Agreements duly executed by all such parties.
(h)
PCAOB Audited Financials. The Company shall have delivered to HCAC the PCAOB Audited Financials.
(i)
Maximum Debt. The Company shall have no indebtedness for borrowed money other than Existing Permitted Indebtedness.
SECTION
8.03 Conditions to the Obligations of the Company. The obligations of the Company to consummate the Transactions, including
the Mergers, are subject to the satisfaction or waiver (where permissible) at or prior to Closing of the following additional
conditions:
(a)
Representations and Warranties. The representations and warranties of HCAC, First Merger Sub, and Second Merger Sub contained
in (i) Section 5.01 (Corporation Organization), Section 5.03 (Capitalization) (other than clauses (a)
and (e) thereof, which is subject to clause (iii) below), Section 5.04 (Authority Relative
to this Agreement) and Section 5.12 (Brokers) shall each be true and correct in all material respects as of the Closing
Date as though made on the Closing Date (without giving effect to any limitation as to “materiality” or “HCAC
Material Adverse Effect” or any similar limitation set forth therein), except to the extent that any changes that reflect
actions permitted in accordance with Section 6.02 of this Agreement and except to the extent that any such representation
and warranty expressly speaks as of an earlier date, in which case such representation and warranty shall be true and correct
as of such earlier date, (ii) Section 5.08(b) (Absence of Certain Changes or Events) shall be true and correct
in all respects as of the date hereof and the Effective Time, (iii) Section 5.03(a) and Section 5.03(e)
(Capitalization) shall be true and correct in all respects except for de minimis inaccuracies as of the date hereof and
as of the Effective Time as though made on and as of such date (except to the extent of any changes that reflect actions permitted
in accordance with Section 6.02 of this Agreement and except to the extent that any such representation or warranty
expressly is made as of an earlier date, in which case such representation and warranty shall be true and correct as of such specified
date), except where the failure of such representations and warranties to be so true and correct would not, individually or in
the aggregate, be reasonably expected to result in more than de minimis additional cost, expense or liability to the Company,
HCAC, First Merger Sub, Second Merger Sub or their affiliates and (iv) other representations and warranties of HCAC, First Merger
Sub, and Second Merger Sub contained in this Agreement shall be true and correct (without giving any effect to any limitation
as to “materiality” or “HCAC Material Adverse Effect” or any similar limitation set forth therein) in
all respects as of the Closing Date, as though made on and as of the Closing Date, except (i) to the extent that any such
representation and warranty expressly speaks as of an earlier date, in which case such representation and warranty shall be true
and correct as of such earlier date and (ii) where the failure of such representations and warranties to be true and correct
(whether as of the Closing Date or such earlier date), taken as a whole, does not result in a HCAC Material Adverse Effect.
(b)
Agreements and Covenants. HCAC, First Merger Sub, and Second Merger Sub shall have performed or complied in all material
respects with all agreements and covenants required by this Agreement to be performed or complied with by it on or prior to the
Effective Time.
(c)
Officer’s Certificate. HCAC shall have delivered to the Company a certificate, dated as of the Closing Date, signed
by an officer of HCAC, certifying as to the satisfaction of the conditions specified in Section 8.03(a), Section 8.03(b)
and Section 8.03(d).
(d)
Material Adverse Effect. No HCAC Material Adverse Effect shall have occurred between the date of this Agreement and the
Closing Date.
(e)
Stock Exchange Listing. A supplemental listing shall have been filed with the Nasdaq Capital Market as of the Closing Date
to list the shares constituting the aggregate Per Share Merger Consideration.
(f)
Registration Rights Agreement. HCAC shall have delivered a copy of the Registration Rights Agreement duly executed by HCAC.
(g)
Lock-Up Agreements. HCAC shall have delivered copies of the Lock-Up Agreements duly executed by HCAC.
(h)
Resignation. Other than those persons identified as continuing directors on Section 2.05(b) of the Company Disclosure
Schedule, all members of the HCAC Board shall have executed written resignations effective as of the Effective Time.
(i)
Exchange and Cancellation Agreement. The Exchange and Cancellation Agreement shall remain in full force and effect, and
the parties thereto shall be in compliance with the terms and conditions thereof in all material respects.
ARTICLE
IX
TERMINATION, AMENDMENT AND WAIVER
SECTION 9.01 Termination.
This Agreement may be terminated and the Merger and the other Transactions may be abandoned at any time prior to the Effective
Time, notwithstanding any requisite approval and adoption of this Agreement and the Transactions by the stockholders of the Company
or HCAC, as follows:
(a)
by mutual written consent of HCAC and the Company;
(b)
by either HCAC or the Company if the Effective Time shall not have occurred prior to April 30, 2021 (the “Outside Date”);
provided, however, that this Agreement may not be terminated under this Section 9.01(b) by or on behalf
of any party that either directly or indirectly through its affiliates is in breach or violation of any representation, warranty,
covenant, agreement or obligation contained herein and such breach or violation is the principal cause of the failure of a condition
set forth in Article VIII on or prior to the Outside Date;
(c)
by either HCAC or the Company if any Governmental Authority in the United States shall have enacted, issued, promulgated, enforced
or entered any injunction, order, decree or ruling (whether temporary, preliminary or permanent) which has become final and nonappealable
and has the effect of making consummation of the Transactions, including the Mergers, illegal or otherwise preventing or prohibiting
consummation of the Transactions, the Merger;
(d)
by either HCAC or the Company if any of the HCAC Proposals shall fail to receive the requisite vote for approval at the HCAC Stockholders’
Meeting;
(e)
by HCAC if the Company shall have failed to obtain the Company Shareholder Approval within ten (10) days after the Registration
Statement becomes effective;
(f)
by HCAC upon a breach of any representation, warranty, covenant or agreement on the part of the Company set forth in this Agreement,
or if any representation or warranty of the Company shall have become untrue, in either case such that the conditions set forth
in Sections 8.02(a) and 8.02(b) would not be satisfied (“Terminating Company Breach”); provided
that HCAC has not waived such Terminating Company Breach and HCAC, First Merger Sub and Second Merger Sub are not then in
material breach of their representations, warranties, covenants or agreements in this Agreement; provided further that,
if such Terminating Company Breach is curable by the Company, HCAC may not terminate this Agreement under this Section 9.01(f)
for so long as the Company continues to exercise its reasonable efforts to cure such breach, unless such breach is not cured
within thirty (30) days after notice of such breach is provided by HCAC to the Company; or
(g)
by the Company upon a breach of any representation, warranty, covenant or agreement on the part of HCAC, First Merger Sub, and
Second Merger Sub set forth in this Agreement, or if any representation or warranty of HCAC, First Merger Sub, and Second Merger
Sub shall have become untrue, in either case such that the conditions set forth in Sections 8.03(a) and 8.03(b)
would not be satisfied (“Terminating HCAC Breach”); provided that the Company has not waived such
Terminating HCAC Breach and the Company are not then in material breach of their representations, warranties, covenants or agreements
in this Agreement; provided, however, that, if such Terminating HCAC Breach is curable by HCAC, First Merger Sub,
and Second Merger Sub, the Company may not terminate this Agreement under this Section 9.01(g) for so long as HCAC,
First Merger Sub, and Second Merger Sub continue to exercise their reasonable efforts to cure such breach, unless such breach
is not cured within thirty (30) days after notice of such breach is provided by the Company to HCAC.
SECTION
9.02 Effect of Termination. In the event of the termination of this Agreement pursuant to Section 9.01,
this Agreement shall forthwith become void, and there shall be no liability under this Agreement on the part of any party hereto,
except as set forth in Section 9.02, Article X, and any corresponding definitions set forth in Article I,
or in the case of termination subsequent to a willful material breach of this Agreement by a party hereto.
SECTION
9.03 Amendment. This Agreement may be amended in writing by the parties hereto at any time prior to the Effective Time.
This Agreement may not be amended except by an instrument in writing signed by each of the parties hereto.
SECTION
9.04 Waiver. At any time prior to the Effective Time, (i) HCAC may (a) extend the time for the performance
of any obligation or other act of the Company, (b) waive any inaccuracy in the representations and warranties of the Company
contained herein or in any document delivered by the Company pursuant hereto and (c) waive compliance with any agreement
of the Company or any condition to its own obligations contained herein and (ii) the Company may (a) extend the time
for the performance of any obligation or other act of HCAC, First Merger Sub, or Second Merger Sub, (b) waive any inaccuracy
in the representations and warranties of HCAC, First Merger Sub, or Second Merger Sub contained herein or in any document delivered
by HCAC or Merger pursuant hereto and (c) waive compliance with any agreement of HCAC, First Merger Sub, or Second Merger
Sub or any condition to its own obligations contained herein. Any such extension or waiver shall be valid if set forth in an instrument
in writing signed by the party or parties to be bound thereby.
ARTICLE
X
GENERAL PROVISIONS
SECTION
10.01 Notices. All notices, requests, claims, demands and other communications hereunder shall be in writing and shall
be given (and shall be deemed to have been duly given upon receipt) by delivery in person, by email or by registered or certified
mail (postage prepaid, return receipt requested) to the respective parties at the following addresses (or at such other address
for a party as shall be specified in a notice given in accordance with this Section 10.01):
if
to HCAC, First Merger Sub or Second Merger Sub:
Hennessy
Capital Acquisition Corp. IV
3485
North Pines Way, Suite 110
Wilson,
WY 83014
Attention:
Dan Hennessy and Nicholas Petruska
Email:
dhennessy@hennessycapllc.com and npetruska@hennessycapllc.com
with
a copy to:
Sidley
Austin LLP
One
South Dearborn St.
Chicago,
IL 60603
Attention:
Jeffrey N. Smith and Dirk W. Andringa
Email:
jnsmith@sidley.com and dandringa@sidley.com
if
to the Company:
Canoo
Holdings Ltd.
19951
Mariner Avenue
Torrance,
CA 90503
Attention:
Ulrich Kranz and Andrew Wolstan
Email:
ulrich@canoo.com and andrew@canoo.com
with
a copy to:
Cooley
LLP
101
California Street
5th
Floor
San
Francisco, CA 94111-5800
Attention:
Garth Osterman, Dave Young
Email:
gosterman@cooley.com and dyoung@cooley.com
SECTION
10.02 Nonsurvival of Representations, Warranties and Covenants. None of the representations, warranties, covenants,
obligations or other agreements in this Agreement or in any certificate, statement or instrument delivered pursuant to this Agreement,
including any rights arising out of any breach of such representations, warranties, covenants, obligations, agreements and other
provisions, shall survive the Closing and all such representations, warranties, covenants, obligations or other agreements shall
terminate and expire upon the occurrence of the Closing (and there shall be no liability after the Closing in respect thereof),
except for (a) those covenants and agreements contained herein that by their terms expressly apply in whole or in part after
the Closing and then only with respect to any breaches occurring after the Closing and (b) this Article X and
any corresponding definitions set forth in Article I.
SECTION
10.03 Severability. If any term or other provision of this Agreement is invalid, illegal or incapable of being enforced
by any rule of law, or public policy, all other conditions and provisions of this Agreement shall nevertheless remain in full
force and effect so long as the economic or legal substance of the Transactions is not affected in any manner materially adverse
to any party. Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the
parties hereto shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties as closely
as possible in a mutually acceptable manner in order that the Transactions be consummated as originally contemplated to the fullest
extent possible.
SECTION
10.04 Entire Agreement; Assignment. This Agreement and the Ancillary Agreements constitute the entire agreement among
the parties with respect to the subject matter hereof and supersede, except as set forth in Section 7.04(b), all prior
agreements and undertakings, both written and oral, among the parties, or any of them, with respect to the subject matter hereof,
except for the Non-Disclosure Agreement. This Agreement shall not be assigned (whether pursuant to a merger, by operation of law
or otherwise) by any party without the prior express written consent of the other parties hereto.
SECTION
10.05 Parties in Interest. This Agreement shall be binding upon and inure solely to the benefit of each party hereto,
and nothing in this Agreement, express or implied, is intended to or shall confer upon any other person any right, benefit or
remedy of any nature whatsoever under or by reason of this Agreement, other than Section 7.07 (which is intended to
be for the benefit of the persons covered thereby and may be enforced by such persons).
SECTION
10.06 Governing Law. This Agreement shall be governed by, and construed in accordance with, the Laws of the State of
Delaware applicable to contracts executed in and to be performed in that State. Notwithstanding the foregoing, the following matters
arising out of or relating to this Agreement shall be construed, performed and enforced in accordance with the Cayman Companies
Law: the First Merger, the vesting of the rights, property, choses in action, business, undertaking, goodwill, benefits, immunities
and privileges, contracts, obligations, claims, debts and liabilities of First Merger Sub, and the Company in the Company, the
cancellation of the shares, the rights provided in Section 238 of the Cayman Companies Law, the fiduciary or other duties of the
Company Board and the board of directors of First Merger Sub and the internal corporate affairs of the Company and First Merger
Sub. All legal actions and proceedings arising out of or relating to this Agreement shall be heard and determined exclusively
in any Delaware Chancery Court; provided, that if jurisdiction is not then available in the Delaware Chancery Court, then
any such legal Action may be brought in any federal court located in the State of Delaware or any other Delaware state court.
The parties hereto hereby (a) irrevocably submit to the exclusive jurisdiction of the aforesaid courts for themselves and
with respect to their respective properties for the purpose of any Action arising out of or relating to this Agreement brought
by any party hereto, and (b) agree not to commence any Action relating thereto except in the courts described above in Delaware,
other than Actions in any court of competent jurisdiction to enforce any judgment, decree or award rendered by any such court
in Delaware as described herein. Each of the parties further agrees that notice as provided herein shall constitute sufficient
service of process and the parties further waive any argument that such service is insufficient. Each of the parties hereby irrevocably
and unconditionally waives, and agrees not to assert, by way of motion or as a defense, counterclaim or otherwise, in any Action
arising out of or relating to this Agreement or the transactions contemplated hereby, (a) any claim that it is not personally
subject to the jurisdiction of the courts in Delaware as described herein for any reason, (b) that it or its property is
exempt or immune from jurisdiction of any such court or from any legal process commenced in such courts (whether through service
of notice, attachment prior to judgment, attachment in aid of execution of judgment, execution of judgment or otherwise) and (c) that
(i) the Action in any such court is brought in an inconvenient forum, (ii) the venue of such Action is improper or (iii) this
Agreement, or the subject matter hereof, may not be enforced in or by such courts.
SECTION
10.07 Waiver of Jury Trial. Each of the parties hereto hereby waives to the fullest extent permitted by applicable
Law any right it may have to a trial by jury with respect to any litigation directly or indirectly arising out of, under or in
connection with this Agreement or the Transactions. Each of the parties hereto (a) certifies that no representative, agent
or attorney of any other party has represented, expressly or otherwise, that such other party would not, in the event of litigation,
seek to enforce that foregoing waiver and (b) acknowledges that it and the other hereto have been induced to enter into this
Agreement and the Transactions, as applicable, by, among other things, the mutual waivers and certifications in this Section 10.07.
SECTION
10.08 Headings. The descriptive headings contained in this Agreement are included for convenience of reference only
and shall not affect in any way the meaning or interpretation of this Agreement.
SECTION
10.09 Counterparts; Electronic Delivery. This Agreement and each other Transaction Document may be executed and delivered
(including by facsimile or portable document format (pdf) transmission) in one or more counterparts, and by the different
parties hereto in separate counterparts, each of which when executed shall be deemed to be an original but all of which taken
together shall constitute one and the same agreement. Delivery by email to counsel for the other parties of a counterpart executed
by a party shall be deemed to meet the requirements of the previous sentence.
SECTION
10.10 Specific Performance. The parties agree that irreparable damage would occur if any provision of this Agreement
were not performed in accordance with the terms hereof, and, accordingly, that the parties shall be entitled to an injunction
or injunctions to prevent breaches of this Agreement or to enforce specifically the performance of the terms and provisions hereof
(including the parties’ obligation to consummate the Merger) in the Court of Chancery of the State of Delaware or, if that
court does not have jurisdiction, any court of the United States located in the State of Delaware without proof of actual damages
or otherwise, in addition to any other remedy to which they are entitled at law or in equity as expressly permitted in this Agreement.
Each of the parties hereby further waives (a) any defense in any action for specific performance that a remedy at law would
be adequate and (b) any requirement under any Law to post security or a bond as a prerequisite to obtaining equitable relief.
SECTION
10.11 No Recourse. Except in the case of fraud, all actions, claims, obligations, liabilities or causes of actions
(whether in contract or in tort, in law or in equity, or granted by statute whether by or through attempted piercing of the corporate,
limited partnership or limited liability company veil) that may be based upon, in respect of, arise under, out or by reason of,
be connected with, or relate in any manner to: (a) this Agreement, (b) the negotiation, execution or performance of
this Agreement (including any representation or warranty made in, in connection with, or as an inducement to, this Agreement),
(c) any breach of this Agreement and (d) any failure of the Merger to be consummated, may be made only against (and,
without prejudice to the rights of any express third party beneficiary to whom rights under this Agreement inure pursuant to Section 10.11),
are those solely of the persons that are expressly identified as parties to this Agreement and not against any Nonparty Affiliate
(as defined below). Except in the case of fraud, no other person, including any director, officer, employee, incorporator, member,
partner, manager, stockholder, optionholder, affiliate, agent, attorney or representative of, or any financial advisor or lender
to, any party to this Agreement, or any director, officer, employee, incorporator, member, partner, manager, stockholder, affiliate,
agent, attorney or representative of, or any financial advisor or lender to (each of the foregoing, a “Nonparty Affiliate”)
any of the foregoing shall have any liabilities (whether in contract or in tort, in law or in equity, or granted by statute whether
by or through attempted piercing of the corporate, limited partnership or limited liability company veil) for any claims, causes
of action, obligations or liabilities arising under, out of, in connection with or related in any manner to the items in the immediately
preceding clauses (a) through (d) and each party, on behalf of itself and its affiliates, hereby irrevocably
releases and forever discharges each of the Nonparty Affiliate from any such liability or obligation.
SECTION
10.12 Waiver of Conflicts. Recognizing that Sidley Austin LLP (“Sidley”) and Ellenoff Grossman &
Schole LLP (“EGS”) has each acted as legal counsel to HCAC, First Merger Sub, Second Merger Sub, Sponsor, certain
HCAC security holders and certain of their respective affiliates prior to the Closing, and that Sidley and EGS may act as legal
counsel to HCAC, the Surviving Corporation, and the Surviving Entity and one or more of its subsidiaries, Sponsor, certain HCAC
security holders and certain of their respective affiliates after the Closing, each of HCAC and the Surviving Corporation (including
on behalf of the Surviving Corporation’s subsidiaries) hereby waives, on its own behalf and agrees to cause its affiliates
to waive, any conflicts that may arise in connection with each of Sidley’s and EGS’ representing HCAC, First Merger
Sub, Second Merger Sub, the Surviving Corporation, the Surviving Entity or any of its subsidiaries, Sponsor, any HCAC security
holder and any of their respective Affiliates after to the Closing. In addition, all communications involving attorney-client
confidences by or among HCAC, First Merger Sub, Second Merger Sub, Sponsor, HCAC security holders or their respective affiliates
in the course of the negotiation, documentation and consummation of the transactions contemplated hereby will be deemed to be
attorney-client confidences that belong solely to Sponsor, such HCAC security holder or such affiliate (and not to HCAC, the Surviving
Corporation, the Surviving Entity or any of its subsidiaries). Accordingly, HCAC, the Surviving Corporation, and the Surviving
Entity, as the case may be, will not have access to any such communications, or to the files of Sidley or EGS relating to such
engagement, whether or not the Closing will have occurred. Without limiting the generality of the foregoing, upon and after the
Closing, (i) Sponsor or the applicable HCAC security holder and its affiliates (and not HCAC, the Surviving Corporation,
the Surviving Entity or any of its subsidiaries) will be the sole holders of the attorney-client privilege with respect to such
engagement, and none of HCAC, the Surviving Corporation, the Surviving Entity and its subsidiaries will be a holder thereof, (ii) to
the extent that files of each of Sidley and EGS in respect of such engagement constitute property of the client, only Sponsor,
the applicable HCAC security holder or their respective affiliates (and not HCAC, the Surviving Corporation, the Surviving Entity
or any of its subsidiaries) will hold such property rights and (iii) each of Sidley and EGS will have no duty whatsoever
to reveal or disclose any such attorney-client communications or files to HCAC after the Closing and before or after the Closing,
the Surviving Corporation, the Surviving Entity or any of its subsidiaries by reason of any attorney-client relationship between
Sidley and EGS (as applicable) and HCAC, First Merger Sub, and Second Merger Sub before the Closing and after the Closing, the
Surviving Corporation and any of its subsidiaries or otherwise. Notwithstanding the foregoing, in the event that a dispute arises
between HCAC, the Surviving Corporation, the Surviving Entity or any of its subsidiaries and a third party (other than a party
to this Agreement or any of their respective affiliates) after the Closing, HCAC, the Surviving Corporation and the Surviving
Entity (including on behalf of its subsidiaries) may assert the attorney-client privilege to prevent disclosure of confidential
communications by Sidley and EGS to such third party; provided, however, that neither HCAC, the Surviving Corporation,
the Surviving Entity nor any of its subsidiaries may waive such privilege without the prior written consent of the Sponsor.
[Signature
Page Follows]
IN
WITNESS WHEREOF, HCAC, First Merger Sub, Second Merger Sub, and the Company have caused this Agreement to be executed as of
the date first written above by their respective officers thereunto duly authorized.
| |
HENNESSY
CAPITAL ACQUISITION CORP. IV |
| |
|
|
| |
By: |
/s/
Daniel J. Hennessy |
| |
Name: |
Daniel
J. Hennessy |
| |
Title: |
Chairman
of the Board and Chief Executive Officer |
[Signature
Page to Merger Agreement and Plan of Reorganization]
| |
HCAC
IV FIRST MERGER SUB, LTD. |
| |
|
|
| |
By: |
/s/
Nicholas A. Petruska |
| |
Name: |
Nicholas
A. Petruska |
| |
Title: |
Director |
[Signature
Page to Merger Agreement and Plan of Reorganization]
| |
HCAC
IV SECOND MERGER SUB, LLC |
| |
|
|
| |
By: |
Hennessy
Capital Acquisition Corp. IV, its sole member |
| |
|
|
| |
By: |
/s/
Daniel J. Hennessy |
| |
Name: |
Daniel
J. Hennessy |
| |
Title: |
Chairman
of the Board and Chief Executive Officer |
[Signature
Page to Merger Agreement and Plan of Reorganization]
| |
CANOO HOLDINGS LTD. |
| |
|
|
| |
By: |
/s/
Ulrich Kranz |
| |
Name: |
Ulrich
Kranz |
| |
Title: |
Chief
Executive Officer |
[Signature
Page to Merger Agreement and Plan of Reorganization]
Annex
I
Earnout
Merger Consideration
$18 Earnout Shares, $25 Earnout Shares and $30 Earnout Shares
This
Annex I sets forth the terms for the calculation of the number (if any) of $18 Earnout Shares, $25 Earnout Shares
and $30 Earnout Shares, as applicable. Terms used but not defined in this Annex I shall have the meanings ascribed
to such terms in the other parts of this Agreement to which this Annex I is a part.
1.
If the closing share price of HCAC Class A Common Stock equals or exceeds $18.00 per share for any 20 trading days within any
consecutive 30-trading day period that occurs after the Closing Date and on or prior to the two (2) year anniversary of the Closing
Date (the first occurrence of the foregoing is referred to herein as the “$18 Share Price Milestone”), then
HCAC shall issue to each holder of Company Securities as of immediately prior to the Effective Time, a number of shares of HCAC
Class A Common Stock equal to (A) the Pro Rata Share in respect of such holder of Company Securities set forth on the Merger Payment
Schedule multiplied by (B) 5,000,000 (such number of shares being referred to as the “$18 Earnout Shares”).
2.
If the closing share price of HCAC Class A Common Stock equals or exceeds $25.00 per share for any 20 trading days within any
consecutive 30-trading day period that occurs after the Closing Date and on or prior to the four (4) year anniversary of the Closing
Date (the first occurrence of the foregoing is referred to herein as the “$25 Share Price Milestone”), then
HCAC shall issue to each holder of Company Securities as of immediately prior to the Effective Time, a number of shares of HCAC
Class A Common Stock equal to (A) the Pro Rata Share in respect of such holder of Company Securities set forth on the Merger Payment
Schedule multiplied by (B) 5,000,000 (such number of shares being referred to as the “$25 Earnout Shares”).
3.
If the closing share price of HCAC Class A Common Stock equals or exceeds $30.00 per share for any 20 trading days within any
consecutive 30-trading day period that occurs after the Closing Date and on or prior to the five (5) year anniversary of the Closing
Date (the first occurrence of the foregoing is referred to herein as the “$30 Share Price Milestone”), then
HCAC shall issue to each holder of Company Securities as of immediately prior to the Effective Time, a number of shares of HCAC
Class A Common Stock equal to (A) the Pro Rata Share in respect of such holder of Company Securities set forth on the Merger Payment
Schedule multiplied by (B) 5,000,000 (such number of shares being referred to as the “$30 Earnout Shares”
and, together with the $18 Earnout Shares and the $25 Earnout Shares, the “Earnout Shares”).
4.
For the avoidance of doubt, if the condition for more than one Milestone is achieved, the Earnout Shares to be earned in connection
with such Milestone shall be cumulative with any Earnout Shares earned prior to such time in connection with the achievement of
any other Milestone; provided that, for avoidance of doubt, Earnout Shares in respect of each Milestone will be issued
and earned only once and the aggregate Earnout Shares issued shall in no event exceed 15,000,000 shares of HCAC Class A Common
Stock.
5.
If, following the two (2), four (4) or five (5) year anniversary of the Closing Date, as applicable, the $18 Share Price Milestone,
the $25 Share Price Milestone and/or the $30 Share Price Milestone have not occurred, none of the Earnout Shares shall be issued.
6.
In the event that after the Closing and prior to (x) with respect to the $18 Share Price Milestone and the $18 Earnout Shares,
the two (2) year anniversary of the Closing Date, (y) with respect to the $25 Share Price Milestone and the $25 Earnout Shares,
the four (4) year anniversary of the Closing Date, or (z) with respect to the $30 Share Price Milestone and the $30 Earnout Shares,
the five (5) year anniversary of the Closing Date, (i) there is a Change of Control (or a definitive agreement providing for a
Change of Control has been entered into prior to (x) with respect to the $18 Share Price Milestone and the $18 Earnout Shares,
the two (2) year anniversary of the Closing Date, (y) with respect to the $25 Share Price Milestone and the $25 Earnout Shares,
the four (4) year anniversary of the Closing Date, or (z) with respect to the $30 Share Price Milestone and the $30 Earnout Shares,
the five (5) year anniversary of the Closing Date and such Change of Control is ultimately consummated, even if such consummation
occurs after (x) with respect to the $18 Share Price Milestone and the $18 Earnout Shares, the two (2) year anniversary of the
Closing Date, (y) with respect to the $25 Share Price Milestone and the $25 Earnout Shares, the four (4) year anniversary of the
Closing Date, or (z) with respect to the $30 Share Price Milestone and the $30 Earnout Shares, the five (5) year anniversary of
the Closing Date), (ii) any liquidation, dissolution or winding up of HCAC (whether voluntary of involuntary) is initiated, (iii)
any bankruptcy, reorganization, debt arrangement or similar proceeding under any bankruptcy, insolvency or similar law, or any
dissolution or liquidation proceeding, is instituted by or against HCAC, or a receiver is appointed for HCAC or a substantial
part of its assets or properties or (iv) HCAC makes an assignment for the benefit of creditors, or petitions or applies to any
Governmental Authority for, or consents or acquiesces to, the appointment of a custodian, receiver or trustee for all or substantially
all of its assets or properties (each of clauses (i) through (iv), an “Acceleration Event”), then any Earnout
Shares that have not been previously issued by HCAC (whether or not previously earned) shall be deemed earned and issued by HCAC
to the holders of Company Securities as of immediately prior to the Effective Time upon such Acceleration Event pursuant to Section
3.01 and Section 3.06 unless, in the case of an Acceleration Event that is a Change of Control, the value of the consideration
to be received by the holders of the HCAC Class A Common Stock in such Change of Control transaction is less than the stock price
threshold applicable to the $18 Share Price Milestone, the $25 Share Price Milestone and/or the $30 Share Price Milestone, as
applicable (provided, that the determinations of such consideration and value shall be determined in good faith by the
disinterested members of the HCAC Board after taking into account the dilutive impact of the issuance of the $18 Earnout Shares,
the $25 Earnout Shares and/or the $30 Earnout Shares, as applicable, and accordingly adjusting the value of the per share consideration
to be received in connection with such Change of Control transaction).
7.
For purposes hereof, a “Change of Control” means the occurrence in a single transaction or as a result of a
series of related transactions, of one or more of the following events:
(i)
any person or any group of persons acting together which would constitute a “group” for purposes of Section 13(d)
of the Exchange Act or any successor provisions thereto (a “Group”) (excluding a corporation or other entity
owned, directly or indirectly, by the stockholders of HCAC in substantially the same proportions as their ownership of stock of
HCAC) (x) is or becomes the beneficial owner, directly or indirectly, of securities of HCAC representing more than fifty percent
(50%) of the combined voting power of HCAC’s then outstanding voting securities or (y) has or acquires control of the HCAC
Board;
(ii)
a merger, consolidation, reorganization or similar business combination transaction involving HCAC , and, immediately after the
consummation of such transaction or series of transactions, either (x) the HCAC Board immediately prior to the merger or consolidation
does not constitute at least a majority of the board of directors of the company surviving the merger or, if the surviving company
is a Subsidiary, the ultimate parent thereof, or (y) the voting securities of HCAC immediately prior to such merger or consolidation
do not continue to represent or are not converted into more than fifty percent (50%) of the combined voting power of the then
outstanding voting securities of the Person resulting from such transaction or series of transactions or, if the surviving company
is a Subsidiary, the ultimate parent thereof; or
(iii)
the sale, lease or other disposition, directly or indirectly, by HCAC of all or substantially all of the assets of HCAC and its
Subsidiaries, taken as a whole, other than such sale or other disposition by HCAC of all or substantially all of the assets of
HCAC and its Subsidiaries, taken as a whole, to an entity at least a majority of the combined voting power of the voting securities
of which are owned by stockholders of HCAC.
8.
The determination of whether the $18 Share Price Milestone, the $25 Share Price Milestone and the $30 Share Price Milestone has
been achieved shall be made after the negating of the effect of any stock manipulation (if any) to the extent then known by the
HCAC Board at the time of such determination.
9.
If HCAC shall, at any time or from time to time, after the date hereof effect a subdivision, stock split, stock dividend, reorganization,
combination, recapitalization or similar transaction affecting the outstanding shares of HCAC Class A Common Stock, the number
of Earnout Shares issuable pursuant to, and the stock price targets set forth in, paragraphs 1, 2 and 3 of this Annex I,
shall be equitably adjusted for such subdivision, stock split, stock dividend, reorganization, combination, recapitalization or
similar transaction. Any adjustment under this paragraph shall become effective at the close of business on the date the subdivision
or combination becomes effective.
Exhibit
A
Form
of Amended and Restated Registration Rights Agreement
[See
attached.]
EXHIBIT
A
AMENDED
AND RESTATED
REGISTRATION
RIGHTS AGREEMENT
THIS
AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of [●], 2020,
is made and entered into by and among Canoo Inc., a Delaware corporation formerly known as Hennessy Capital Acquisition Corp.
IV (the “Company”), Hennessy Capital Partners IV LLC, a Delaware limited liability company (the “Sponsor”),
each of the undersigned parties that holds Founder Shares (as defined below) and is identified as an “Other Pre-IPO Holder”
on the signature pages hereto (collectively, with the Sponsor, the “Existing Holders”), and the undersigned
parties identified as “New Holders” on the signature pages hereto (collectively, the “New Holders”)
(each of the foregoing parties (other than the Company) and any person or entity who hereafter becomes a party to this Agreement
pursuant to Section 5.2 of this Agreement, a “Holder” and collectively, the “Holders”).
Capitalized terms used but not otherwise defined in this Agreement shall have the meanings ascribed thereto in the Merger Agreement
(as defined below).
RECITALS
WHEREAS,
each of the Company and the Existing Holders is a party to, and hereby consents to, this amendment and restatement of that certain
Registration Rights Agreement, dated February 28, 2019 (the “Existing Registration Rights Agreement”),
pursuant to which the Company granted the Existing Holders certain registration rights with respect to certain securities of the
Company, as set forth therein;
WHEREAS,
the Company and the Sponsor have entered into that certain Securities Subscription Agreement, dated as of August 16, 2018, pursuant
to which the Sponsor purchased an aggregate of 7,187,500 shares (871,930 of which were subsequently cancelled or forfeited) of
the Company’s Class B common stock, par value $0.0001 per share (“Class B Common Stock”), which
were issued in a private placement prior to the closing of the Company’s initial public offering;
WHEREAS,
in October 2018, the Sponsor subsequently transferred an aggregate of 975,000 shares of Class B Common Stock to the Company’s
directors and officers;
WHEREAS,
on February 28, 2019, in connection with the declaration of an approximate 1.05 to 1 stock split of the shares of Class B Common
Stock payable in the form of a dividend of shares of Class B Common Stock by the Company, certain officers and directors of the
Company transferred an aggregate of 48,283 shares of Class B Common Stock to the Sponsor and the Anchor Investor waived its right
to the stock dividend (the outstanding shares of Class B Common Stock held by each of the Sponsor, certain officers and directors
of the Company and the Anchor Investor following such dividend, transfer, and waiver being referred to herein as the “Founder
Shares”);
WHEREAS,
the Company and the Sponsor entered into those certain Subscription Agreements, dated February 11, 2019 (the “Anchor
Subscription Agreements”) with HC NCBR Fund or BlackRock Credit Alpha Master Fund L.P. (collectively, the “Anchor
Investor”), pursuant to which the Sponsor agreed to forfeit to the Company for no consideration and the Anchor Investor
agreed to purchase from the Company an aggregate of 871,930 shares of Class B Common Stock for an aggregate purchase price of
$3,033, or approximately $0.003 per share;
WHEREAS,
on February 28, 2019, the Company and the Sponsor entered into that certain Private Placement Warrants Purchase Agreement, pursuant
to which the Sponsor purchased an aggregate of 11,739,394 warrants (the “Sponsor Private Placement Warrants”)
in a private placement transaction occurring simultaneously with the closing of the Company’s initial public offering (the
“IPO”);
WHEREAS,
pursuant to the Anchor Subscription Agreements, the Anchor Investor purchased 1,842,106 warrants in connection with the Company’s
initial public offering (the “Anchor Private Placement Warrants”; together with the Sponsor Private
Placement Warrants, the “Private Placement Warrants”);
WHEREAS,
in order to finance the Company’s transaction costs in connection with an intended initial Business Combination (as defined
below) the Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may loan to the Company
funds as the Company may require, of which up to $1,500,000 of such loans may be convertible into warrants (“Working
Capital Warrants”) at a price of $1.00 per warrant;
WHEREAS,
the Company, HCAC IV First Merger Sub, Ltd., an exempted company incorporated with limited liability in the Cayman Islands and
a wholly-owned subsidiary of the Company, HCAC IV Second Merger Sub, LLC, a Delaware limited liability company and a direct, wholly
owned subsidiary of HCAC, and Canoo Holdings Ltd., an exempted company incorporated with limited liability in the Cayman Islands
(“Canoo”), have entered into that certain Merger Agreement (as may be amended from time to time, the
“Merger Agreement”), dated as of August 17, 2020, pursuant to which, through a series of mergers at
the Closing (as defined below) with HCAC IV First Merger Sub, Ltd. and HCAC IV Second Merger Sub, LLC, Canoo will become a wholly-owned
subsidiary of the Company;
WHEREAS, pursuant
to the transactions contemplated by the Merger Agreement and subject to the terms and conditions set forth therein, the New Holders
will receive shares of the Class A common stock, par value $0.0001 per share, of the Company (“Common Stock”)
upon the closing of such transactions (the “Closing”);
WHEREAS, concurrently
with the execution of the Merger Agreement, on August 17, 2020, the Company and the Sponsor entered into that Warrant Exchange
and Share Cancellation Agreement, pursuant to which the Sponsor has agreed that immediately prior to (and contingent upon) the
Closing, and subject to the terms and conditions set forth therein, (a) the Sponsor shall exchange 11,739,394 Sponsor Private
Placement Warrants for 2,347,879 newly issued shares of Class B common stock of the Company (the “New Sponsor Shares”)
and (b) the Sponsor shall forfeit an equivalent number (2,347,879) of Founder Shares held by the Sponsor, which shall be cancelled
by the Company; and
WHEREAS,
the Company and all of the Existing Holders desire to amend and restate the Existing Registration Rights Agreement in order to
provide the Existing Holders and New Holders certain registration rights with respect to certain securities of the Company, on
the terms and conditions set forth in this Agreement; and
NOW, THEREFORE,
in consideration of the representations, covenants and agreements contained herein, and certain other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, hereby agree
as follows:
ARTICLE
I
DEFINITIONS
1.1 Definitions.
The terms defined in this Article I shall, for all purposes of this Agreement, have the respective meanings set forth
below:
“Adverse
Disclosure” shall mean any public disclosure of material non-public information, which disclosure, in the good faith
judgment of the Chief Executive Officer or principal financial officer of the Company, after consultation with counsel to the
Company, (i) would be required to be made in any Registration Statement or Prospectus in order for the applicable Registration
Statement or Prospectus not to contain any untrue statement of a material fact or omit to state a material fact necessary to make
the statements contained therein (in the case of any prospectus and any preliminary prospectus, in the light of the circumstances
under which they were made) not misleading, (ii) would not be required to be made at such time if the Registration Statement
were not being filed, and (iii) the Company has a bona fide business purpose for not making such information public.
“Agreement”
shall have the meaning given in the Preamble.
“Anchor
Investor” shall have the meaning given in the Recitals.
“Anchor
Private Placement Warrants” shall have the meaning given in the Recitals.
“Anchor
Subscription Agreements” shall have the meaning given in the Recitals.
“Board”
shall mean the Board of Directors of the Company.
“business
day” means a day, other than a Saturday or Sunday, on which commercial banks in New York, New York or Seattle, Washington
are open for the general transaction of business.
“Canoo”
shall have the meaning given in the Recitals hereto.
“Class
B Common Stock” shall have the meaning given in the Recitals hereto.
“Commission”
shall mean the Securities and Exchange Commission.
“Company”
shall have the meaning given in the Preamble.
“Common
Stock” shall have the meaning given in the Recitals hereto.
“Company”
shall have the meaning given in the Preamble.
“Company
Underwritten Demand Notice” shall have the meaning given in subsection 2.1.3.
“Demanding
Holders” shall have the meaning given in subsection 2.1.3.
“Effectiveness
Deadline” shall have the meaning given in subsection 2.1.1.
“Exchange
Act” shall mean the Securities Exchange Act of 1934, as it may be amended from time to time.
“Existing
Holders” shall have the meaning given in the Preamble hereto.
“Existing
Registration Rights Agreement” shall have the meaning given in the Recitals hereto.
“Form
S-1 Registration Statement” shall have the meaning given in subsection 2.1.1.
“Form
S-3 Shelf” shall have the meaning given in subsection 2.1.1.
“Founder
Shares” shall have the meaning given in the Recitals hereto and shall be deemed to include the shares of Common
Stock issuable upon conversion thereof.
“Founder
Shares Lock-Up Period” shall mean, with respect to the Founder Shares, from the date hereof until the earlier of
(A) one year after the date hereof; (B) the first date the closing price of the Common Stock equals or exceeds $12.00 per share
(as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within
any 30-trading day period commencing at least 150 days after the date hereof; and (C) the date on which the Company completes
a liquidation, merger, capital stock exchange, reorganization or other similar transaction that results in all of the Company’s
stockholders having the right to exchange their shares of Common Stock for cash, securities or other property.
“Holders”
shall mean the Existing Holders and the New Holders and any person or entity who hereafter becomes a party to this Agreement pursuant
to Section 5.2.
“Insider
Letter” shall mean that certain letter agreement, dated as of February 28, 2019, by and among the Company, the Sponsor
and each of the Company’s officers, directors and director nominees.
“Lock-Up
Periods” shall mean the Founder Shares Lock-Up Period, the New Sponsor Shares Lock-Up Period and the Private Placement
Lock-Up Period.
“Maximum
Number of Securities” shall have the meaning given in subsection 2.1.5.
“Merger
Agreement” shall have the meaning given in the Recitals hereto.
“Misstatement”
shall mean an untrue statement of a material fact or an omission to state a material fact required to be stated in a Registration
Statement or Prospectus, or necessary to make the statements in a Registration Statement or Prospectus (in the case of the Prospectus,
in the light of the circumstances under which they were made) not misleading.
“New
Holders” shall have the meaning given in the Preamble.
“New
Sponsor Shares” shall have the meaning given in the Recitals hereto.
“New
Sponsor Shares Lock-Up Period” shall mean, with respect to the New Sponsor Shares held by the Sponsor or its Permitted
Transferees, from the date hereof until the earliest to occur of (A) 180 days after the date hereof; (B) the first date the closing
price of the Common Stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations,
recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the
date hereof; and (C) the date on which the Company completes a liquidation, merger, capital stock exchange, reorganization or
other similar transaction that results in all of the Company’s stockholders having the right to exchange their shares of
Common Stock for cash, securities or other property.
“Permitted
Transferees” shall mean any person or entity (i) to whom a Holder of Registrable Securities is permitted to transfer
such Registrable Securities prior to the expiration of the applicable Lock-Up Period, under the Insider Letter, this Agreement
and any other applicable agreement between such Holder and the Company, and to any transferee thereafter and (ii) who agrees to
become bound by the transfer restrictions set forth in this Agreement.
“Piggyback
Registration” shall have the meaning given in subsection 2.2.1.
“Private
Placement Lock-Up Period” shall mean, with respect to Private Placement Warrants that are held by the initial purchasers
of such Private Placement Warrants or their Permitted Transferees, and any of the Common Stock issued or issuable upon the exercise
or conversion of the Private Placement Warrants and that are held by the initial purchasers of the Private Placement Warrants
or their Permitted Transferees, the period ending 30 days after the date hereof.
“Private
Placement Warrants” shall have the meaning given in the Recitals hereto.
“Pro
Rata” shall have the meaning given in subsection 2.1.5.
“Prospectus”
shall mean the prospectus included in any Registration Statement, as supplemented by any and all prospectus supplements and as
amended by any and all post-effective amendments and including all material incorporated by reference in such prospectus.
“Registrable
Security” shall mean (a) the Founder Shares and the shares of Common Stock issued or issuable upon the conversion
of any Founder Shares, (b) the Private Placement Warrants (including any shares of the Common Stock issued or issuable upon the
exercise of any such Private Placement Warrants), (c) the New Sponsor Shares, (d) any issued and outstanding share of
Common Stock or any other equity security (including the shares of Common Stock issued or issuable upon the exercise of any other
equity security) of the Company held by an Existing Holder as of the date of this Agreement, (e) any shares of Common Stock issued
or issuable upon the exercise the of Working Capital Warrants, (f) any outstanding shares of Common Stock or any other equity
security of the Company held by a New Holder as of the date of this Agreement (including shares transferred to a Permitted Transferee
and the shares of Common Stock issued or issuable upon the exercise of any such other equity security) and (g) any other equity
security of the Company issued or issuable with respect to any such share of the Common Stock described in the foregoing clauses
(a) through (g) by way of a stock dividend or stock split or in connection with a combination of shares, distribution, recapitalization,
merger, consolidation or reorganization or other similar event; provided, however, that, as to any particular Registrable
Security, such securities shall cease to be Registrable Securities when: (i) a Registration Statement with respect to the sale
of such securities shall have become effective under the Securities Act and such securities shall have been sold, transferred,
disposed of or exchanged in accordance with such Registration Statement; (ii) such securities shall have been otherwise transferred,
new certificates or book entry positions for such securities not bearing a legend restricting further transfer shall have been
delivered by the Company and subsequent public distribution of such securities shall not require registration under the Securities
Act; (iii) such securities shall have ceased to be outstanding; (iv) such securities may be sold without registration pursuant
to Rule 144 promulgated under the Securities Act (together with any successor rule promulgated thereafter by the Commission, “Rule
144”) (but with no volume or other restrictions or limitations thereunder); or (v) such securities have been sold
to, or through, a broker, dealer or underwriter in a public distribution or other public securities transaction.
“Registration”
shall mean a registration effected by preparing and filing a registration statement or similar document in compliance with the
requirements of the Securities Act, and the applicable rules and regulations promulgated thereunder, and such registration statement
becoming effective.
“Registration
Expenses” shall mean the out-of-pocket expenses of a Registration, including, without limitation, the following:
(A)
all registration and filing fees (including fees with respect to filings required to be made with the Financial Industry Regulatory
Authority, Inc.) and any securities exchange on which the Common Stock is then listed;
(B)
fees and expenses of compliance with securities or blue sky laws (including reasonable fees and disbursements of counsel for the
Underwriters in connection with blue sky qualifications of Registrable Securities);
(C)
printing, messenger, telephone and delivery expenses;
(D)
reasonable fees and disbursements of counsel for the Company;
(E)
reasonable fees and disbursements of all independent registered public accountants of the Company incurred specifically in connection
with such Registration; and
(F)
reasonable fees and expenses of one (1) legal counsel selected by the majority-in-interest of the Demanding Holders initiating
an Underwritten Demand to be registered for offer and sale in the applicable Registration.
“Registration
Statement” shall mean any registration statement that covers the Registrable Securities pursuant to the provisions
of this Agreement, including the Prospectus included in such registration statement, amendments (including post-effective amendments)
and supplements to such registration statement, and all exhibits to and all material incorporated by reference in such registration
statement.
“Requesting
Holder” shall have the meaning given in subsection 2.1.3.
“Restricted
Securities” shall have the meaning given in subsection 3.6.1.
“Rule
144” shall have the meaning given in the definition of “Registrable Security.”
“Rule
415” shall have the meaning given in subsection 2.1.1.
“SEC”
shall mean the United States Securities and Exchange Commission.
“Securities
Act” shall mean the Securities Act of 1933, as amended from time to time.
“Sponsor”
shall have the meaning given in the Preamble hereto.
“Sponsor
Private Placement Warrants” shall have the meaning given in the Recitals hereto.
“Underwriter”
shall mean a securities dealer who purchases any Registrable Securities as principal in an Underwritten Offering and not as part
of such dealer’s market-making activities.
“Underwritten
Demand” shall have the meaning given in subsection 2.1.3.
“Underwritten
Demand Notice” shall have the meaning given in subsection 2.1.3.
“Underwritten
Registration” or “Underwritten Offering” shall mean a Registration in which securities
of the Company are sold to an Underwriter in a firm commitment underwriting for distribution to the public, including an offering
and/or sale of Registrable Securities by any Holder in a block trade or on an underwritten basis (whether firm commitment or otherwise)
without substantial marketing efforts prior to pricing, including, without limitation, a same day trade, overnight trade or similar
transaction, but excluding a variable price reoffer.
“Working
Capital Warrants” shall have the meaning given in the Recitals hereto.
ARTICLE
II
REGISTRATIONS
2.1 Shelf
Registration.
2.1.1 Initial
Registration. The Company shall, as promptly as reasonably practicable, but in no event later than fifteen (15) business days
after the consummation of the transactions contemplated by the Merger Agreement, use its reasonable best efforts to file a Registration
Statement under the Securities Act to permit the public resale of all the Registrable Securities held by the Holders (and certain
other outstanding equity securities of the Company) from time to time as permitted by Rule 415 under the Securities Act (or any
successor or similar provision adopted by the Commission then in effect) (“Rule 415”) on the terms and
conditions specified in this subsection 2.1.1 and shall use its reasonable best efforts to cause such Registration Statement
to be declared effective as promptly as reasonably practicable after the initial filing thereof, but in no event later than sixty
(60) business days following the filing deadline (the “Effectiveness Deadline”); provided, that
the Effectiveness Deadline shall be extended to one hundred and twenty (120) days after the filing deadline if the Registration
Statement is reviewed by, and receives comments from, the Commission. The Registration Statement filed with the Commission pursuant
to this subsection 2.1.1 shall be a shelf registration statement on Form S-3 (a “Form S-3 Shelf”)
or, if Form S-3 is not then available to the Company, on Form S-1 (a “Form S-1 Registration Statement”)
or such other form of registration statement as is then available to effect a registration for resale of such Registrable Securities,
covering such Registrable Securities, and shall contain a Prospectus in such form as to permit any Holder to sell such Registrable
Securities pursuant to Rule 415 at any time beginning on the effective date for such Registration Statement. A Registration Statement
filed pursuant to this subsection 2.1.1 shall provide for the resale pursuant to any method or combination of methods legally
available to, and requested prior to effectiveness by, the Holders. The Company shall use its reasonable best efforts to cause
a Registration Statement filed pursuant to this subsection 2.1.1 to remain effective, and to be supplemented and amended
to the extent necessary to ensure that such Registration Statement is available or, if not available, that another Registration
Statement is available, for the resale of all the Registrable Securities held by the Holders until all such Registrable Securities
have ceased to be Registrable Securities. When effective, a Registration Statement filed pursuant to this subsection 2.1.1
(including the documents incorporated therein by reference) will comply as to form in all material respects with all applicable
requirements of the Securities Act and the Exchange Act and will not contain any untrue statement of a material fact or omit to
state a material fact required to be stated therein or necessary to make the statements therein not misleading (in the case of
any Prospectus contained in such Registration Statement, in the light of the circumstances under which such statement is made).
2.1.2 Form
S-3 Shelf. If the Company files a Form S-3 Shelf and thereafter the Company becomes ineligible to use Form S-3 for secondary
sales, the Company shall use its reasonable best efforts to file a Form S-1 Registration Statement as promptly as reasonably practicable
to replace the shelf registration statement that is a Form S-3 Shelf and have the Form S-1 Registration Statement declared effective
as promptly as reasonably practicable and to cause such Form S-1 Registration Statement to remain effective, and to be supplemented
and amended to the extent necessary to ensure that such Registration Statement is available or, if not available, that another
Registration Statement is available, for the resale of all the Registrable Securities held by the Holders until all such Registrable
Securities have ceased to be Registrable Securities.
2.1.3 Underwritten
Offering. At any time and from time to time following the effectiveness of the Registration Statement required by subsection 2.1.1
or 2.1.2, any Holder may request to sell all or a portion of their Registrable Securities (a “Demanding Holder”)
in an underwritten offering that is registered pursuant to such Registration Statement (an “Underwritten Demand”),
provided that such Holder(s) (a) reasonably expect aggregate gross proceeds in excess of $50,000,000 from such Underwritten
Offering or (b) reasonably expects to sell all of the Registrable Securities held by such Holder in such Underwritten Offering
but in no event less than $10,000,000 in aggregate gross proceeds. All requests for an Underwritten Offering shall be made by
giving written notice to the Company (the “Underwritten Demand Notice”). Each Underwritten Demand Notice
shall specify the approximate number of Registrable Securities proposed to be sold in the Underwritten Offering and the expected
price range (net of underwriting discounts and commissions) of such Underwritten Offering. Within five (5) business days after
receipt of any Underwritten Demand Notice, the Company shall give written notice of such requested Underwritten Offering (the
“Company Underwritten Demand Notice”) to all other Holders of Registrable Securities (the “Requesting
Holders”) and, subject to reductions consistent with the Pro Rata calculations in Section 2.1.5, shall include in
such Underwritten Offering all Registrable Securities with respect to which the Company has received written requests for inclusion
therein, within five (5) days after sending the Company Underwritten Demand Notice. The Company shall enter into an underwriting
agreement in a form as is customary in Underwritten Offerings of securities by the Company with the managing Underwriter or Underwriters
selected by the initiating Demanding Holders with the written consent of the Company (such consent not to be unreasonably withheld,
delayed or conditioned) and shall take all such other reasonable actions as are requested by the managing Underwriter or Underwriters
in order to expedite or facilitate the disposition of such Registrable Securities. In connection with any Underwritten Offering
contemplated by this subsection 2.1.3, subject to Section 3.3 and Article IV, the underwriting agreement into which each
Holder and the Company shall enter shall contain such representations, covenants, indemnities and other rights and obligations
of the Company and such Holders as are customary in underwritten offerings of securities. Under no circumstances shall the Company
be obligated to effect (x) more than an aggregate of three (3) Underwritten Offerings pursuant to an Underwritten Demand by the
Holders under this subsection 2.1.3 with respect to any or all Registrable Securities held by such Holders and (y) more than
two (2) Underwritten Offerings per year pursuant to this subsection 2.1.3; provided, however, that an Underwritten
Offering pursuant to an Underwritten Demand shall not be counted for such purposes unless a Registration Statement that may be
available at such time has become effective and all of the Registrable Securities requested by the Requesting Holders and the
Demanding Holders to be registered on behalf of the Requesting Holders and the Demanding Holders in such Registration Statement
have been sold, in accordance with Section 3.1 of this Agreement.
2.1.4 Holder
Information Required for Participation in Underwritten Offering. At least ten (10) business days prior to the first anticipated
filing date of a Registration Statement pursuant to this Article II, the Company shall use reasonable best efforts to notify
each Holder in writing (which may be by email) of the information reasonably necessary about the Holder to include such Holder’s
Registrable Securities in such Registration Statement. Notwithstanding anything else in this Agreement, the Company shall not
be obligated to include such Holder’s Registrable Securities to the extent the Company has not received such information,
and received any other reasonably requested agreements or certificates, on or prior to the fifth business day prior to the first
anticipated filing date of a Registration Statement pursuant to this Article II.
2.1.5 Reduction
of Underwritten Offering. If the managing Underwriter or Underwriters in an Underwritten Offering, in good faith, advises
the Company, the Demanding Holders and the Requesting Holders (if any) in writing that the dollar amount or number of Registrable
Securities that the Demanding Holders and the Requesting Holders (if any) desire to sell, taken together with all other Common
Stock or other equity securities that the Company desires to sell and the Common Stock, if any, as to which a Registration has
been requested pursuant to separate written contractual piggy-back registration rights held by any other stockholders who desire
to sell, exceeds the maximum dollar amount or maximum number of equity securities that can be sold in the Underwritten Offering
without adversely affecting the proposed offering price, the timing, the distribution method, or the probability of success of
such offering (such maximum dollar amount or maximum number of such securities, as applicable, the “Maximum Number
of Securities”), then the Company shall include in such Underwritten Offering, as follows: (i) first, the Registrable
Securities of the Demanding Holders (pro rata based on the respective number of Registrable Securities that each Demanding Holder
has requested be included in such Underwritten Registration and the aggregate number of Registrable Securities that the Demanding
Holders have requested be included in such Underwritten Registration (such proportion is referred to herein as “Pro
Rata”)) that can be sold without exceeding the Maximum Number of Securities; (ii) second, to the extent that
the Maximum Number of Securities has not been reached under the foregoing clause (i), the Registrable Securities of Requesting
Holders (Pro Rata, based on the respective number of Registrable Securities that each Requesting Holder has so requested) exercising
their rights to register their Registrable Securities pursuant to subsection 2.1.3 hereof, without exceeding the Maximum
Number of Securities; and (iii) third, to the extent that the Maximum Number of Securities has not been reached under the
foregoing clauses (i) and (ii), the Common Stock or other equity securities that the Company desires to sell, which can be
sold without exceeding the Maximum Number of Securities; and (iv) fourth, to the extent that the Maximum Number of Securities
has not been reached under the foregoing clauses (i), (ii) and (iii), the Common Stock or other equity securities of other
persons or entities that the Company is obligated to register in a Registration pursuant to separate written contractual arrangements
with such persons and that can be sold without exceeding the Maximum Number of Securities.
2.1.6 Underwritten
Offering Withdrawal. A majority-in-interest of the Demanding Holders initiating an Underwritten Demand or a majority-in-interest
of the Requesting Holders (if any), pursuant to a Registration under subsection 2.1.3 shall have the right to withdraw
from a Registration pursuant to an Underwritten Offering pursuant to subsection 2.1.3 for any or no reason whatsoever upon
written notification to the Company and the Underwriter or Underwriters (if any) of their intention to withdraw from such Registration
at least five (5) business days prior to the effectiveness of the Registration Statement filed with the Commission with respect
to the Registration of their Registrable Securities pursuant to such Underwritten Offering (or in the case of an Underwritten
Registration pursuant to Rule 415, at least five (5) business days prior to the time of pricing of the applicable offering). Notwithstanding
anything to the contrary in this Agreement, the Company shall be responsible for the Registration Expenses incurred in connection
with a Registration pursuant to an Underwritten Offering prior to its withdrawal under this subsection 2.1.6.
2.2 Piggyback
Registration.
2.2.1 Piggyback
Rights. If the Company proposes to file a Registration Statement under the Securities Act with respect to an offering of equity
securities, or securities or other obligations exercisable or exchangeable for, or convertible into, equity securities, for its
own account or for the account of stockholders of the Company (or by the Company and by the stockholders of the Company, including,
without limitation, pursuant to Section 2.1 hereof), other than a Registration Statement (i) filed in connection with
any employee stock option or other benefit plan, (ii) for a rights offering or an exchange offer or offering of securities
solely to the Company’s existing stockholders, (iii) for an offering of debt that is convertible into equity securities
of the Company or (iv) for a dividend reinvestment plan, then the Company shall give written notice of such proposed filing
to all of the Holders of Registrable Securities as soon as practicable but not less than ten (10) days before the anticipated
filing date of such Registration Statement, which notice shall (A) describe the amount and type of securities to be included
in such offering, the intended method(s) of distribution, and the name of the proposed managing Underwriter or Underwriters, if
any, in such offering, and (B) offer to all of the Holders of Registrable Securities the opportunity to register the sale
of such number of Registrable Securities as such Holders may request in writing within five (5) days after receipt of such written
notice (such Registration a “Piggyback Registration”). The Company shall, in good faith, cause such
Registrable Securities to be included in such Piggyback Registration and shall use its reasonable best efforts to cause the managing
Underwriter or Underwriters of a proposed Underwritten Offering to permit the Registrable Securities requested by the Holders
pursuant to this subsection 2.2.1 to be included in a Piggyback Registration on the same terms and conditions as any
similar securities of the Company included in such Registration and to permit the sale or other disposition of such Registrable
Securities in accordance with the intended method(s) of distribution thereof. All such Holders proposing to distribute their Registrable
Securities through an Underwritten Offering under this subsection 2.2.1 shall enter into an underwriting agreement
in customary form with the Underwriter(s) selected for such Underwritten Offering by the Company.
2.2.2 Reduction
of Piggyback Registration. If the managing Underwriter or Underwriters in an Underwritten Registration that is to be a Piggyback
Registration, in good faith, advises the Company and the Holders of Registrable Securities participating in the Piggyback Registration
in writing that the dollar amount or number of the shares of Common Stock that the Company desires to sell, taken together with
(i) the shares of Common Stock, if any, as to which Registration has been demanded pursuant to separate written contractual
arrangements with persons or entities other than the Holders of Registrable Securities hereunder (ii) the Registrable Securities
as to which registration has been requested pursuant to Section 2.2 hereof, and (iii) the shares of Common Stock,
if any, as to which Registration has been requested pursuant to separate written contractual piggy-back registration rights of
other stockholders of the Company, exceeds the Maximum Number of Securities, then:
(a) If
the Registration is undertaken for the Company’s account, the Company shall include in any such Registration (A) first,
the Common Stock or other equity securities that the Company desires to sell, which can be sold without exceeding the Maximum
Number of Securities; (B) second, to the extent that the Maximum Number of Securities has not been reached under the foregoing
clause (A), the Registrable Securities of Holders exercising their rights to register their Registrable Securities pursuant to
subsection 2.2.1 hereof, Pro Rata, which can be sold without exceeding the Maximum Number of Securities; and (C) third,
to the extent that the Maximum Number of Securities has not been reached under the foregoing clauses (A) and (B), the Common
Stock, if any, as to which Registration has been requested or demanded pursuant to written contractual piggyback registration
rights of other stockholders of the Company, which can be sold without exceeding the Maximum Number of Securities;
(b) If
the Registration is pursuant to a request by persons or entities other than the Holders of Registrable Securities, then the Company
shall include in any such Registration (A) first, the Common Stock or other equity securities, if any, of such requesting
persons or entities, other than the Holders of Registrable Securities, which can be sold without exceeding the Maximum Number
of Securities; (B) second, to the extent that the Maximum Number of Securities has not been reached under the foregoing clause
(A), the Registrable Securities of Holders exercising their rights to register their Registrable Securities pursuant to subsection 2.2.1,
Pro Rata, which can be sold without exceeding the Maximum Number of Securities; (C) third, to the extent that the Maximum
Number of Securities has not been reached under the foregoing clauses (A) and (B), the Common Stock or other equity securities
that the Company desires to sell, which can be sold without exceeding the Maximum Number of Securities; and (D) fourth, to the
extent that the Maximum Number of Securities has not been reached under the foregoing clauses (A), (B) and (C), the Common Stock
or other equity securities for the account of other persons or entities that the Company is obligated to register pursuant to
separate written contractual arrangements with such persons or entities, which can be sold without exceeding the Maximum Number
of Securities.
2.2.3 Piggyback
Registration Withdrawal. Any Holder of Registrable Securities shall have the right to withdraw from a Piggyback Registration
for any or no reason whatsoever upon written notification to the Company and the Underwriter or Underwriters (if any) of his,
her or its intention to withdraw from such Piggyback Registration at least five (5) business days prior to the effectiveness of
the Registration Statement filed with the Commission with respect to such Piggyback Registration (or in the case of an Underwritten
Registration pursuant to Rule 415, at least five (5) business days prior to the time of pricing of the applicable offering). The
Company (whether on its own good faith determination or as the result of a request for withdrawal by persons pursuant to separate
written contractual obligations) may withdraw a Registration Statement filed with the Commission in connection with a Piggyback
Registration at any time prior to the effectiveness of such Registration Statement. Notwithstanding anything to the contrary in
this Agreement, the Company shall be responsible for the Registration Expenses incurred in connection with the Piggyback Registration
prior to its withdrawal under this subsection 2.2.3.
2.2.4 Unlimited
Piggyback Registration Rights. For purposes of clarity, any Registration effected pursuant to Section 2.2 hereof
shall not be counted as a Registration pursuant to an Underwritten Offering effected under subsection 2.1.3.
2.3 Restrictions
on Registration Rights. Notwithstanding anything to the contrary contained herein, the Company shall not be obligated to (but
may, at its sole option) (A) effect an Underwritten Offering (i) within sixty (60) days after the closing of an Underwritten Offering
or (ii) during the period starting with the date sixty (60) days prior to the Company’s good faith estimate of the date
of the filing of, and ending on a date one hundred and twenty (120) days after the effective date of, a Company-initiated Registration
and provided that the Company has delivered written notice to the Holders prior to receipt of an Underwritten Demand pursuant
to subsection 2.1.3 and it continues to actively employ, in good faith, all reasonable best efforts to cause the applicable
Registration Statement to become effective or (B) file a Registration Statement (or any amendment thereto) or effect an Underwritten
Offering (or, if the Company has filed a shelf Registration Statement and has included Registrable Securities therein, the Company
shall be entitled to suspend the offer and sale of Registrable Securities pursuant to such Registration Statement) for a period
of up to forty-five (45) days (i) if the Holders have requested an Underwritten Demand and the Company and the Holders are unable
to obtain the commitment of Underwriters to firmly underwrite the offer; or (ii) in the good faith judgment of the Board such
Underwritten Offering would be materially detrimental to the Company and the Board concludes as a result that it is essential
to defer the filing of such Registration Statement at such time, provided that in each case of (i) and (ii) the Company
shall furnish to such Holders a certificate signed by the Chairman of the Board stating that in the good faith judgment of the
Board it would be materially detrimental to the Company for such Registration Statement to be filed in the near future and that
it is therefore essential to defer the filing of such Registration Statement and provided, further, that the Company
shall not defer its obligation in this manner more than once in any 12 month period.
2.4 Waiver.
Notwithstanding anything in this Agreement to the contrary, unless the Company is notified in writing to the contrary by the Anchor
Investor, (A) each Anchor Investor hereby waives any and all rights (i) to receive notice of any Underwritten Offering as provided
for in this Section 2 or (ii) to participate in any such Underwritten Offering, and (B) the Company hereby agrees not to
notify any Anchor Investor of any Underwritten Offering or provide any Anchor Investor with any information relating thereto.
ARTICLE
III
COMPANY PROCEDURES
3.1 General
Procedures. If the Company is required to effect the Registration of Registrable Securities, the Company shall use its reasonable
best efforts to effect such Registration to permit the sale of such Registrable Securities in accordance with the intended plan
of distribution thereof, and pursuant thereto the Company shall, as expeditiously as possible:
3.1.1 prepare
and file with the Commission within fifteen (15) business days a Registration Statement with respect to such Registrable Securities
and use its reasonable best efforts to cause such Registration Statement to become effective and remain effective until all Registrable
Securities covered by such Registration Statement have been sold;
3.1.2 prepare
and file with the Commission such amendments and post-effective amendments to the Registration Statement, and such supplements
to the Prospectus, as may be reasonably requested by any Holder or any Underwriter of Registrable Securities or as may be required
by the rules, regulations or instructions applicable to the registration form used by the Company or by the Securities Act or
rules and regulations thereunder to keep the Registration Statement effective until all Registrable Securities covered by such
Registration Statement are sold in accordance with the intended plan of distribution set forth in such Registration Statement
or supplement to the Prospectus;
3.1.3 prior
to filing a Registration Statement or the Prospectus, or any amendment or supplement thereto, furnish without charge to the Underwriters,
if any, and each Holder of Registrable Securities included in such Registration, and such Holder’s legal counsel, copies
of such Registration Statement as proposed to be filed, each amendment and supplement to such Registration Statement (in each
case including all exhibits thereto and documents incorporated by reference therein), the Prospectus included in such Registration
Statement (including each preliminary Prospectus), and such other documents as the Underwriters and each Holder of Registrable
Securities included in such Registration or the legal counsel for any such Holders may request in order to facilitate the disposition
of the Registrable Securities owned by such Holders;
3.1.4 prior
to any Underwritten Offering of Registrable Securities, use its reasonable best efforts to (i) register or qualify the Registrable
Securities covered by the Registration Statement under such securities or “blue sky” laws of such jurisdictions in
the United States as any Holder of Registrable Securities included in such Registration Statement (in light of their intended
plan of distribution) may request and (ii) take such action necessary to cause such Registrable Securities covered by the
Registration Statement to be registered with or approved by such other governmental authorities as may be necessary by virtue
of the business and operations of the Company and do any and all other acts and things that may be necessary or advisable to enable
the Holders of Registrable Securities included in such Registration Statement to consummate the disposition of such Registrable
Securities in such jurisdictions; provided, however, that the Company shall not be required to qualify generally
to do business in any jurisdiction where it would not otherwise be required to qualify or take any action to which it would be
subject to general service of process or taxation in any such jurisdiction where it is not then otherwise so subject;
3.1.5 cause
all such Registrable Securities to be listed on each securities exchange or automated quotation system on which similar securities
issued by the Company are then listed;
3.1.6 provide
a transfer agent or warrant agent, as applicable, and registrar for all such Registrable Securities no later than the effective
date of such Registration Statement;
3.1.7 advise
each seller of such Registrable Securities, promptly after it shall receive notice or obtain knowledge thereof, of the issuance
of any stop order by the Commission suspending the effectiveness of such Registration Statement or the initiation or threatening
of any proceeding for such purpose and promptly use its reasonable best efforts to prevent the issuance of any stop order or to
obtain its withdrawal if such stop order should be issued;
3.1.8 at
least five (5) days prior to the filing of any Registration Statement or Prospectus or any amendment or supplement to such Registration
Statement or Prospectus or any document that is to be incorporated by reference into such Registration Statement or Prospectus,
furnish a copy thereof to each seller of such Registrable Securities and its counsel, including, without limitation, providing
copies promptly upon receipt of any comment letters received with respect to any such Registration Statement or Prospectus;
3.1.9 notify
the Holders at any time when a Prospectus relating to such Registration Statement is required to be delivered under the Securities
Act, of the happening of any event as a result of which the Prospectus included in such Registration Statement, as then in effect,
includes a Misstatement, and then to correct such Misstatement as set forth in Section 3.4 hereof;
3.1.10 permit
a representative of the Holders (such representative to be selected by a majority of the participating Holders), the Underwriter(s),
if any, and any attorney or accountant retained by such Holders or Underwriter(s) to participate, at each such person’s
own expense, in the preparation of the Registration Statement, and cause the Company’s officers, directors and employees
to supply all information reasonably requested by any such representative, Underwriter, attorney or accountant in connection with
the Registration; provided, however, that any such representative or Underwriter enters into a confidentiality agreement,
in form and substance reasonably satisfactory to the Company, prior to the release or disclosure of any such information; and
provided further, the Company may not include the name of any Holder or Underwriter or any information regarding any Holder
or Underwriter in any Registration Statement or Prospectus, any amendment or supplement to such Registration Statement or Prospectus,
any document that is to be incorporated by reference into such Registration Statement or Prospectus, or any response to any comment
letter, without the prior written consent of such Holder or Underwriter and providing each such Holder or Underwriter a reasonable
amount of time to review and comment on such applicable document, which comments the Company shall include unless contrary to
applicable law;
3.1.11 obtain
a “cold comfort” letter from the Company’s independent registered public accountants in the event of an Underwritten
Registration which the participating Holders may rely on, in customary form and covering such matters of the type customarily
covered by “cold comfort” letters as the managing Underwriter may reasonably request, and reasonably satisfactory
to a majority-in-interest of the participating Holders;
3.1.12 on
the date the Registrable Securities are delivered for sale pursuant to such Registration, obtain an opinion and negative assurance
letter, dated such date, of counsel representing the Company for the purposes of such Registration, addressed to the Holders,
the placement agent or sales agent, if any, and the Underwriter(s), if any, covering such legal matters with respect to the Registration
in respect of which such opinion is being given as the Holders, placement agent, sales agent, or Underwriter(s) may reasonably
request and as are customarily included in such opinions and negative assurance letters, and reasonably satisfactory to a majority
in interest of the participating Holders;
3.1.13 in
the event of any Underwritten Offering, enter into and perform its obligations under an underwriting agreement, in usual and customary
form, with the managing Underwriter of such offering;
3.1.14 make
available to its security holders, as soon as reasonably practicable, an earnings statement covering the period of at least twelve
(12) months beginning with the first day of the Company’s first full calendar quarter after the effective date of the Registration
Statement which satisfies the provisions of Section 11(a) of the Securities Act and Rule 158 thereunder (or any successor
rule promulgated thereafter by the Commission);
3.1.15 if
the Registration involves the Registration of Registrable Securities involving gross proceeds in excess of $50,000,000, use its
reasonable best efforts to make available senior executives of the Company to participate in customary “road show”
presentations that may be reasonably requested by the Underwriter(s) in any Underwritten Offering; and
3.1.16 otherwise,
in good faith, cooperate reasonably with, and take such customary actions as may reasonably be requested by the Holders, in connection
with such Registration.
3.2 Registration
Expenses. Except as otherwise provided herein, the Registration Expenses of all Registrations shall be borne by the Company.
It is acknowledged by the Holders that the Holders shall bear all incremental selling expenses relating to the sale of Registrable
Securities, such as Underwriters’ commissions and discounts, brokerage fees, Underwriter marketing costs and, other than
as set forth in the definition of “Registration Expenses,” all reasonable fees and expenses of any legal counsel representing
any Holder.
3.3 Requirements
for Participation in Underwritten Offerings. No person or entity may participate in any Underwritten Offering for equity securities
of the Company pursuant to a Registration initiated by the Company hereunder unless such person or entity (i) agrees to sell
such person’s or entity’s securities on the basis provided in any underwriting arrangements approved by the Company
and (ii) completes and executes all customary questionnaires, powers of attorney, indemnities, lock-up agreements, underwriting
agreements and other customary documents as may be reasonably required under the terms of such underwriting arrangements.
3.4 Suspension
of Sales; Adverse Disclosure. Upon receipt of written notice from the Company that a Registration Statement or Prospectus
contains a Misstatement, each of the Holders shall forthwith discontinue disposition of Registrable Securities until it has received
copies of a supplemented or amended Prospectus correcting the Misstatement (it being understood that the Company hereby covenants
to prepare and file such supplement or amendment as soon as practicable after the time of such notice), or until it is advised
in writing by the Company that the use of the Prospectus may be resumed. If the filing, initial effectiveness or continued use
of a Registration Statement in respect of any Registration at any time would require the Company to make an Adverse Disclosure
or would require the inclusion in such Registration Statement of financial statements that are unavailable to the Company for
reasons beyond the Company’s control, the Company may, upon giving prompt written notice of such action to the Holders,
delay the filing or initial effectiveness of, or suspend use of, such Registration Statement for the shortest period of time,
but in no event more than forty-five (45) days, determined in good faith by the Company to be necessary for such purpose. In the
event the Company exercises its rights under the preceding sentence, the Holders agree to suspend, immediately upon their receipt
of the notice referred to above, their use of the Prospectus relating to any Registration in connection with any sale or offer
to sell Registrable Securities. The Company shall immediately notify the Holders of the expiration of any period during which
it exercised its rights under this Section 3.4.
3.5 Reporting
Obligations. As long as any Holder shall own Registrable Securities, the Company, at all times while it shall be a reporting
company under the Exchange Act, covenants to file timely (or obtain extensions in respect thereof and file within the applicable
grace period) all reports required to be filed by the Company after the date hereof pursuant to Sections 13(a) or 15(d) of
the Exchange Act. The Company further covenants that it shall take such further action as any Holder may reasonably request, all
to the extent required from time to time to enable such Holder to sell shares of the Common Stock held by such Holder without
registration under the Securities Act within the limitation of the exemptions provided by Rule 144, including providing any legal
opinions. Upon the request of any Holder, the Company shall deliver to such Holder a written certification of a duly authorized
officer as to whether it has complied with such requirements.
3.6 Lock-Up
Restrictions.
3.6.1 During
the applicable Lock-Up Periods, none of the Existing Holders shall offer, sell, contract to sell, pledge, grant any option to
purchase, make any short sale or otherwise dispose of or distribute any shares of Common Stock that are subject to an applicable
Lock-Up Period or any securities convertible into, exercisable for, exchangeable for or that represent the right to receive shares
of Common Stock that are subject to an applicable Lock-Up Period, whether now owned or hereinafter acquired, that is owned directly
by such Existing Holder (including securities held as a custodian) or with respect to which such Existing Holder has beneficial
ownership within the rules and regulations of the Commission (such securities that are subject to an applicable Lock-Up Period,
the “Restricted Securities”), other than any transfer to an affiliate of an Existing Holder or to a
Permitted Transferee, as applicable. The foregoing restriction is expressly agreed to preclude each Existing Holder, as applicable,
from engaging in any hedging or other transaction with respect to Restricted Securities which is designed to or which reasonably
could be expected to lead to or result in a sale or disposition of the Restricted Securities even if such Restricted Securities
would be disposed of by someone other than such Existing Holder. Such prohibited hedging or other transactions include any short
sale or any purchase, sale or grant of any right (including any put or call option) with respect to any of the Restricted Securities
of the applicable Existing Holder, or with respect to any security that includes, relates to, or derives any significant part
of its value from such Restricted Securities.
3.6.2 Each
Existing Holder hereby represents and warrants that it now has and, except as contemplated by this subsection 3.6.2 for
the duration of the applicable Lock-Up Period, will have good and marketable title to its Restricted Securities, free and clear
of all liens, encumbrances, and claims that could impact the ability of such Existing Holder to comply with the foregoing restrictions
Each Existing Holder agrees and consents to the entry of stop transfer instructions with the Company’s transfer agent and
registrar against the transfer of any Restricted Securities during the applicable Lock-Up Period.
ARTICLE
IV
INDEMNIFICATION AND CONTRIBUTION
4.1 Indemnification.
4.1.1 The
Company agrees to indemnify, to the extent permitted by law, each Holder of Registrable Securities, its officers and directors
and each person who controls such Holder (within the meaning of the Securities Act) against all losses, claims, damages, liabilities
and expenses (including attorneys’ fees) caused by any untrue or alleged untrue statement of material fact contained in
any Registration Statement, Prospectus or preliminary Prospectus or any amendment thereof or supplement thereto or any omission
or alleged omission of a material fact required to be stated therein or necessary to make the statements therein not misleading,
except insofar as the same are caused by or contained in any information furnished in writing to the Company by such Holder expressly
for use therein. The Company shall indemnify the Underwriters, their officers and directors and each person who controls such
Underwriters (within the meaning of the Securities Act) to the same extent as provided in the foregoing with respect to the indemnification
of the Holder.
4.1.2 In
connection with any Registration Statement in which a Holder of Registrable Securities is participating, such Holder shall furnish
to the Company in writing such information and affidavits as the Company reasonably requests for use in connection with any such
Registration Statement or Prospectus and, to the extent permitted by law, shall indemnify the Company, its directors and officers
and agents and each person who controls the Company (within the meaning of the Securities Act) against any losses, claims, damages,
liabilities and expenses (including without limitation reasonable attorneys’ fees) resulting from any untrue statement of
material fact contained in the Registration Statement, Prospectus or preliminary Prospectus or any amendment thereof or supplement
thereto or any omission of a material fact required to be stated therein or necessary to make the statements therein not misleading,
but only to the extent that such untrue statement or omission is contained in any information or affidavit so furnished in writing
by such Holder expressly for use therein; The Holders of Registrable Securities shall indemnify the Underwriters, their officers,
directors and each person who controls such Underwriters (within the meaning of the Securities Act) to the same extent as provided
in the foregoing with respect to indemnification of the Company. For the avoidance of doubt, the obligation to indemnify under
this Section 4.1.2 shall be several, not joint and several, among the Holders of Registrable Securities, and the total
liability of a Holder under this Section 4.1.2 shall be in proportion to and limited to the net proceeds received by such
Holder from the sale of Registrable Securities pursuant to such Registration Statement.
4.1.3 Any
person entitled to indemnification herein shall (i) give prompt written notice to the indemnifying party of any claim with
respect to which it seeks indemnification (provided that the failure to give prompt notice shall not impair any person’s
right to indemnification hereunder to the extent such failure has not materially prejudiced the indemnifying party) and (ii) unless
in such indemnified party’s reasonable judgment a conflict of interest between such indemnified and indemnifying parties
may exist with respect to such claim, permit such indemnifying party to assume the defense of such claim with counsel reasonably
satisfactory to the indemnified party. If such defense is assumed, the indemnifying party shall not be subject to any liability
for any settlement made by the indemnified party without its consent (but such consent shall not be unreasonably withheld). An
indemnifying party who is not entitled to, or elects not to, assume the defense of a claim shall not be obligated to pay the fees
and expenses of more than one counsel (plus local counsel) for all parties indemnified by such indemnifying party with respect
to such claim, unless in the reasonable judgment of any indemnified party a conflict of interest may exist between such indemnified
party and any other of such indemnified parties with respect to such claim. No indemnifying party shall, without the consent of
the indemnified party, consent to the entry of any judgment or enter into any settlement which cannot be settled in all respects
by the payment of money (and such money is so paid by the indemnifying party pursuant to the terms of such settlement) or which
settlement does not include as an unconditional term thereof the giving by the claimant or plaintiff to such indemnified party
of a release from all liability in respect to such claim or litigation.
4.1.4 The
indemnification provided for under this Agreement shall remain in full force and effect regardless of any investigation made by
or on behalf of the indemnified party or any officer, director or controlling person of such indemnified party and shall survive
the transfer of securities.
4.1.5 If
the indemnification provided under Section 4.1 hereof from the indemnifying party is unavailable or insufficient to
hold harmless an indemnified party in respect of any losses, claims, damages, liabilities and expenses referred to herein, then
the indemnifying party, in lieu of indemnifying the indemnified party, shall contribute to the amount paid or payable by the indemnified
party as a result of such losses, claims, damages, liabilities and expenses in such proportion as is appropriate to reflect the
relative fault of the indemnifying party and the indemnified party, as well as any other relevant equitable considerations. The
relative fault of the indemnifying party and indemnified party shall be determined by reference to, among other things, whether
any action in question, including any untrue or alleged untrue statement of a material fact or omission or alleged omission to
state a material fact, was made by, or relates to information supplied by, such indemnifying party or indemnified party, and the
indemnifying party’s and indemnified party’s relative intent, knowledge, access to information and opportunity to
correct or prevent such action; provided, however, that the liability of any Holder under this subsection 4.1.5
shall be limited to the amount of the net proceeds received by such Holder in such offering giving rise to such liability.
The amount paid or payable by a party as a result of the losses or other liabilities referred to above shall be deemed to include,
subject to the limitations set forth in subsections 4.1.1, 4.1.2 and 4.1.3 above, any legal or other
fees, charges or expenses reasonably incurred by such party in connection with any investigation or proceeding. The parties hereto
agree that it would not be just and equitable if contribution pursuant to this subsection 4.1.5 were determined by
Pro Rata allocation or by any other method of allocation, which does not take account of the equitable considerations referred
to in this subsection 4.1.5. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f)
of the Securities Act) shall be entitled to contribution pursuant to this subsection 4.1.5 from any person who was
not guilty of such fraudulent misrepresentation.
ARTICLE
V
MISCELLANEOUS
5.1 Notices.
Any notice or communication under this Agreement must be in writing and given by (i) deposit in the United States mail, addressed
to the party to be notified, postage prepaid and registered or certified with return receipt requested, (ii) delivery in
person or by courier service providing evidence of delivery, or (iii) transmission by hand delivery, facsimile or electronic
mail Each notice or communication that is mailed, delivered, or transmitted in the manner described above shall be deemed sufficiently
given, served, sent, and received, in the case of mailed notices, on the third business day following the date on which it is
mailed and, in the case of notices delivered by courier service, hand delivery, facsimile or electronic mail, at such time as
it is delivered to the addressee (with the delivery receipt or the affidavit of messenger) or at such time as delivery is refused
by the addressee upon presentation. Any notice or communication under this Agreement must be addressed, if to the Company, to:
Canoo Inc., Attention: Ulrich Kranz & Andrew Wolstan, 19951 Mariner Avenue, Torrance, CA 90503 with a copy to Cooley LLP,
Attention: Dave Peinsipp, Kristin Vanderpas, Garth Osterman and Dave Young, 101 California Street, 5th Floor, San Francisco, CA
94111, and, if to any Holder, at such Holder’s address or contact information as set forth in the Company’s books
and records. Any party may change its address for notice at any time and from time to time by written notice to the other parties
hereto, and such change of address shall become effective thirty (30) days after delivery of such notice as provided in this Section 5.1.
5.2 Assignment;
No Third Party Beneficiaries.
5.2.1 This
Agreement and the rights, duties and obligations of the Company and the Holder of Registrable Securities, as the case may be,
hereunder may not be assigned or delegated by the Company or the Holders of Registrable Securities, as the case may be, in whole
or in part, except in connection with a transfer of Registrable Securities by such Holder to a Permitted Transferee but only if
such Permitted Transferee agrees to become bound by the transfer restrictions set forth in this Agreement.
5.2.2 Prior
to the expiration of any Lock-Up Period, no Holder subject to any such Lock-Up Period may assign or delegate such Holder’s
rights, duties or obligations under this Agreement, in whole or in part, in violation of the applicable Lock-Up Period, except
in connection with a transfer of Registrable Securities by such Holder to a Permitted Transferee but only if such Permitted Transferee
agrees to become bound by the transfer restrictions set forth in this Agreement.
5.2.3 This
Agreement and the provisions hereof shall be binding upon and shall inure to the benefit of each of the parties and its successors
and the permitted assigns of the Holders, which shall include Permitted Transferees.
5.2.4 This
Agreement shall not confer any rights or benefits on any persons that are not parties hereto, other than as expressly set forth
in this Agreement and Section 5.2 hereof.
5.2.5 No
assignment by any party hereto of such party’s rights, duties and obligations hereunder shall be binding upon or obligate
the Company unless and until the Company shall have received (i) written notice of such assignment as provided in Section 5.1
hereof and (ii) the written agreement of the assignee, in a form reasonably satisfactory to the Company, to be bound
by the terms and provisions of this Agreement (which may be accomplished by an addendum or certificate of joinder to this Agreement).
Any transfer or assignment made other than as provided in this Section 5.2 shall be null and void.
5.3 Counterparts.
This Agreement may be executed in multiple counterparts (including facsimile or PDF counterparts), each of which shall be deemed
an original, and all of which together shall constitute the same instrument, but only one of which need be produced.
5.4 Governing
Law; Venue. NOTWITHSTANDING THE PLACE WHERE THIS AGREEMENT MAY BE EXECUTED BY ANY OF THE PARTIES HERETO, THE PARTIES EXPRESSLY
AGREE THAT (I) THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED UNDER THE LAWS OF THE STATE OF NEW YORK AS APPLIED TO AGREEMENTS
AMONG NEW YORK RESIDENTS ENTERED INTO AND TO BE PERFORMED ENTIRELY WITHIN NEW YORK, WITHOUT REGARD TO THE CONFLICT OF LAW PROVISIONS
OF SUCH JURISDICTION AND (II) THE VENUE FOR ANY ACTION TAKEN WITH RESPECT TO THIS AGREEMENT SHALL BE ANY STATE OR FEDERAL
COURT IN NEW YORK COUNTY IN THE STATE OF NEW YORK.
5.5 Amendments
and Modifications. Upon the written consent of the Company and the Holders of at least a majority in interest of the Registrable
Securities at the time in question, compliance with any of the provisions, covenants and conditions set forth in this Agreement
may be waived, or any of such provisions, covenants or conditions may be amended or modified; provided, however,
that notwithstanding the foregoing, (a) any amendment hereto or waiver hereof that adversely affects either the Existing Holders
as a group or the New Holders as a group, as the case may be, in a manner that is materially adversely different from the New
Holders or the Existing Holders, respectively, shall require the consent of at least a majority-in-interest of the Registrable
Securities held by such Existing Holders or a majority-in-interest of the Registrable Securities held by the New Holders, as applicable,
at the time in question so affected; provided, further, that notwithstanding the foregoing, any amendment hereto
or waiver hereof that adversely affects one Holder or group of affiliated Holders, solely in its capacity as a holder of the shares
of capital stock of the Company, in a manner that is materially different from the other Holders (in such capacity) shall require
the consent of the Holder or group of affiliated Holders so affected and (b) any amendment hereto or waiver hereof that adversely
affects the rights of any Anchor Investor shall require the consent of such entity. No course of dealing between any Holder or
the Company and any other party hereto or any failure or delay on the part of a Holder or the Company in exercising any rights
or remedies under this Agreement shall operate as a waiver of any rights or remedies of any Holder or the Company. No single or
partial exercise of any rights or remedies under this Agreement by a party shall operate as a waiver or preclude the exercise
of any other rights or remedies hereunder or thereunder by such party.
5.6 Other
Registration Rights. The Company represents and warrants that no person, other than a Holder of Registrable Securities, has
any right to require the Company to register any securities of the Company for sale or to include such securities of the Company
in any Registration filed by the Company for the sale of securities for its own account or for the account of any other person.
Further, the Company represents and warrants that this Agreement supersedes any other registration rights agreement or agreement
with similar terms and conditions and in the event of a conflict between any such agreement or agreements and this Agreement,
the terms of this Agreement shall prevail.
5.7 Term.
This Agreement shall terminate upon the earlier of (i) the tenth anniversary of the date of this Agreement and (ii) the
date as of which (A) all of the Registrable Securities have been sold or disposed of or (B) the Holders of all Registrable
Securities are permitted to sell the Registrable Securities under Rule 144 (or any similar provision) under the Securities Act
without limitation on the amount of securities sold or the manner of sale and without compliance with the current public reporting
requirements set forth under Rule 144(i)(2). The provisions of Section 3.5 and Article IV shall survive
any termination.
5.8
Entire Agreement. This Agreement constitutes the entire understanding and agreement between the parties as to the matters
covered herein and supersedes and replaces any prior understanding, agreement or statement of intent, in each case, written or
oral, of any and every nature with respect thereto.
[Signature
Page Follows]
IN
WITNESS WHEREOF, the undersigned have caused this Agreement to be executed as of the date first written above.
| |
COMPANY: |
| |
|
|
| |
CANOO
INC., a Delaware corporation |
| |
|
|
|
| |
By: |
|
|
| |
|
Name: |
|
| |
|
Title: |
|
| |
|
|
|
| |
SPONSOR: |
|
| |
|
|
| |
HENNESSY
CAPITAL PARTNERS IV LLC, a
Delaware limited liability company |
| |
|
|
|
| |
By: |
Hennessy
Capital LLC, its managing member |
| |
|
|
|
| |
By: |
|
|
| |
|
Name: |
Daniel
J. Hennessy |
| |
|
Title:
|
Manager |
| |
|
|
|
| |
OTHER
PRE-IPO HOLDERS:
|
| |
|
|
|
| |
HC
NCBR Fund
|
| |
|
|
|
| |
By: |
|
|
| |
|
Name: |
|
| |
|
Title: |
|
| |
|
|
|
| |
blackrock
credit alpha master fund l.p.
|
| |
|
|
|
| |
By: |
|
|
| |
|
Name: |
|
| |
|
Title: |
|
| |
|
|
|
| |
|
|
|
| |
Name:
Greg Ethridge |
| |
|
|
| |
|
|
| |
Name:
Nicholas A. Petruska |
| |
|
|
| |
|
|
| |
Name:
Bradley Bell |
[Signature
Page to Amended and Restated Registration Rights Agreement]
| |
|
| |
Name: Richard Burns |
| |
|
| |
|
|
| |
Name: Juan Carlos Mas |
| |
|
|
| |
|
|
| |
Name: Gretchen W. McClain |
| |
|
|
| |
|
|
| |
Name: James F. O’Neil III |
| |
|
|
| |
|
|
| |
Name: Peter Shea |
| |
|
|
| |
NEW HOLDERS: |
| |
|
|
|
| |
[●]: |
|
|
| |
|
|
|
| |
By: |
|
|
| |
|
Name: |
|
| |
|
Title: |
|
| |
|
|
|
| |
[●]: |
|
|
| |
|
|
|
| |
By: |
|
|
| |
|
Name: |
|
| |
|
Title: |
|
[Signature
Page to Amended and Restated Registration Rights Agreement]
Exhibit
B
Form
of Lock-Up Agreement
[See
attached.]
EXHIBIT
B
FORM
OF LOCK-UP AGREEMENT
[___],
2020
Canoo
Inc.
19951
Mariner Ave
Torrance,
California 90503
Re:
Lock-Up Agreement
Ladies
and Gentlemen:
This
letter agreement (this “Letter Agreement”) is being delivered to you in accordance with the Merger Agreement
and Plan of Reorganization (the “Merger Agreement”) entered into by and among Canoo Inc., a Delaware
corporation f/k/a Hennessy Capital Acquisition Corp. IV (the “Company”), HCAC IV First Merger Sub, Ltd.,
an exempted company incorporated with limited liability in the Cayman Islands and a direct, wholly owned subsidiary of the Company
(“First Merger Sub”), HCAC IV Second Merger Sub, LLC, a Delaware limited liability company and a direct,
wholly owned subsidiary of the Company (“Second Merger Sub”), and Canoo Holdings Ltd., an exempted company
incorporated with limited liability in the Cayman Islands (“Canoo”), pursuant to which, through a series
of mergers at the Closing with HCAC IV First Merger Sub, Ltd. and HCAC IV Second Merger Sub, LLC, Canoo will become a wholly-owned
subsidiary of the Company. Capitalized terms used but not otherwise defined in this Agreement shall have the meanings ascribed
thereto in the Merger Agreement.
In
order to induce the Company to proceed with the Transactions and for other good and valuable consideration, the receipt and sufficiency
of which are hereby acknowledged, the undersigned (the “Securityholder”) hereby agrees with the Company
as follows:
1.
Subject to the exceptions set forth herein, the Securityholder agrees not to, without the prior written consent of the board of
directors of the Company, (i) sell, offer to sell, contract or agree to sell, hypothecate, pledge, grant any option to purchase
or otherwise dispose of or agree to dispose of, directly or indirectly, or establish or increase a put equivalent position or
liquidate or decrease a call equivalent position within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended
(the “Exchange Act”), and the rules and regulations of the Securities and Exchange Commission promulgated
thereunder, any shares of Common Stock, par value $0.0001 per share, of the Company (“Common Stock”)
held by it immediately after the Closing, any shares of Common Stock issuable upon the exercise of options to purchase shares
of Common Stock held by it immediately after the Closing, or any securities convertible into or exercisable or exchangeable for
Common Stock held by it immediately after the Closing, (ii) enter into any swap or other arrangement that transfers to another,
in whole or in part, any of the economic consequences of ownership of any of such shares of Common Stock or securities convertible
into or exercisable or exchangeable for Common Stock, whether any such transaction is to be settled by delivery of such securities,
in cash or otherwise or (iii) publicly announce any intention to effect any transaction specified in clause (i) or (ii) (the actions
specified in clauses (i)-(iii), collectively, “Transfer”) until 180 days after the Closing (the “Lock-up”).
2.
The restrictions set forth in paragraph 1 shall not apply to:
| |
(i) |
in the case of an entity, Transfers to a stockholder,
partner, member or affiliate of such entity; |
| |
(ii) |
in the case of an individual, Transfers by gift to members
of the individual’s immediate family (as defined below) or to a trust, the beneficiary of which is a member of one of the
individual’s immediate family, an affiliate of such person or to a charitable organization; |
| |
(iii) |
in the case of an individual, Transfers by virtue of
laws of descent and distribution upon death of the individual; |
| |
(iv) |
in the case of an individual, Transfers pursuant to
a qualified domestic relations order; |
| |
(v) |
in the case of an entity, Transfers by virtue of the
laws of the state of the entity’s organization and the entity’s organizational documents upon dissolution of the entity; |
| |
(vi) |
transactions relating to Common Stock or other securities
convertible into or exercisable or exchangeable for Common Stock acquired in open market transactions after the Closing, provided
that no such transaction is required to be, or is, publicly announced (whether on Form 4, Form 5 or otherwise, other than
a required filing on Schedule 13F, 13G or 13G/A) during the Lock-Up; |
| |
(vii) |
the exercise of any options or warrants to purchase
Common Stock (which exercises may be effected on a cashless basis to the extent the instruments representing such options or warrants
permit exercises on a cashless basis); |
| |
(viii) |
Transfers to the Company to satisfy tax withholding
obligations pursuant to the Company’s equity incentive plans or arrangements; |
| |
(ix) |
Transfers to the Company pursuant to any contractual
arrangement in effect at the Closing that provides for the repurchase by the Company or forfeiture of the Securityholder’s
Common Stock or other securities convertible into or exercisable or exchangeable for Common Stock in connection with the termination
of the Securityholder’s service to the Company; |
| |
(x) |
the entry, by the Securityholder, at any time after
the Closing, of any trading plan providing for the sale of Common Stock by the Securityholder, which trading plan meets the requirements
of Rule 10b5-1(c) under the Exchange Act, provided, however, that such plan does not provide for, or permit, the
sale of any Common Stock during the Lock-Up and no public announcement or filing is voluntarily made or required regarding such
plan during the Lock-Up; |
| |
(xi) |
transactions in the event of completion of a liquidation,
merger, stock exchange or other similar transaction which results in all of the Company’s securityholders having the right
to exchange their shares of Common Stock for cash, securities or other property; and |
| |
(xii) |
transactions to satisfy any U.S. federal, state, or
local income tax obligations of the Securityholder (or its direct or indirect owners) arising from a change in the U.S. Internal
Revenue Code of 1986, as amended (the “Code”), or the U.S. Treasury Regulations promulgated thereunder
(the “Regulations”) after the date on which the Merger Agreement was executed by the parties, and such
change prevents the Transactions from qualifying as a “reorganization” pursuant to Section 368 of the Code (and the
Transactions do not qualify for similar tax-free treatment pursuant to any successor or other provision of the Code or Regulations
taking into account such changes). |
provided,
however, that in the case of clauses (i) through (v), these permitted transferees must enter into a written agreement, in
substantially the form of this Letter Agreement (it being understood that any references to “immediate family” in
the agreement executed by such transferee shall expressly refer only to the immediate family of the Securityholder and not to
the immediate family of the transferee), agreeing to be bound by these Transfer restrictions. For purposes of this paragraph,
“immediate family” shall mean a spouse, domestic partner, child, grandchild or other lineal descendant (including
by adoption), father, mother, brother or sister of the Securityholder; and “affiliate” shall have the meaning set
forth in Rule 405 under the Securities Act of 1933, as amended.
3.
The Securityholder hereby represents and warrants that such Securityholder has full power and authority to enter into this Letter
Agreement and that this Letter Agreement constitutes the legal, valid and binding obligation of the Securityholder, enforceable
in accordance with its terms. Upon request, the Securityholder will execute any additional documents necessary in connection with
enforcement hereof. Any obligations of the Securityholder shall be binding upon the successors and assigns of the Securityholder
from and after the date hereof.
4.
This Letter Agreement constitutes the entire agreement and understanding of the parties hereto in respect of the subject matter
hereof and supersedes all prior understandings, agreements or representations by or among the parties hereto, written or oral,
to the extent they relate in any way to the subject matter hereof or the transactions contemplated hereby. This Letter Agreement
may not be changed, amended, modified or waived (other than to correct a typographical error) as to any particular provision,
except by a written instrument executed by all parties hereto.
5.
No party hereto may assign either this Letter Agreement or any of its rights, interests or obligations hereunder without the prior
written consent of the other party. Any purported assignment in violation of this paragraph shall be void and ineffectual and
shall not operate to transfer or assign any interest or title to the purported assignee. This Letter Agreement shall be binding
on the Securityholder and each of its respective successors, heirs and assigns and permitted transferees.
6.
This Letter Agreement shall be governed by and construed and enforced in accordance with the laws of the State of Delaware, without
giving effect to conflicts of law principles that would result in the application of the substantive laws of another jurisdiction.
The parties hereto (i) all agree that any action, proceeding, claim or dispute arising out of, or relating in any way to, this
Letter Agreement shall be brought and enforced in any Delaware Chancery Court, and irrevocably submit to such jurisdiction and
venue, which jurisdiction and venue shall be exclusive and (ii) waive any objection to such exclusive jurisdiction and venue or
that such courts represent an inconvenient forum.
7.
This Letter Agreement shall terminate on the expiration of the Lock-up.
[remainder
of page intentionally left blank]
| |
Very
truly yours, |
| |
|
| |
|
| |
(Name
of Securityholder – Please Print) |
| |
|
| |
|
| |
(Signature) |
| |
|
| |
|
| |
(Name
of Signatory if Securityholder is an entity – Please Print) |
| |
|
| |
|
| |
(Title
of Signatory if Securityholder is an entity – Please Print) |
| |
|
|
| |
Address: |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
[Signature Page to Letter Agreement]
Exhibit
C
Form
of Third Amended and Restated Charter of the Surviving Corporation
[See
attached.]
EXHIBIT C
THE COMPANIES LAW (2020 REVISION)
OF THE CAYMAN ISLANDS
COMPANY LIMITED BY SHARES
THIRD AMENDED AND RESTATED
MEMORANDUM AND ARTICLES OF ASSOCIATION
OF
CANOO
HOLDINGS LTD.
(as adopted with effect from ___ August
2020)
Registered Office:
c/o International Corporation Services
Ltd.
P.O. Box 472
Harbour Place, 2nd Floor
103 South Church Street
George Town
Grand Cayman KY1-1106
Cayman Islands
THE COMPANIES LAW (2020 REVISION)
OF THE CAYMAN ISLANDS
COMPANY LIMITED BY SHARES
THIRD AMENDED AND RESTATED
MEMORANDUM OF ASSOCIATION
OF
CANOO
HOLDINGS LTD.
(as adopted with effect from ___ August
2020)
| 1 | The name of the Company is Canoo Holdings Ltd.. |
| 2 | The registered office of the Company shall be at the offices of International
Corporation Services Ltd., P.O. Box 472, Harbour Place, 2nd Floor, 103 South Church Street, George Town, Grand Cayman KY1-1106,
Cayman Islands, or at such other place as the Directors may from time to time decide. |
| 3 | The objects for which the Company is established are unrestricted
and the Company shall have full power and authority to carry out any object not prohibited by the Companies Law (2020 Revision)
as the same may be revised from time to time, or any other law of the Cayman Islands. |
| 4 | The liability of each Member is limited to the amount from time to
time unpaid on such Member’s shares. |
| 5 | The share capital of the Company is US$1.00 divided into 10,000 ordinary
shares of a par value of US$0.0001 each. |
| 6 | The Company has power to register by way of continuation as a body
corporate limited by shares under the laws of any jurisdiction outside the Cayman Islands and to be deregistered in the Cayman
Islands. |
| 7 | Capitalised terms that are not defined in this Memorandum of Association
bear the same meaning as those given in the Articles of Association of the Company. |
THE COMPANIES LAW (2020 REVISION)
OF THE CAYMAN ISLANDS
COMPANY LIMITED BY SHARES
THIRD AMENDED AND RESTATED
ARTICLES OF ASSOCIATION
OF
CANOO
HOLDINGS LTD.
(as adopted with effect from ___ August
2020)
| 1.1 | In these Articles Table A in the First Schedule to the Statute does
not apply and, unless there is something in the subject or context inconsistent therewith: |
|
“Articles” |
means these articles of association of the Company. |
| |
|
| “Auditor” |
means the person for the time being performing the duties of auditor of the Company (if any). |
| |
|
| “Company” |
means the above-named company. |
| |
|
| “Directors” |
means the directors for the time being of the Company. |
| |
|
| “Dividend” |
includes an interim dividend. |
| |
|
| “Electronic Record” |
has the same meaning as in the Electronic Transactions Law (2003 Revision) of the Cayman Islands, as may be amended from time to time. |
| |
|
| “Member” |
has the same meaning as in the Statute. |
| |
|
| “Memorandum” |
means the memorandum of association of the Company. |
| |
|
| “Ordinary Resolution” |
means a resolution passed by a simple majority of the Members as, being entitled to do so, vote in person or, where proxies are allowed, by proxy at a general meeting, and includes a unanimous written resolution. In computing the majority when a poll is demanded regard shall be had to the number of votes to which each Member is entitled by the Articles. |
| |
|
| “Register of Members” |
means the register maintained in accordance with the Statute and includes (except where otherwise stated) any duplicate Register of Members. |
| “Registered Office” |
means the registered office for the time being of the Company. |
| |
|
| “Seal” |
means the common seal of the Company and includes every duplicate seal. |
| |
|
| “Share” and “Shares” |
means a share or shares in the Company and includes a fraction of a share. |
| |
|
| “Special Resolution” |
has the same meaning as in the Statute, and includes a unanimous written resolution. |
| |
|
| “Statute” |
means the Companies Law (2020 Revision) of the Cayman Islands, as may be amended from time to time. |
| |
|
| “Treasury Share” |
means a Share held in the name of the Company as a treasury share in accordance with the Statute. |
| (a) | words importing the singular number include the plural number and
vice versa; |
| (b) | words importing the masculine gender include the feminine gender; |
| (c) | words importing persons include corporations; |
| (d) | “written” and “in writing” include all modes
of representing or reproducing words in visible form, including in the form of an Electronic Record; |
| (e) | references to provisions of any law or regulation shall be construed
as references to those provisions as amended, modified, re-enacted or replaced from time to time; |
| (f) | any phrase introduced by the terms “including”, “include”,
“in particular” or any similar expression shall be construed as illustrative and shall not limit the sense of the words
preceding those terms; |
| (g) | headings are inserted for reference only and shall be ignored in
construing these Articles; and |
| (h) | in these Articles Section 8 of the Electronic Transactions Law (2003
Revision) of the Cayman Islands shall not apply. |
| 2.1 | Subject to the provisions, if any, in the Memorandum (and to any
direction that may be given by the Company in general meeting) and without prejudice to any rights attached to any existing Shares,
the Directors may allot, issue, grant options over or otherwise dispose of Shares (including fractions of a Share) with or without
preferred, deferred or other rights or restrictions, whether in regard to Dividend, voting, return of capital or otherwise and
to such persons, at such times and on such other terms as they think proper. |
| 2.2 | The Company shall not issue shares to bearer. The Company may hold
Treasury Shares. |
The Company shall maintain or
cause to be maintained the Register of Members in accordance with the Statute.
| 4 | Closing Register of Members or Fixing Record Date |
| 4.1 | For the purpose of determining Members entitled to notice of, or
to vote at any meeting of Members or any adjournment thereof, or Members entitled to receive payment of any Dividend, or in order
to make a determination of Members for any other purpose, the Directors may provide that the Register of Members shall be closed
for transfers for a stated period which shall not in any case exceed forty days. If the Register of Members shall be closed for
the purpose of determining Members entitled to notice of, or to vote at, a meeting of Members the Register of Members shall be
closed for at least ten days immediately preceding the meeting. |
| 4.2 | In lieu of, or apart from, closing the Register of Members, the Directors
may fix in advance or arrears a date as the record date for any such determination of Members entitled to notice of, or to vote
at any meeting of the Members or any adjournment thereof, or for the purpose of determining the Members entitled to receive payment
of any Dividend or in order to make a determination of Members for any other purpose. |
| 4.3 | If the Register of Members is not so closed and no record date is
fixed for the determination of Members entitled to notice of, or to vote at, a meeting of Members or Members entitled to receive
payment of a Dividend, the date on which notice of the meeting is sent or the date on which the resolution of the Directors declaring
such Dividend is adopted, as the case may be, shall be the record date for such determination of Members. When a determination
of Members entitled to vote at any meeting of Members has been made as provided in this Article, such determination shall apply
to any adjournment thereof. |
| 5.1 | A Member shall only be entitled to a share certificate if the Directors
resolve that share certificates shall be issued. Share certificates representing Shares, if any, shall be in such form as the Directors
may determine. Share certificates shall be signed by one or more Directors or other person authorised by the Directors. The Directors
may authorise certificates to be issued with the authorised signature(s) affixed by mechanical process. All certificates for Shares
shall be consecutively numbered or otherwise identified and shall specify the Shares to which they relate. All certificates surrendered
to the Company for transfer shall be cancelled and subject to these Articles no new certificate shall be issued until the former
certificate representing a like number of relevant Shares shall have been surrendered and cancelled. |
| 5.2 | The Company shall not be bound to issue more than one certificate
for Shares held jointly by more than one person and delivery of a certificate to one joint holder shall be a sufficient delivery
to all of them. |
| 5.3 | If a share certificate is defaced, worn out, lost or destroyed, it
may be renewed on such terms (if any) as to evidence and indemnity and on the payment of such expenses reasonably incurred by the
Company in investigating evidence, as the Directors may prescribe, and (in the case of defacement or wearing out) upon delivery
of the old certificate. |
| 6.1 | Shares are transferable subject to the consent of the Directors who
may, in their absolute discretion, decline to register any transfer of Shares without giving any reason. If the Directors refuse
to register a transfer they shall notify the transferee within two months of such refusal. |
| 6.2 | The instrument of transfer of any Share shall be in writing and shall
be executed by or on behalf of the transferor (and if the Directors so require, signed by the transferee). The transferor shall
be deemed to remain the holder of a Share until the name of the transferee is entered in the Register of Members. |
| 7 | Redemption and Repurchase of Shares |
| 7.1 | Subject to the provisions of the Statute the Company may issue Shares
that are to be redeemed or are liable to be redeemed at the option of the Member or the Company. |
| 7.2 | Subject to the provisions of the Statute, the Company may redeem
its own Shares or purchase its own Shares (including any redeemable Shares) provided that the Members shall have approved the manner
and terms of the redemption or purchase by Ordinary Resolution or as determined by a resolution of the Directors. |
| 7.3 | The Company may make a payment in respect of the redemption or purchase
of its own Shares in any manner permitted by the Statute, including out of capital. |
| 8.1 | The Directors may, prior to the purchase, redemption or surrender
of any Share, determine that such Share shall be held as a Treasury Share. |
| 8.2 | The Directors may determine to cancel a Treasury Share or transfer
a Treasury Share on such terms as they think proper (including, without limitation, for nil consideration). |
| 9 | Variation of Rights of Shares |
| 9.1 | If at any time the share capital of the Company is divided into different
classes of Shares, the rights attached to any class (unless otherwise provided by the terms of issue of the Shares of that class)
may, whether or not the Company is being wound up, be varied with the consent in writing of the holders of three-quarters of the
issued Shares of that class, or with the sanction of a Special Resolution passed at a general meeting of the holders of the Shares
of that class. |
| 9.2 | The provisions of these Articles relating to general meetings shall
apply to every class meeting of the holders of one class of Shares except that the necessary quorum shall be one person holding
or representing by proxy at least one third of the issued Shares of the class and that any holder of Shares of the class present
in person or by proxy may demand a poll. |
| 9.3 | The rights conferred upon the holders of the Shares of any class
issued with preferred or other rights shall not, unless otherwise expressly provided by the terms of issue of the Shares of that
class, be deemed to be varied by the creation or issue of further Shares ranking pari passu therewith. |
| 10 | Commission on Sale of Shares |
The Company may, in so far as
the Statute permits, pay a commission to any person in consideration of his subscribing or agreeing to subscribe whether absolutely
or conditionally for any Shares of the Company. Such commissions may be satisfied by the payment of cash and/or the issue of fully
or partly paid-up Shares. The Company may also on any issue of Shares pay such brokerage as may be lawful.
| 11 | Non Recognition of Trusts |
The Company shall not be bound
by or compelled to recognise in any way (even when notified) any equitable, contingent, future or partial interest in any Share,
or (except only as is otherwise provided by these Articles or the Statute) any other rights in respect of any Share other than
an absolute right to the entirety thereof in the registered holder.
| 12.1 | The Company shall have a first and paramount lien on all Shares (whether
fully paid-up or not) registered in the name of a Member (whether solely or jointly with others) for all debts, liabilities or
engagements to or with the Company (whether presently payable or not) by such Member or his estate, either alone or jointly with
any other person, whether a Member or not, but the Directors may at any time declare any Share to be wholly or in part exempt from
the provisions of this Article. The registration of a transfer of any such Share shall operate as a waiver of the Company’s lien
thereon. The Company’s lien on a Share shall also extend to any amount payable in respect of that Share. |
| 12.2 | The Company may sell, in such manner as the Directors think fit,
any Shares on which the Company has a lien, if a sum in respect of which the lien exists is presently payable, and is not paid
within fourteen clear days after notice has been given to the holder of the Shares, or to the person entitled to it in consequence
of the death or bankruptcy of the holder, demanding payment and stating that if the notice is not complied with the Shares may
be sold. |
| 12.3 | To give effect to any such sale the Directors may authorise any person
to execute an instrument of transfer of the Shares sold to, or in accordance with the directions of, the purchaser. The purchaser
or his nominee shall be registered as the holder of the Shares comprised in any such transfer, and he shall not be bound to see
to the application of the purchase money, nor shall his title to the Shares be affected by any irregularity or invalidity in the
sale or the exercise of the Company’s power of sale under these Articles. |
| 12.4 | The net proceeds of such sale after payment of costs, shall be applied
in payment of such part of the amount in respect of which the lien exists as is presently payable and any residue shall (subject
to a like lien for sums not presently payable as existed upon the Shares before the sale) be paid to the person entitled to the
Shares at the date of the sale. |
| 13.1 | Subject to the terms of the allotment the Directors may from time
to time make calls upon the Members in respect of any monies unpaid on their Shares (whether in respect of par value or premium),
and each Member shall (subject to receiving at least fourteen days notice specifying the time or times of payment) pay to the Company
at the time or times so specified the amount called on the Shares. A call may be revoked or postponed as the Directors may determine.
A call may be required to be paid by instalments. A person upon whom a call is made shall remain liable for calls made upon him
notwithstanding the subsequent transfer of the Shares in respect of which the call was made. |
| 13.2 | A call shall be deemed to have been made at the time when the resolution
of the Directors authorising such call was passed. |
| 13.3 | The joint holders of a Share shall be jointly and severally liable
to pay all calls in respect thereof. |
| 13.4 | If a call remains unpaid after it has become due and payable, the
person from whom it is due shall pay interest on the amount unpaid from the day it became due and payable until it is paid at such
rate as the Directors may determine, but the Directors may waive payment of the interest wholly or in part. |
| 13.5 | An amount payable in respect of a Share on allotment or at any fixed
date, whether on account of the par value of the Share or premium or otherwise, shall be deemed to be a call and if it is not paid
all the provisions of these Articles shall apply as if that amount had become due and payable by virtue of a call. |
| 13.6 | The Directors may issue Shares with different terms as to the amount
and times of payment of calls, or the interest to be paid. |
| 13.7 | The Directors may, if they think fit, receive an amount from any
Member willing to advance all or any part of the monies uncalled and unpaid upon any Shares held by him, and may (until the amount
would otherwise become payable) pay interest at such rate as may be agreed upon between the Directors and the Member paying such
amount in advance. |
| 13.8 | No such amount paid in advance of calls shall entitle the Member
paying such amount to any portion of a Dividend declared in respect of any period prior to the date upon which such amount would,
but for such payment, become payable. |
| 14.1 | If a call remains unpaid after it has become due and payable the
Directors may give to the person from whom it is due not less than fourteen clear days notice requiring payment of the amount unpaid
together with any interest, which may have accrued. The notice shall specify where payment is to be made and shall state that if
the notice is not complied with the Shares in respect of which the call was made will be liable to be forfeited. |
| 14.2 | If the notice is not complied with any Share in respect of which
it was given may, before the payment required by the notice has been made, be forfeited by a resolution of the Directors. Such
forfeiture shall include all Dividends or other monies declared payable in respect of the forfeited Share and not paid before the
forfeiture. |
| 14.3 | A forfeited Share may be sold, re-allotted or otherwise disposed
of on such terms and in such manner as the Directors think fit and at any time before a sale, re-allotment or disposition the forfeiture
may be cancelled on such terms as the Directors think fit. Where for the purposes of its disposal a forfeited Share is to be transferred
to any person the Directors may authorise some person to execute an instrument of transfer of the Share in favour of that person. |
| 14.4 | A person any of whose Shares have been forfeited shall cease to be
a Member in respect of them and shall surrender to the Company for cancellation the certificate for the Shares forfeited and shall
remain liable to pay to the Company all monies which at the date of forfeiture were payable by him to the Company in respect of
those Shares together with interest, but his liability shall cease if and when the Company shall have received payment in full
of all monies due and payable by him in respect of those Shares. |
| 14.5 | A certificate in writing under the hand of one Director or officer
of the Company that a Share has been forfeited on a specified date shall be conclusive evidence of the fact as against all persons
claiming to be entitled to the Share. The certificate shall (subject to the execution of an instrument of transfer) constitute
a good title to the Share and the person to whom the Share is disposed of shall not be bound to see to the application of the purchase
money, if any, nor shall his title to the Share be affected by any irregularity or invalidity in the proceedings in reference to
the forfeiture, sale or disposal of the Share. |
| 14.6 | The provisions of these Articles as to forfeiture shall apply in
the case of non payment of any sum which, by the terms of issue of a Share, becomes payable at a fixed time, whether on account
of the par value of the Share or by way of premium as if it had been payable by virtue of a call duly made and notified. |
| 15.1 | If a Member dies the survivor or survivors where he was a joint holder
or his legal personal representatives where he was a sole holder, shall be the only persons recognised by the Company as having
any title to his interest. The estate of a deceased Member is not thereby released from any liability in respect of any Share,
which had been jointly held by him. |
| 15.2 | Any person becoming entitled to a Share in consequence of the death
or bankruptcy or liquidation or dissolution of a Member (or in any other way than by transfer) may, upon such evidence being produced
as may from time to time be required by the Directors, elect, by a notice in writing sent by him, either to become the holder of
such Share or to have some person nominated by him become the holder of such Share but the Directors shall, in either case, have
the same right to decline or suspend registration as they would have had in the case of a transfer of the Share by the relevant
Member before his death or bankruptcy or liquidation or dissolution, as the case may be. |
| 15.3 | A person becoming entitled to a Share by reason of the death or bankruptcy
or liquidation or dissolution of a Member (or in any other case than by transfer) shall be entitled to the same Dividends and other
advantages to which he would be entitled if he were the registered holder of such Share. However, he shall not, before becoming
a Member in respect of a Share, be entitled in respect of it to exercise any right conferred by membership in relation to meetings
of the Company and the Directors may at any time give notice requiring any such person to elect either to be registered himself
or to have some person nominated by him become the holder of the Share (but the Directors shall, in either case, have the same
right to decline or suspend registration as they would have had in the case of a transfer of the Share by the relevant Member before
his death or bankruptcy or liquidation or dissolution or any other case than by transfer, as the case may be). If the notice is
not complied with within ninety days the Directors may thereafter withhold payment of all Dividends, bonuses or other monies payable
in respect of the Share until the requirements of the notice have been complied with. |
| 16 | Amendments of Memorandum and Articles of Association and Alteration
of Capital |
| 16.1 | The Company may by Ordinary Resolution: |
| (a) | increase the share capital by such sum as the resolution shall prescribe
and with such rights, priorities and privileges annexed thereto, as the Company in general meeting may determine; |
| (b) | consolidate and divide all or any of its share capital into Shares
of larger amount than its existing Shares; |
| (c) | by subdivision of its existing Shares or any of them divide the whole
or any part of its Share capital into Shares of smaller amount than is fixed by the Memorandum or into Shares without par value;
and |
| (d) | cancel any Shares that at the date of the passing of the resolution
have not been taken or agreed to be taken by any person. |
| 16.2 | All new Shares created in accordance with the provisions of the preceding
Article shall be subject to the same provisions of the Articles with reference to the payment of calls, liens, transfer, transmission,
forfeiture and otherwise as the Shares in the original share capital. |
| 16.3 | Subject to the provisions of the Statute and the provisions of these
Articles as regards the matters to be dealt with by Ordinary Resolution, the Company may by Special Resolution: |
| (b) | alter or add to these Articles; |
| (c) | alter or add to the Memorandum with respect to any objects, powers
or other matters specified therein; and |
| (d) | reduce its share capital and any capital redemption reserve fund. |
Subject to the provisions of
the Statute, the Company may by resolution of the Directors change the location of its Registered Office.
| 18.1 | All general meetings other than annual general meetings shall be
called extraordinary general meetings. |
| 18.2 | The Company shall, if required by the Statute, in each year hold
a general meeting as its annual general meeting, and shall specify the meeting as such in the notices calling it. The annual general
meeting shall be held at such time and place as the Directors shall appoint and if no other time and place is prescribed by them,
it shall be held at the Registered Office on the second Wednesday in December of each year at ten o’clock in the morning. At these
meetings the report of the Directors (if any) shall be presented. |
| 18.3 | The Company may hold an annual general meeting, but shall not (unless
required by Statute) be obliged to hold an annual general meeting. |
| 18.4 | The Directors may call general meetings, and they shall on a Members
requisition forthwith proceed to convene an extraordinary general meeting of the Company. |
| 18.5 | A Members requisition is a requisition of Members of the Company
holding at the date of deposit of the requisition not less than ten per cent. in par value of the capital of the Company as at
that date carries the right of voting at general meetings of the Company. |
| 18.6 | The requisition must state the objects of the meeting and must be
signed by the requisitionists and deposited at the Registered Office, and may consist of several documents in like form each signed
by one or more requisitionists. |
| 18.7 | If the Directors do not within twenty-one days from the date of the
deposit of the requisition duly proceed to convene a general meeting to be held within a further twenty-one days, the requisitionists,
or any of them representing more than one-half of the total voting rights of all of them, may themselves convene a general meeting,
but any meeting so convened shall not be held after the expiration of three months after the expiration of the said twenty-one
days. |
| 18.8 | A general meeting convened as aforesaid by requisitionists shall
be convened in the same manner as nearly as possible as that in which general meetings are to be convened by Directors. |
| 19 | Notice of General Meetings |
| 19.1 | At least five days’ notice shall be given of any general meeting.
Every notice shall be exclusive of the day on which it is given or deemed to be given and of the day for which it is given and
shall specify the place, the day and the hour of the meeting and the general nature of the business and shall be given in the manner
hereinafter mentioned or in such other manner if any as may be prescribed by the Company, provided that a general meeting of the
Company shall, whether or not the notice specified in this regulation has been given and whether or not the provisions of the Articles
regarding general meetings have been complied with, be deemed to have been duly convened if it is so agreed: |
| (a) | in the case of an annual general meeting, by all the Members (or
their proxies) entitled to attend and vote thereat; and |
| (b) | in the case of an extraordinary general meeting, by a majority in
number of the Members (or their proxies) having a right to attend and vote at the meeting, being a majority together holding not
less than ninety five per cent in par value of the Shares giving that right. |
| 19.2 | The accidental omission to give notice of a general meeting to, or
the non receipt of notice of a meeting by, any person entitled to receive notice shall not invalidate the proceedings of that meeting. |
| 20 | Proceedings at General Meetings |
| 20.1 | No business shall be transacted at any general meeting unless a quorum
is present. Two Members being individuals present in person or by proxy or if a corporation or other non-natural person by its
duly authorised representative or proxy shall be a quorum unless the Company has only one Member entitled to vote at such general
meeting in which case the quorum shall be that one Member present in person or by proxy or (in the case of a corporation or other
non-natural person) by a duly authorised representative or proxy. |
| 20.2 | A person may participate at a general meeting by conference telephone
or other communications equipment by means of which all the persons participating in the meeting can communicate with each other.
Participation by a person in a general meeting in this manner is treated as presence in person at that meeting. |
| 20.3 | A resolution (including a Special Resolution) in writing (in one
or more counterparts) signed by all Members for the time being entitled to receive notice of and to attend and vote at general
meetings (or, being corporations, signed by their duly authorised representatives) shall be as valid and effective as if the resolution
had been passed at a general meeting of the Company duly convened and held. |
| 20.4 | If a quorum is not present within half an hour from the time appointed
for the meeting or if during such a meeting a quorum ceases to be present, the meeting, if convened upon the requisition of Members,
shall be dissolved and in any other case it shall stand adjourned to the same day in the next week at the same time and place or
to such other day, time or such other place as the Directors may determine, and if at the adjourned meeting a quorum is not present
within half an hour from the time appointed for the meeting the Members present shall be a quorum. |
| 20.5 | The chairman, if any, of the board of Directors shall preside as
chairman at every general meeting of the Company, or if there is no such chairman, or if he shall not be present within fifteen
minutes after the time appointed for the holding of the meeting, or is unwilling to act, the Directors present shall elect one
of their number to be chairman of the meeting. |
| 20.6 | If no Director is willing to act as chairman or if no Director is
present within fifteen minutes after the time appointed for holding the meeting, the Members present shall choose one of their
number to be chairman of the meeting. |
| 20.7 | The chairman may, with the consent of a meeting at which a quorum
is present, (and shall if so directed by the meeting), adjourn the meeting from time to time and from place to place, but no business
shall be transacted at any adjourned meeting other than the business left unfinished at the meeting from which the adjournment
took place. When a general meeting is adjourned for thirty days or more, notice of the adjourned meeting shall be given as in the
case of an original meeting. Otherwise it shall not be necessary to give any such notice. |
| 20.8 | A resolution put to the vote of the meeting shall be decided on a
show of hands unless before, or on the declaration of the result of, the show of hands, the chairman demands a poll, or any other
Member or Members collectively present in person or by proxy and holding at least ten per cent. in par value of the Shares giving
a right to attend and vote at the meeting demand a poll. |
| 20.9 | Unless a poll is duly demanded a declaration by the chairman that
a resolution has been carried or carried unanimously, or by a particular majority, or lost or not carried by a particular majority,
an entry to that effect in the minutes of the proceedings of the meeting shall be conclusive evidence of that fact without proof
of the number or proportion of the votes recorded in favour of or against such resolution. |
| 20.10 | The demand for a poll may be withdrawn. |
| 20.11 | Except on a poll demanded on the election of a chairman or on a question
of adjournment, a poll shall be taken as the chairman directs, and the result of the poll shall be deemed to be the resolution
of the general meeting at which the poll was demanded. |
| 20.12 | A poll demanded on the election of a chairman or on a question of
adjournment shall be taken forthwith. A poll demanded on any other question shall be taken at such time as the chairman of the
general meeting directs, and any business other than that upon which a poll has been demanded or is contingent thereon may proceed
pending the taking of the poll. |
| 20.13 | In the case of an equality of votes, whether on a show of hands or
on a poll, the chairman shall be entitled to a second or casting vote. |
| 21.1 | Subject to any rights or restrictions attached to any Shares, on
a show of hands every Member who (being an individual) is present in person or by proxy or, if a corporation or other non-natural
person is present by its duly authorised representative or proxy, shall have one vote and on a poll every Member shall have one
vote for every Share of which he is the holder. |
| 21.2 | In the case of joint holders of record the vote of the senior holder
who tenders a vote, whether in person or by proxy, shall be accepted to the exclusion of the votes of the other joint holders,
and seniority shall be determined by the order in which the names of the holders stand in the Register of Members. |
| 21.3 | A Member of unsound mind, or in respect of whom an order has been
made by any court, having jurisdiction in lunacy, may vote, whether on a show of hands or on a poll, by his committee, receiver,
curator bonis, or other person on such Member’s behalf appointed by that court, and any such committee, receiver, curator bonis
or other person may vote by proxy. |
| 21.4 | No person shall be entitled to vote at any general meeting or at
any separate meeting of the holders of a class of Shares unless he is registered as a Member on the record date for such meeting
nor unless all calls or other monies then payable by him in respect of Shares have been paid. |
| 21.5 | No objection shall be raised to the qualification of any voter except
at the general meeting or adjourned general meeting at which the vote objected to is given or tendered and every vote not disallowed
at the meeting shall be valid. Any objection made in due time shall be referred to the chairman whose decision shall be final and
conclusive. |
| 21.6 | On a poll or on a show of hands votes may be cast either personally
or by proxy. A Member may appoint more than one proxy or the same proxy under one or more instruments to attend and vote at a meeting.
Where a Member appoints more than one proxy the instrument of proxy shall state which proxy is entitled to vote on a show of hands. |
| 21.7 | A Member holding more than one Share need not cast the votes in respect
of his Shares in the same way on any resolution and therefore may vote a Share or some or all such Shares either for or against
a resolution and/or abstain from voting a Share or some or all of the Shares and, subject to the terms of the instrument appointing
him, a proxy appointed under one or more instruments may vote a Share or some or all of the Shares in respect of which he is appointed
either for or against a resolution and/or abstain from voting. |
| 22.1 | The instrument appointing a proxy shall be in writing, be executed
under the hand of the appointor or of his attorney duly authorised in writing, or, if the appointor is a corporation under the
hand of an officer or attorney duly authorised for that purpose. A proxy need not be a Member of the Company. |
| 22.2 | The instrument appointing a proxy shall be deposited at the Registered
Office or at such other place as is specified for that purpose in the notice convening the meeting, or in any instrument of proxy
sent out by the Company: |
| (a) | not less than 48 hours before the time for holding the meeting or
adjourned meeting at which the person named in the instrument proposes to vote; or |
| (b) | in the case of a poll taken more than 48 hours after it is demanded,
be deposited as aforesaid after the poll has been demanded and not less than 24 hours before the time appointed for the taking
of the poll; or |
| (c) | where the poll is not taken forthwith but is taken not more than
48 hours after it was demanded be delivered at the meeting at which the poll was demanded to the chairman or to the secretary or
to any director; |
provided that the Directors may
in the notice convening the meeting, or in an instrument of proxy sent out by the Company, direct that the instrument appointing
a proxy may be deposited (no later than the time for holding the meeting or adjourned meeting) at the Registered Office or at such
other place as is specified for that purpose in the notice convening the meeting, or in any instrument of proxy sent out by the
Company. The chairman may in any event at his discretion direct that an instrument of proxy shall be deemed to have been duly deposited.
An instrument of proxy that is not deposited in the manner permitted shall be invalid.
| 22.3 | The instrument appointing a proxy may be in any usual or common form
and may be expressed to be for a particular meeting or any adjournment thereof or generally until revoked. An instrument appointing
a proxy shall be deemed to include the power to demand or join or concur in demanding a poll. |
| 22.4 | Votes given in accordance with the terms of an instrument of proxy
shall be valid notwithstanding the previous death or insanity of the principal or revocation of the proxy or of the authority under
which the proxy was executed, or the transfer of the Share in respect of which the proxy is given unless notice in writing of such
death, insanity, revocation or transfer was received by the Company at the Registered Office before the commencement of the general
meeting, or adjourned meeting at which it is sought to use the proxy. |
Any corporation or other non-natural
person which is a Member may in accordance with its constitutional documents, or in the absence of such provision by resolution
of its directors or other governing body, authorise such person as it thinks fit to act as its representative at any meeting of
the Company or of any class of Members, and the person so authorised shall be entitled to exercise the same powers on behalf of
the corporation which he represents as the corporation could exercise if it were an individual Member.
| 24 | Shares that May Not be Voted |
Shares in the Company that are
beneficially owned by the Company shall not be voted, directly or indirectly, at any meeting and shall not be counted in determining
the total number of outstanding Shares at any given time.
There shall be a board of Directors
consisting of not less than one person (exclusive of alternate Directors) provided however that the Company may from time to time
by Ordinary Resolution increase or reduce the limits in the number of Directors. The first Directors of the Company shall be determined
in writing by, or appointed by a resolution of, the subscriber(s) to the Memorandum.
| 26.1 | Subject to the provisions of the Statute, the Memorandum and the
Articles and to any directions given by Special Resolution, the business of the Company shall be managed by the Directors who may
exercise all the powers of the Company. No alteration of the Memorandum or Articles and no such direction shall invalidate any
prior act of the Directors which would have been valid if that alteration had not been made or that direction had not been given.
A duly convened meeting of Directors at which a quorum is present may exercise all powers exercisable by the Directors. |
| 26.2 | All cheques, promissory notes, drafts, bills of exchange and other
negotiable instruments and all receipts for monies paid to the Company shall be signed, drawn, accepted, endorsed or otherwise
executed as the case may be in such manner as the Directors shall determine by resolution. |
| 26.3 | The Directors on behalf of the Company may pay a gratuity or pension
or allowance on retirement to any Director who has held any other salaried office or place of profit with the Company or to his
widow or dependants and may make contributions to any fund and pay premiums for the purchase or provision of any such gratuity,
pension or allowance. |
| 26.4 | The Directors may exercise all the powers of the Company to borrow
money and to mortgage or charge its undertaking, property and uncalled capital or any part thereof and to issue debentures, debenture
stock, mortgages, bonds and other such securities whether outright or as security for any debt, liability or obligation of the
Company or of any third party. |
| 27 | Appointment and Removal of Directors |
| 27.1 | The Company may by Ordinary Resolution appoint any person to be a
Director or may by Ordinary Resolution remove any Director. |
| 27.2 | The Directors may appoint any person to be a Director, either to
fill a vacancy or as an additional Director provided that the appointment does not cause the number of Directors to exceed any
number fixed by or in accordance with the Articles as the maximum number of Directors. |
| 28 | Vacation of Office of Director |
The office of a Director shall
be vacated if:
| (a) | he gives notice in writing to the Company that he resigns the office
of Director; or |
| (b) | if he absents himself (without being represented by proxy or an alternate
Director appointed by him) from three consecutive meetings of the board of Directors without special leave of absence from the
Directors, and they pass a resolution that he has by reason of such absence vacated office; or |
| (c) | if he dies, becomes bankrupt or makes any arrangement or composition
with his creditors generally; or |
| (d) | if he is found to be or becomes of unsound mind; or |
| (e) | if all the other Directors of the Company (being not less than two
in number) resolve that he should be removed as a Director. |
| 29 | Proceedings of Directors |
| 29.1 | The quorum for the transaction of the business of the Directors may
be fixed by the Directors, and unless so fixed shall be two if there are two or more Directors, and shall be one if there is only
one Director. A person who holds office as an alternate Director shall, if his appointor is not present, be counted in the quorum.
A Director who also acts as an alternate Director shall, if his appointor is not present, count twice towards the quorum. |
| 29.2 | Subject to the provisions of the Articles, the Directors may regulate
their proceedings as they think fit. Questions arising at any meeting shall be decided by a majority of votes. In the case of an
equality of votes, the chairman shall have a second or casting vote. A Director who is also an alternate Director shall be entitled
in the absence of his appointor to a separate vote on behalf of his appointor in addition to his own vote. |
| 29.3 | A person may participate in a meeting of the Directors or committee
of Directors by conference telephone or other communications equipment by means of which all the persons participating in the meeting
can communicate with each other at the same time. Participation by a person in a meeting in this manner is treated as presence
in person at that meeting. Unless otherwise determined by the Directors the meeting shall be deemed to be held at the place where
the chairman is at the start of the meeting. |
| 29.4 | A resolution in writing (in one or more counterparts) signed by all
the Directors or all the members of a committee of Directors (an alternate Director being entitled to sign such a resolution on
behalf of his appointor) shall be as valid and effectual as if it had been passed at a meeting of the Directors, or committee of
Directors as the case may be, duly convened and held. |
| 29.5 | A Director or alternate Director may, or other officer of the Company
on the requisition of a Director or alternate Director shall, call a meeting of the Directors by at least two days’ notice in writing
to every Director and alternate Director which notice shall set forth the general nature of the business to be considered unless
notice is waived by all the Directors (or their alternates) either at, before or after the meeting is held. |
| 29.6 | The continuing Directors may act notwithstanding any vacancy in their
body, but if and so long as their number is reduced below the number fixed by or pursuant to these Articles as the necessary quorum
of Directors the continuing Directors or Director may act for the purpose of increasing the number of Directors to that number,
or of summoning a general meeting of the Company, but for no other purpose. |
| 29.7 | The Directors may elect a chairman of their board and determine the
period for which he is to hold office; but if no such chairman is elected, or if at any meeting the chairman is not present within
five minutes after the time appointed for holding the same, the Directors present may choose one of their number to be chairman
of the meeting. |
| 29.8 | All acts done by any meeting of the Directors or of a committee of
Directors (including any person acting as an alternate Director) shall, notwithstanding that it be afterwards discovered that there
was some defect in the appointment of any Director or alternate Director, or that they or any of them were disqualified, be as
valid as if every such person had been duly appointed and qualified to be a Director or alternate Director as the case may be. |
| 29.9 | A Director but not an alternate Director may be represented at any
meetings of the board of Directors by a proxy appointed in writing by him. The proxy shall count towards the quorum and the vote
of the proxy shall for all purposes be deemed to be that of the appointing Director. |
A Director of the Company who
is present at a meeting of the board of Directors at which action on any Company matter is taken shall be presumed to have assented
to the action taken unless his dissent shall be entered in the minutes of the meeting or unless he shall file his written dissent
from such action with the person acting as the chairman or secretary of the meeting before the adjournment thereof or shall forward
such dissent by registered post to such person immediately after the adjournment of the meeting. Such right to dissent shall not
apply to a Director who voted in favour of such action.
| 31.1 | A Director may hold any other office or place of profit under the
Company (other than the office of Auditor) in conjunction with his office of Director for such period and on such terms as to remuneration
and otherwise as the Directors may determine. |
| 31.2 | A Director may act by himself or his firm in a professional capacity
for the Company and he or his firm shall be entitled to remuneration for professional services as if he were not a Director or
alternate Director. |
| 31.3 | A Director or alternate Director of the Company may be or become
a director or other officer of or otherwise interested in any company promoted by the Company or in which the Company may be interested
as shareholder or otherwise, and no such Director or alternate Director shall be accountable to the Company for any remuneration
or other benefits received by him as a director or officer of, or from his interest in, such other company. |
| 31.4 | No person shall be disqualified from the office of Director or alternate
Director or prevented by such office from contracting with the Company, either as vendor, purchaser or otherwise, nor shall any
such contract or any contract or transaction entered into by or on behalf of the Company in which any Director or alternate Director
shall be in any way interested be or be liable to be avoided, nor shall any Director or alternate Director so contracting or being
so interested be liable to account to the Company for any profit realised by any such contract or transaction by reason of such
Director holding office or of the fiduciary relation thereby established. A Director (or his alternate Director in his absence)
shall be at liberty to vote in respect of any contract or transaction in which he is interested provided that the nature of the
interest of any Director or alternate Director in any such contract or transaction shall be disclosed by him at or prior to its
consideration and any vote thereon. |
| 31.5 | A general notice that a Director or alternate Director is a shareholder,
director, officer or employee of any specified firm or company and is to be regarded as interested in any transaction with such
firm or company shall be sufficient disclosure for the purposes of voting on a resolution in respect of a contract or transaction
in which he has an interest, and after such general notice it shall not be necessary to give special notice relating to any particular
transaction. |
The Directors shall cause minutes
to be made in books kept for the purpose of all appointments of officers made by the Directors, all proceedings at meetings of
the Company or the holders of any class of Shares and of the Directors, and of committees of Directors including the names of the
Directors or alternate Directors present at each meeting.
| 33 | Delegation of Directors’ Powers |
| 33.1 | The Directors may delegate any of their powers to any committee consisting
of one or more Directors. They may also delegate to any managing director or any Director holding any other executive office such
of their powers as they consider desirable to be exercised by him provided that an alternate Director may not act as managing director
and the appointment of a managing director shall be revoked forthwith if he ceases to be a Director. Any such delegation may be
made subject to any conditions the Directors may impose, and either collaterally with or to the exclusion of their own powers and
may be revoked or altered. Subject to any such conditions, the proceedings of a committee of Directors shall be governed by the
Articles regulating the proceedings of Directors, so far as they are capable of applying. |
| 33.2 | The Directors may establish any committees, local boards or agencies
or appoint any person to be a manager or agent for managing the affairs of the Company and may appoint any person to be a member
of such committees or local boards. Any such appointment may be made subject to any conditions the Directors may impose, and either
collaterally with or to the exclusion of their own powers and may be revoked or altered. Subject to any such conditions, the proceedings
of a committee of Directors shall be governed by the Articles regulating the proceedings of Directors, so far as they are capable
of applying. |
| 33.3 | The Directors may by power of attorney or otherwise appoint any person
to be the agent of the Company on such conditions as the Directors may determine, provided that the delegation is not to the exclusion
of their own powers and may be revoked by the Directors at any time. |
| 33.4 | The Directors may by power of attorney or otherwise appoint any company,
firm, person or body of persons, whether nominated directly or indirectly by the Directors, to be the attorney or authorised signatory
of the Company for such purpose and with such powers, authorities and discretions (not exceeding those vested in or exercisable
by the Directors under these Articles) and for such period and subject to such conditions as they may think fit, and any such powers
of attorney or other appointment may contain such provisions for the protection and convenience of persons dealing with any such
attorneys or authorised signatories as the Directors may think fit and may also authorise any such attorney or authorised signatory
to delegate all or any of the powers, authorities and discretions vested in him. |
| 33.5 | The Directors may appoint such officers as they consider necessary
on such terms, at such remuneration and to perform such duties, and subject to such provisions as to disqualification and removal
as the Directors may think fit. Unless otherwise specified in the terms of his appointment an officer may be removed by resolution
of the Directors or Members. |
| 34.1 | Any Director (other than an alternate Director) may by writing appoint
any other Director, or any other person willing to act, to be an alternate Director and by writing may remove from office an alternate
Director so appointed by him. |
| 34.2 | An alternate Director shall be entitled to receive notice of all
meetings of Directors and of all meetings of committees of Directors of which his appointor is a member, to attend and vote at
every such meeting at which the Director appointing him is not personally present, and generally to perform all the functions of
his appointor as a Director in his absence. |
| 34.3 | An alternate Director shall cease to be an alternate Director if
his appointor ceases to be a Director. |
| 34.4 | Any appointment or removal of an alternate Director shall be by notice
to the Company signed by the Director making or revoking the appointment or in any other manner approved by the Directors. |
| 34.5 | An alternate Director shall be deemed for all purposes to be a Director
and shall alone be responsible for his own acts and defaults and shall not be deemed to be the agent of the Director appointing
him. |
| 35 | No Minimum Shareholding |
The Company in general meeting
may fix a minimum shareholding required to be held by a Director, but unless and until such a shareholding qualification is fixed
a Director is not required to hold Shares.
| 36 | Remuneration of Directors |
| 36.1 | The remuneration to be paid to the Directors, if any, shall be such
remuneration as the Directors shall determine. The Directors shall also be entitled to be paid all travelling, hotel and other
expenses properly incurred by them in connection with their attendance at meetings of Directors or committees of Directors, or
general meetings of the Company, or separate meetings of the holders of any class of Shares or debentures of the Company, or otherwise
in connection with the business of the Company, or to receive a fixed allowance in respect thereof as may be determined by the
Directors, or a combination partly of one such method and partly the other. |
| 36.2 | The Directors may by resolution approve additional remuneration to
any Director for any services other than his ordinary routine work as a Director. Any fees paid to a Director who is also counsel
or solicitor to the Company, or otherwise serves it in a professional capacity shall be in addition to his remuneration as a Director. |
| 37.1 | The Company may, if the Directors so determine, have a Seal. The
Seal shall only be used by the authority of the Directors or of a committee of the Directors authorised by the Directors. Every
instrument to which the Seal has been affixed shall be signed by at least one person who shall be either a Director or some officer
or other person appointed by the Directors for the purpose. |
| 37.2 | The Company may have for use in any place or places outside the Cayman
Islands a duplicate Seal or Seals each of which shall be a facsimile of the common Seal of the Company and, if the Directors so
determine, with the addition on its face of the name of every place where it is to be used. |
| 37.3 | A Director or officer, representative or attorney of the Company
may without further authority of the Directors affix the Seal over his signature alone to any document of the Company required
to be authenticated by him under seal or to be filed with the Registrar of Companies in the Cayman Islands or elsewhere wheresoever. |
| 38 | Dividends, Distributions and Reserve |
| 38.1 | Subject to the Statute and this Article, the Directors may declare
Dividends and distributions on Shares in issue and authorise payment of the Dividends or distributions out of the funds of the
Company lawfully available therefor. No Dividend or distribution shall be paid except out of the realised or unrealised profits
of the Company or out of the share premium account or as otherwise permitted by the Statute. |
| 38.2 | Except as otherwise provided by the rights attached to Shares, all
Dividends shall be declared and paid according to the par value of the Shares that a Member holds. If any Share is issued on terms
providing that it shall rank for Dividend as from a particular date, that Share shall rank for Dividend accordingly. |
| 38.3 | The Directors may deduct from any Dividend or distribution payable
to any Member all sums of money (if any) then payable by him to the Company on account of calls or otherwise. |
| 38.4 | The Directors may declare that any Dividend or distribution be paid
wholly or partly by the distribution of specific assets and in particular of shares, debentures, or securities of any other company
or in any one or more of such ways and where any difficulty arises in regard to such distribution, the Directors may settle the
same as they think expedient and in particular may issue fractional Shares and fix the value for distribution of such specific
assets or any part thereof and may determine that cash payments shall be made to any Members upon the basis of the value so fixed
in order to adjust the rights of all Members and may vest any such specific assets in trustees as may seem expedient to the Directors. |
| 38.5 | Any Dividend, distribution, interest or other monies payable in cash
in respect of Shares may be paid by wire transfer to the holder or by cheque or warrant sent through the post directed to the registered
address of the holder or, in the case of joint holders, to the registered address of the holder who is first named on the Register
of Members or to such person and to such address as such holder or joint holders may in writing direct. Every such cheque or warrant
shall be made payable to the order of the person to whom it is sent. Any one of two or more joint holders may give effectual receipts
for any Dividends, bonuses, or other monies payable in respect of the Share held by them as joint holders. |
| 38.6 | No Dividend or distribution shall bear interest against the Company. |
| 38.7 | Any Dividend which cannot be paid to a Member and/or which remains
unclaimed after six months from the date of the declaration of such Dividend may, in the discretion of the Directors, be paid into
a separate account in the Company’s name, provided that the Company shall not be constituted as a trustee in respect of that
account and the Dividend shall remain as a debt due to the Member. Any Dividend which remains unclaimed after a period of six years
from the date of the declaration of such dividend shall be forfeited and shall revert to the Company. |
The Directors may capitalise
any sum standing to the credit of any of the Company’s reserve accounts (including share premium account and capital redemption
reserve fund) or any sum standing to the credit of profit and loss account or otherwise available for distribution and to appropriate
such sum to Members in the proportions in which such sum would have been divisible amongst them had the same been a distribution
of profits by way of Dividend and to apply such sum on their behalf in paying up in full unissued Shares for allotment and distribution
credited as fully paid-up to and amongst them in the proportion aforesaid. In such event the Directors shall do all acts and things
required to give effect to such capitalisation, with full power to the Directors to make such provisions as they think fit for
the case of Shares becoming distributable in fractions (including provisions whereby the benefit of fractional entitlements accrue
to the Company rather than to the Members concerned). The Directors may authorise any person to enter on behalf of all of the Members
interested into an agreement with the Company providing for such capitalisation and matters incidental thereto and any agreement
made under such authority shall be effective and binding on all concerned.
| 40.1 | The Directors shall cause proper books of account to be kept with
respect to all sums of money received and expended by the Company and the matters in respect of which the receipt or expenditure
takes place, all sales and purchases of goods by the Company and the assets and liabilities of the Company. Proper books shall
not be deemed to be kept if there are not kept such books of account as are necessary to give a true and fair view of the state
of the Company’s affairs and to explain its transactions. The Company shall cause all books of account to be maintained for
a minimum period of five years from the date on which they were prepared. |
| 40.2 | The Directors shall from time to time determine whether and to what
extent and at what times and places and under what conditions or regulations the accounts and books of the Company or any of them
shall be open to the inspection of Members not being Directors and no Member (not being a Director) shall have any right of inspecting
any account or book or document of the Company except as conferred by Statute or authorised by the Directors or by the Company
in general meeting. |
| 40.3 | The Directors may from time to time cause to be prepared and to be
laid before the Company in general meeting profit and loss accounts, balance sheets, group accounts (if any) and such other reports
and accounts as may be required by law. |
| 41.1 | The Directors may appoint an Auditor of the Company who shall hold
office until removed from office by a resolution of the Directors, and may fix his or their remuneration. |
| 41.2 | Every Auditor of the Company shall have a right of access at all
times to the books and accounts and vouchers of the Company and shall be entitled to require from the Directors and officers of
the Company such information and explanation as may be necessary for the performance of the duties of the Auditor. |
| 41.3 | Auditors shall, if so required by the Directors, make a report on
the accounts of the Company during their tenure of office at the next annual general meeting following their appointment in the
case of a company which is registered with the Registrar of Companies as an ordinary company, and at the next extraordinary general
meeting following their appointment in the case of a company which is registered with the Registrar of Companies as an exempted
company, and at any other time during their term of office, upon request of the Directors or any general meeting of the Members. |
| 42.1 | Notices shall be in writing and may be given by the Company to any
Member either personally or by sending it by courier, post, cable, telex, fax or e-mail to him or to his address as shown in the
Register of Members (or where the notice is given by e-mail by sending it to the e-mail address provided by such Member). Any notice,
if posted from one country to another, is to be sent airmail. |
| 42.2 | Where a notice is sent by courier, service of the notice shall be
deemed to be effected by delivery of the notice to a courier company, and shall be deemed to have been received on the third day
(not including Saturdays or Sundays or public holidays) following the day on which the notice was delivered to the courier. Where
a notice is sent by post, service of the notice shall be deemed to be effected by properly addressing, pre paying and posting a
letter containing the notice, and shall be deemed to have been received on the fifth day (not including Saturdays or Sundays or
public holidays) following the day on which the notice was posted. Where a notice is sent by cable, telex or fax, service of the
notice shall be deemed to be effected by properly addressing and sending such notice and shall be deemed to have been received
on the same day that it was transmitted. Where a notice is given by e-mail service shall be deemed to be effected by transmitting
the e-mail to the e-mail address provided by the intended recipient and shall be deemed to have been received on the same day that
it was sent, and it shall not be necessary for the receipt of the e-mail to be acknowledged by the recipient. |
| 42.3 | A notice may be given by the Company to the person or persons which
the Company has been advised are entitled to a Share or Shares in consequence of the death or bankruptcy of a Member in the same
manner as other notices which are required to be given under these Articles and shall be addressed to them by name, or by the title
of representatives of the deceased, or trustee of the bankrupt, or by any like description at the address supplied for that purpose
by the persons claiming to be so entitled, or at the option of the Company by giving the notice in any manner in which the same
might have been given if the death or bankruptcy had not occurred. |
| 42.4 | Notice of every general meeting shall be given in any manner hereinbefore
authorised to every person shown as a Member in the Register of Members on the record date for such meeting except that in the
case of joint holders the notice shall be sufficient if given to the joint holder first named in the Register of Members and every
person upon whom the ownership of a Share devolves by reason of his being a legal personal representative or a trustee in bankruptcy
of a Member of record where the Member of record but for his death or bankruptcy would be entitled to receive notice of the meeting,
and no other person shall be entitled to receive notices of general meetings. |
| 43.1 | If the Company shall be wound up and the assets available for distribution
amongst the Members shall be insufficient to pay the whole of the share capital, such assets shall be distributed so that, as nearly
as may be, the losses shall be borne by the Members in proportion to the par value of the Shares held by them. |
| 43.2 | If in a winding up the assets available for distribution amongst
the Members shall be more than sufficient to repay the whole of the share capital at the commencement of the winding up, the surplus
shall be distributed amongst the Members in proportion to the par value of the Shares held by them at the commencements of the
winding up subject to a deduction from those Shares in respect of which there are monies due, of all monies payable to the Company
for unpaid calls or otherwise. This Article is without prejudice to the rights of the holders of Shares issued upon special terms
and conditions. |
| 43.3 | If the Company shall be wound up the liquidator may, with the sanction
of a Special Resolution of the Company and any other sanction required by the Statute, divide in kind amongst the Members the whole
or any part of the assets of the Company (whether such assets shall consist of property of the same kind or not) and may for that
purpose value any assets and determine how the division shall be carried out as between the Members or different classes of Members.
The liquidator may, with the like sanction, vest the whole or any part of such assets in trustees upon such trusts for the benefit
of the Members as the liquidator, with the like sanction, shall think fit, but so that no Member shall be compelled to accept any
asset upon which there is a liability. |
To the fullest
extent permitted by applicable law, the Company is authorized to provide indemnification of (and advancement of expenses to) directors,
officers and agents of the Company (and any other persons to which applicable law permits the Company to provide indemnification)
through agreements with such agents or other persons, vote of shareholders or disinterested directors or otherwise in excess of
the indemnification and advancement otherwise permitted by such applicable law. If applicable law is amended after approval by
the shareholders of this Article 44 to authorize corporate action further eliminating or limiting the personal liability of directors,
then the liability of a director to the Company shall be eliminated or limited to the fullest extent permitted by applicable law
as so amended.
Unless the Directors otherwise
prescribe, the financial year of the Company shall end on 31st December in each year and, following the year of incorporation,
shall begin on 1st January in each year.
| 46 | Transfer by way of Continuation |
If the Company is exempted as
defined in the Statute, it shall, subject to the provisions of the Statute and with the approval of a Special Resolution, have
the power to register by way of continuation as a body corporate under the laws of any jurisdiction outside the Cayman Islands
and to be deregistered in the Cayman Islands.
| 47 | Mergers and Consolidations |
The Company shall have the
power to merge or consolidate with one or more other constituent companies (as defined in the Statute) upon such terms as the Directors
may determine and (to the extent required by the Statute) with the approval of a Special Resolution.
Exhibit
D
Form
of Second Amended and Restated Certificate of Incorporation of HCAC
[See
attached.]
EXHIBIT D
SECOND
AMENDED AND RESTATED
CERTIFICATE OF INCORPORATION
OF
HENNESSY CAPITAL ACQUISITION CORP. IV
Hennessy Capital Acquisition Corp. IV, a corporation organized
and existing under the laws of the State of Delaware, hereby certifies that:
ONE: The name of this company is Hennessy Capital Acquisition
Corp. IV and the date of filing the original Certificate of Incorporation of this corporation with the Secretary of State of Delaware
was August 6, 2018.
TWO: Ulrich Kranz is the duly elected and acting Chief
Executive Officer of Hennessy Capital Acquisition Corp. IV, a Delaware corporation.
THREE: The Amended and Restated Certificate of Incorporation
of this corporation is hereby amended and restated to read as follows:
I.
The name of this corporation is Canoo Inc. (the “Company”).
II.
The address of the Company’s registered office in the
State of Delaware is Corporation Service Company, 251 Little Falls Drive, in the City of Wilmington, County of New Castle, Delaware
19808. The name of its registered agent at such address is Corporation Service Company.
III.
The purpose of the Company is to engage in any lawful act or
activity for which a corporation may be organized under the Delaware General Corporation Law (“DGCL”).
IV.
A. The Company is authorized to issue two classes of
stock to be designated, respectively, “Common Stock” and “Preferred Stock.”
The total number of shares which the Company is authorized to issue is 510,000,000 shares. 500,000,000 shares shall be Common Stock,
each having a par value of one-hundredth of one cent ($0.0001). 10,000,000 shares shall be Preferred Stock, each having a par value
of one-hundredth of one cent ($0.0001).
B. Effective immediately upon the filing and effectiveness
of this Second Amended and Restated Certificate of Incorporation with the Office of the Secretary of State of the State of Delaware
(the “Effective Time”), each one share of the Company’s Class A Common Stock, par value $0.0001
per share (the “Class A Common Stock”), that was issued and outstanding immediately prior to the Effective
Time shall automatically be reclassified, redesignated and changed into one validly issued, fully paid and non-assessable share
of Common Stock of the Company, par value $0.0001 per share (the “Common Stock”), without any further
action by the Company or any stockholder thereof. Each certificate that immediately prior to the Effective Time represented shares
of Class A Common Stock (each, a “Prior Certificate”) shall, until surrendered to the Company in exchange
for a certificate representing the same number of shares of Common Stock, automatically represent that number of shares of Common
Stock into which the shares of Class A Common Stock represented by the Prior Certificate shall have been reclassified and redesignated.
C. The Preferred Stock may be issued from time to time
in one or more series. The Board of Directors of the Company (the “Board of Directors”) is hereby expressly
authorized to provide for the issue of all or any number of the shares of the Preferred Stock in one or more series, and to fix
the number of shares and to determine or alter for each such series, such voting powers, full or limited, or no voting powers,
and such designation, preferences, and relative, participating, optional, or other rights and such qualifications, limitations,
or restrictions thereof, as shall be stated and expressed in the resolution or resolutions adopted by the Board of Directors providing
for the issuance of such shares and as may be permitted by the DGCL. The Board of Directors is also expressly authorized to increase
(but not above the total number of authorized shares of the class) or decrease (but not below the number of shares of such series
then outstanding) the number of shares of any series subsequent to the issuance of shares of that series. In case the number of
shares of any series shall be decreased in accordance with the foregoing sentence, the shares constituting such decrease shall
resume the status that they had prior to the adoption of the resolution originally fixing the number of shares of such series.
The number of authorized shares of Preferred Stock may be increased or decreased (but not below the number of shares thereof then
outstanding) by the affirmative vote of the holders of a majority of the voting power of the stock of the Company entitled to vote
thereon, without a separate vote of the holders of the Preferred Stock, or of any series thereof, unless a vote of any such holders
is required pursuant to the terms of any certificate of designation filed with respect to any series of Preferred Stock.
D. Each outstanding share of Common Stock shall entitle
the holder thereof to one vote on each matter properly submitted to the stockholders of the Company for their vote; provided, however,
that, except as otherwise required by law, holders of Common Stock shall not be entitled to vote on any amendment to this Second
Amended and Restated Certificate of Incorporation (including any certificate of designation filed with respect to any series of
Preferred Stock) that relates solely to the terms of one or more outstanding series of Preferred Stock if the holders of such affected
series are entitled, either separately or together as a class with the holders of one or more other such series, to vote thereon
by law or pursuant to this Second Amended and Restated Certificate of Incorporation (including any certificate of designation filed
with respect to any series of Preferred Stock).
V.
For the management of the business and for the conduct of the
affairs of the Company, and in further definition, limitation and regulation of the powers of the Company, of its directors and
of its stockholders or any class thereof, as the case may be, it is further provided that:
A.
1. The management of the business and the conduct of
the affairs of the Company shall be vested in the Board of Directors. The number of directors which shall constitute the Board
of Directors shall be fixed exclusively by resolutions adopted by a majority of the authorized number of directors constituting
the Board of Directors.
2. BOARD OF DIRECTORS
Subject to the rights of the holders of any series of Preferred
Stock to elect additional directors under specified circumstances, the directors shall be divided into three classes designated
as Class I, Class II and Class III, respectively. The Board of Directors is authorized to assign members of the Board of Directors
already in office to such classes at the time the classification becomes effective. At the first annual meeting of stockholders
after the date hereof, the term of office of the Class I directors shall expire and Class I directors shall be elected for a full
term of three years. At the second annual meeting of stockholders after the date hereof, the term of office of the Class II directors
shall expire and Class II directors shall be elected for a full term of three years. At the third annual meeting of stockholders
after the date hereof, the term of office of the Class III directors shall expire and Class III directors shall be elected for
a full term of three years. At each succeeding annual meeting of stockholders, directors shall be elected for a full term of three
years to succeed the directors of the class whose terms expire at such annual meeting.
No stockholder entitled to vote at an election for directors
may cumulate votes to which such stockholder is entitled unless required by applicable law at the time of such election. During
such time or times that applicable law requires cumulative voting, every stockholder entitled to vote at an election for directors
may cumulate such stockholder’s votes and give one candidate a number of votes equal to the number of directors to be elected
multiplied by the number of votes to which such stockholder’s shares are otherwise entitled, or distribute the stockholder’s
votes on the same principle among as many candidates as such stockholder thinks fit. No stockholder, however, shall be entitled
to so cumulate such stockholder’s votes unless (i) the names of such candidate or candidates have been placed in nomination
prior to the voting and (ii) the stockholder has given notice at the meeting, prior to the voting, of such stockholder’s
intention to cumulate such stockholder’s votes. If any stockholder has given proper notice to cumulate votes, all stockholders
may cumulate their votes for any candidates who have been properly placed in nomination. Under cumulative voting, the candidates
receiving the highest number of votes, up to the number of directors to be elected, are elected.
Notwithstanding the foregoing provisions of this section, each
director shall serve until his or her successor is duly elected and qualified or until his or her earlier death, resignation or
removal. No decrease in the number of directors constituting the Board of Directors shall shorten the term of any incumbent director.
3. REMOVAL OF DIRECTORS. Subject to any limitations imposed
by applicable law, any individual director or directors may be removed with cause by the affirmative vote of the holders of at
least a majority of the voting power of all then-outstanding shares of capital stock of the Company entitled to vote generally
at an election of directors.
4. VACANCIES. Subject to any limitations imposed by applicable
law and subject to the rights of the holders of any series of Preferred Stock, any vacancies on the Board of Directors resulting
from death, resignation, disqualification, removal or other causes and any newly created directorships resulting from any increase
in the number of directors, shall, unless the Board of Directors determines by resolution that any such vacancies or newly created
directorships shall be filled by the stockholders and except as otherwise provided by applicable law, be filled only by the affirmative
vote of a majority of the directors then in office, even if less than a quorum of the Board of Directors, and not by the stockholders.
Any director elected in accordance with the preceding sentence shall hold office for the remainder of the full term of the director
for which the vacancy was created or occurred and until such director’s successor shall have been elected and qualified.
B.
1. BYLAW AMENDMENTS. The Board of Directors is expressly
empowered to adopt, amend or repeal the Bylaws of the Company. Any adoption, amendment or repeal of the Bylaws of the Company by
the Board of Directors shall require the approval of a majority of the authorized number of directors. The stockholders shall also
have power to adopt, amend or repeal the Bylaws of the Company; provided, however, that, in addition to any vote of the
holders of any class or series of stock of the Company required by law or by this Second Amended and Restated Certificate of Incorporation,
such action by stockholders shall require the affirmative vote of the holders of at least 66 2/3% of the voting power of all of
the then-outstanding shares of the capital stock of the Company entitled to vote generally in the election of directors, voting
together as a single class.
2. The directors of the Company need not be elected by
written ballot unless the Bylaws so provide.
3. Subject to the rights of the holders of shares of
Preferred Stock permitting the holders of such series of Preferred Stock to act by written consent, no action shall be taken by
the stockholders of the Company except at a duly called annual or special meeting of stockholders called in accordance with the
Bylaws, and no action shall be taken by the stockholders by written consent or electronic transmission.
4. Advance notice of stockholder nominations for the
election of directors and of business to be brought by stockholders before any meeting of the stockholders of the Company shall
be given in the manner provided in the Bylaws of the Company.
5. Subject to the rights of the holders of shares of
Preferred Stock permitting the holders of such series of Preferred Stock to call a special meeting of the holders of such series,
special meetings of the stockholders of the Company may be called only by the chairperson of the Board of Directors, the chief
executive officer of the Company or the Board of Directors, and the ability of the stockholders to call a special meeting of the
stockholders is hereby specifically denied.
VI.
A. The liability of the directors for monetary damages
shall be eliminated to the fullest extent permitted by applicable law.
B. To the fullest extent permitted by applicable law,
the Company shall provide indemnification of (and advancement of expenses to) directors, officers and agents of the Company (and
any other persons to which applicable law permits the Company to provide indemnification) through Bylaw provisions, agreements
with such agents or other persons, vote of stockholders or disinterested directors or otherwise in excess of the indemnification
and advancement otherwise permitted by such applicable law. If applicable law is amended after approval by the stockholders of
this Article VI to authorize corporate action further eliminating or limiting the personal liability of directors, then the liability
of a director to the Company shall be eliminated or limited to the fullest extent permitted by applicable law as so amended.
C. Any repeal or modification of this Article VI shall
only be prospective and shall not affect the rights or protections or increase the liability of any director under this Article
VI in effect at the time of the alleged occurrence of any act or omission to act giving rise to liability or indemnification.
VII.
A. Unless the Company consents in writing to the selection
of an alternative forum, the Court of Chancery of the State of Delaware shall (or, if and only if the Court of Chancery of the
State of Delaware lacks subject matter jurisdiction, any state court located within the State of Delaware or, if and only if all
such state courts lack subject matter jurisdiction, the federal district court for the District of Delaware), to the fullest extent
permitted by applicable law, be the sole and exclusive forum for the following types of actions or proceedings under Delaware statutory
or common law: (A) any derivative action or proceeding brought on behalf of the Company; (B) any action or proceeding (including
any class action) asserting a claim of breach of a fiduciary duty owed by any current or former director, officer or other employee
of the Company to the Company or the Company’s stockholders; (C) any action or proceeding (including any class action) asserting
a claim against the Company or any current or former director, officer or other employee of the Company arising out of or pursuant
to any provision of the DGCL, this Second Amended and Restated Certificate of Incorporation or the Bylaws of the Company (as each
may be amended from time to time); (D) any action or proceeding (including any class action) to interpret, apply, enforce or determine
the validity of this Second Amended and Restated Certificate of Incorporation or the Bylaws of the Company (including any right,
obligation or remedy thereunder); (E) any action or proceeding as to which the DGCL confers jurisdiction to the Court of Chancery
of the State of Delaware; or (F) any action asserting a claim against the Company or any director, officer or other employee of
the Company governed by the internal affairs doctrine, in all cases to the fullest extent permitted by law and subject to the court’s
having personal jurisdiction over the indispensable parties named as defendants. This Article VII shall not apply to suits brought
to enforce a duty or liability created by the Securities Exchange Act of 1934, as amended, or any other claim for which the federal
courts have exclusive jurisdiction.
B. If any action the subject matter of which is within
the scope of Section VII.A is filed in a court other than a court located within the State of Delaware (a “Foreign
Action”) in the name of any stockholder, such stockholder shall be deemed to have consented to (i) the personal jurisdiction
of the state and federal courts located within the State of Delaware in connection with any action brought in any such court to
enforce Section VII.A (an “Enforcement Action”) and (ii) having service of process made upon such stockholder
in any such Enforcement Action by service upon such stockholder’s counsel in the Foreign Action as agent for such stockholder.
C. Unless the Company consents in writing to the selection
of an alternative forum, the federal district courts of the United States of America shall be the exclusive forum for the resolution
of any complaint asserting a cause of action arising under the Securities Act of 1933, as amended.
D. Any person or entity purchasing, holding, owning or
otherwise acquiring any interest in any security of the Company shall be deemed to have notice of and to have consented to the
provisions of this Article VII.
VIII.
A. The Company reserves the right to amend, alter, change
or repeal any provision contained in this Second Amended and Restated Certificate of Incorporation, in the manner now or hereafter
prescribed by statute, except as provided in paragraph B. of this Article VIII, and all rights conferred upon the stockholders
herein are granted subject to this reservation.
B. Notwithstanding any other provisions of this Second
Amended and Restated Certificate of Incorporation or any provision of law which might otherwise permit a lesser vote or no vote,
but in addition to any affirmative vote of the holders of any particular class or series of the Company required by law or by this
Second Amended and Restated Certificate of Incorporation or any certificate of designation filed with respect to a series of Preferred
Stock, the affirmative vote of the holders of at least 66 2/3% of the voting power of all of the then-outstanding shares of capital
stock of the Company entitled to vote generally in the election of directors, voting together as a single class, shall be required
to alter, amend or repeal Articles V, VI, VII and VIII.
C. If any provision or provisions of this Second Amended
and Restated Certificate of Incorporation shall be held to be invalid, illegal or unenforceable as applied to any circumstance
for any reason whatsoever, the validity, legality and enforceability of such provision in any other circumstance and of the remaining
provisions of this Second Amended and Restated Certificate of Incorporation (including, without limitation, each portion of any
paragraph of this Second Amended and Restated Certificate of Incorporation containing any such provision held to be invalid, illegal
or unenforceable that is not itself held to be invalid, illegal or unenforceable) shall not in any way be affected or impaired
thereby.
IX.
To the extent allowed by law, the doctrine of corporate opportunity,
or any other analogous doctrine, shall not apply with respect to the Company or any of its officers or directors, or any of their
respective affiliates, in circumstances where the application of any such doctrine would conflict with any fiduciary duties or
contractual obligations they may have as of the date of this Second Amended and Restated Certificate or in the future, and the
Company renounces any expectancy that any of the directors or officers of the Company will offer any such corporate opportunity
of which he or she may become aware to the Company, except, the doctrine of corporate opportunity shall apply with respect to any
of the directors or officers of the Company with respect to a corporate opportunity that was offered to such person solely in his
or her capacity as a director or officer of the Company and (i) such opportunity is one the Company is legally and contractually
permitted to undertake and would otherwise be reasonable for the Company to pursue and (ii) the director or officer is permitted
to refer that opportunity to the Company without violating any legal obligation.
* * * *
FOUR: This Second Amended and Restated Certificate of
Incorporation has been duly approved by the Board of Directors of the Company.
FIVE: This Second Amended and Restated Certificate of
Incorporation was approved by the holders of the requisite number of shares of the Company. This Second Amended and Restated Certificate
of Incorporation has been duly adopted in accordance with the provisions of Sections 242 and 245 of the DGCL by the stockholders
of the Company.
IN WITNESS WHEREOF, the undersigned has caused this Second
Amended and Restated Certificate of Incorporation to be signed on this [—]
day of [—], 2020.
| |
HENNESSY CAPITAL ACQUISITION CORP. IV |
| |
|
| |
|
| |
Ulrich Kranz |
| |
Chief Executive Officer |
